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RÉSUMÉ  
Malgré des efforts indéniables, l’élaboration de prothèses vasculaires (VGs) de petit diamètre    
(6 mm) pour le remplacement de vaisseaux occlus ou la déviation du flux sanguin (bypass) se 
heurte encore à des résultats mitigés. Parmi les principaux requis d’un greffon vasculaire 
synthétique de petit diamètre (SDVG) et pour l'ingénierie tissulaire de vaisseaux sanguins, citons 
l’hémocompatibilité et la compliance mécanique. En particulier, il est essentiel d’assurer la 
formation d’une monocouche continue de cellules endothéliales (ECs) à l’intérieur de la lumière, 
qui résiste aux contraintes de cisaillement physiologiques. Pour ce faire, une approche classique 
consiste à ensemencer la lumière du greffon avec des ECs, antérieurement à l’intervention. 
Néanmoins, une faible rétention des cellules sous flux sanguin, et la morphologie des textiles 
conventionnels constituent des freins à la formation de la monocouche. Les matériaux électrofilés 
permettent d’améliorer la conformité du greffon, et reproduisent plus fidèlement la morphologie 
de la matrice extracellulaire des vaisseaux sanguins ; ils présentent cependant le même problème 
de rétention et croissance des ECs. Dans cette recherche, il a été démontré qu’un tapis de 
nanofibres de PET électrofilées (ePET), organisées de façon aléatoire, et subséquemment 
recouvert d’une couche mince de polymère-plasma riche en amines primaires (L-PPE:N) permet 
un contrôle relativement fin des propriétés structurelles et de surface, nécessaires la formation de 
monocouches d’ECs confluentes sur VGs. En effet, il a été démontré que ces dépôts L-PPE:N 
augmentent significativement l’adhésion et la croissance d’ECs, même sous contrainte 
d'écoulement induite par cisaillement. La rétention cellulaire se voit aussi améliorée, mais n’est 
cependant pas encore idéale. En outre, les couches L-PPE:N sont également thrombogènes. Pour 
pallier à cela, il a été proposé de greffer du sulfate de chondroïtine (CS) sur les couches L-PPE:N; 
le CS est connu pour empêcher l’adhérence de plaquettes ainsi que pour favoriser l’adhésion et 
croissance de cellules endothéliales de la veine ombilicale humaine (HUVECs). Le greffage de 
CS sur L-PPE:N, lui-même déposé sur tapis électrofilés a effectivement montré une forte 
augmentation de la colonisation en HUVEC, et une amélioration de leur rétention (résistance au 
détachement). 
De plus, l’alignement des ECs dans la direction du flux sanguin est connu pour renforcer la 
rétention des cellules dans les artères. L’approche classique pour obtenir artificiellement une 
monocouche de cellules alignées implique un pré-conditionnement long et coûteux de l’implant 
dans un bioréacteur (in vitro), sous flux. Ici, nous avons testé et comparé des tapis de PET 
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obtenus à la fois par électrofilage aléatoire et aligné : nous avons pu observer une légère 
augmentation de la résistance des ECs à la contrainte de cisaillement dans le cas des fibres 
alignées. 
Nous avons également évalué et optimisé le potentiel de ces structures électrofilées pour la media 
des vaisseaux naturels, qui est constituée de cellules musculaires lisses vasculaires (VSMCs) et 
de fibres de collagène alignées circonférentiellement, essentielles à la contraction, à la dilatation 
et au contrôle de la pression sanguine. Nous avons ainsi fabriqué des structures de ePET aligné et 
avons cherché à optimiser leur compliance à l’aide de trois différentes approches d’érosion 
(chimique) par plasma,  dans le but d’approcher au mieux les propriétés mécaniques et 
surfaciques des vaisseaux sanguins naturels : (i) décharges corona dans l’air, à pression 
atmosphérique (HP ); (ii) plasma radio-fréquencé à basse pression (LP) et (iii) plasma micro-
ondes, (ii) et (iii) étant utilisés soit avec de l’oxygène (O2), pur ou mélangé avec Ar, ou encore 
avec CF4. L’approche (iii) a notamment permis une réduction significative du module de Young 
après à peine 5 min. de traitement avec O2, sans endommager les fibres. De plus, les changements 
observés dans la composition de surface et l’amélioration drastique de la mouillabilité/capillarité 
en découlant ont mené à une adhésion et une croissance accrues de cellules musculaires lisses 
(SMCs). 
Finalement, les tapis alignés ont été modifiées avec des couches bioactives, basées sur les dépôts 
L-PPE:N décorés de CS, ce dernier servant de plus de site d’ancrage du facteur de croissance 
épidermique (EGF). Nous avons pu observer que ces couches (CS-EGF) promeuvent fortement 
l’adhésion, la croissance et la survie des VSCMs. Ceci suggère que le dépôt de couches 
bioactives sur tapis électrofilés constitue un excellent moyen de produire des échafaudages pour 
les parties luminale et médiane des SDVGs, offrant un contrôle fin sur les propriétés structurelles, 
mécaniques, surfaciques et biologiques nécessaires à une endothélialisation complète et stable de 
l’implant.  
 
Mot clés : prothèse vasculaire; électrofilage; nanofibres; poly(ethylene terephthalate); 
polymérisation plasma; érosion par plasma; revêtements bioactifs; morphologie; propriétés 
mécaniques; chimie de surface; endothélialisation.   
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ABSTRACT 
There have been considerable efforts in developing prosthetic small-diameter (below 6mm) 
vascular grafts (VGs) as an alternative to autologous grafts to bypass or replace occluded blood 
vessels. Primary requirements for functional synthetic small-diameter vascular grafts (SDVGs) or 
tissue engineered blood vessels are hemocompatibility and favorable compliance. Particularly 
critical is the formation of a continuous, stable monolayer of endothelial cells (ECs) on the lumen 
under physiological shear stress. To that purpose, seeding autologous ECs on the lumen side of 
the graft prior to implantation is commonly done. But its success is limited by low cell retention 
under flow and by the large pore size of conventional textiles that do not favor the formation of a 
continuous monolayer. Electrospinning enables one to enhance graft compliance and to mimic 
the morphology of the extracellular matrix of blood vessels, but EC growth and retention on 
electrospun mats still remain a problem. In this research, it was shown that random electrospun 
PET (ePET) nanofiber mat coated by primary-amine rich plasma polymer coating (L-PPE:N) 
lead to finely controlled structural and surface properties that are required for a confluent EC 
monolayer on VGs. EC adhesion, -growth, and -retention under shear-induced flow stress were 
shown to be increased by L-PPE:N coating. However, cell retention is still not ideal. Moreover, 
this underlying L-PPE:N substrate is thrombogenic. To tackle this problem, chondroitin sulfate 
(CS) was grafted on LP which is known to prevent platelet adhesion while promoting human 
umbilical vein endothelial cell (HUVEC) adhesion and growth. It was observed that grafting CS 
on L-PPE:N coated electrospun mats could significantly enhance HUVEC adhesion, growth and 
their resistance to detachment.  
In addition, EC alignment in the direction of blood flow in the natural arteries is known to 
increase the cell capability to resist detachment under shear stress. This is typically achieved by a 
long and resource-consuming method involving in vitro fluid flow preconditioning in a bioreactor 
prior to implantation. Random and aligned electrospun PET mats were fabricated as scaffolds for 
the luminal layer. It was observed that EC resistance to shear stress was slightly further improved 
when it was directed by tuning electrospun alignment.  
On the other hand, the media layer of native vessels contains vascular smooth muscle cells 
(VSMCs) and circumferentially-aligned collagen fibres, which are essential for contraction, 
dilation and blood pressure control. In this research, aligned ePET mats were fabricated as 
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scaffolds for the media layer, and three different plasma etching techniques were used to bring 
their mechanical and surface properties in line with those of natural blood vessels: (i) 
atmospheric pressure (“HP”) corona discharge in air; (ii) low-pressure radio-frequency plasma 
(“LP”) and (iii) microwave plasma asher, (ii) and (iii) in pure oxygen (O2), or O2 mixture with Ar 
or CF4. (iii) gave substantial reduction in Young's modulus after as little as 5 min. treatment in 
O2, without damage to the fibers. Changes in surface composition and drastic improvement in 
wettability/wicking were also observed, which resulted in promoting adhesion and growth of 
smooth muscle cells (SMCs). The aligned mats were then grafted with bioactive coatings, based 
on L-PPE:N coating, CS with tethered epidermal growth factor (EGF). It was found that a CS-
EGF coating promoted the VSMC adhesion, growth, survival and infiltration. Our findings 
suggest that electrospun mats coated with bioactive coatings provides adequate scaffolds for the 
luminal and media side of SDVGs, with finely-controlled structural, mechanical and bioactive 
surface properties required for complete and stable endothelialization. 
 
Keywords: electrospinning; nanofibers; poly(ethylene terephthalate); plasma polymerization; 
plasma-etching; bioactive coatings, morphology, mechanical property; surface chemistry; In vitro 
cell experiment; endothelialization; vascular graft  
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CHAPTER 1 INTRODUCTION 
Cardiovascular diseases are the leading cause of death worldwide [1, 2]. Small-diameter blood 
vessels in the body, including fine arteries of the heart and limbs, have a high prevalence of 
occlusion [3]. Bypass grafts from the patients’ own veins or arteries are currently the only 
therapeutic approach when endovascular procedures (angioplasty and stenting) are not feasible or 
successful: A frequent major obstacle in bypass grafts is that many patients cannot provide 
suitable veins or arteries, due to previous surgery or antecedent vascular disease. Consequently, 
to address this vital demand, development of prosthetic VGs has been a rapidly growing area of 
research [3]. 
Current off-the-shelf large diameter prosthetic VGs such as expanded poly(tetrafluoroethylene) 
(ePTFE) or woven poly(ethylene terephthalate (PET Dacron®) have shown poor 
endothelialization and compliance mismatch, which lead to lack of patency when used for small 
diameter vessels (below 6 mm) [4]. To overcome these issues, researchers have introduced 
electrospun nano/micro-fiber scaffolds which possess adequate structural and mechanical 
properties to imitate the extracellular matrix (ECM) of the native blood vessels. These scaffolds 
offer great promise by possessing interconnected open structure with high porosity and surface 
area. Furthermore, mechanical properties of the scaffolds can be optimized to fine-tune those of 
native blood vessels. 
While the structural and mechanical characteristics of the graft is of great importance in its 
performance and success, a critical design requirement for small-diameter VGs is the formation 
of a continuous monolayer of endothelial cells (ECs) on the lumen of the VGs which remains 
stable under physiological shear-flow conditions. To that purpose, seeding autologous ECs on the 
lumen side of the graft prior to implantation is commonly done, but its success is limited by low 
cell retention under flow and by the large pore size of conventional textiles that do not favor the 
formation of a continuous monolayer. Electrospinning enables the mimicking of the nanofibrous 
morphology of the ECM of blood vessels, but EC growth and retention on electrospun mats still 
remain a problem and present particularly severe challenges. To this aim, a suitable strategy is 
needed to provide the requisite strong cell-adhesion. Among the different techniques employed to 
improve cell adhesion and biocompatibility of polymeric scaffolds, several focus on the 
immobilization of bio-molecules that function as anchors for adhesion of cultured cells [5, 6]. A 
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particularly powerful method used to promote bio-molecule immobilization and eventually cell-
adhesion is plasma-polymer deposition. Plasma-polymerization is a versatile approach for 
depositing polymer-like coatings with various selected functional groups (e.g., hydroxyl-, 
carboxyl-, or primary amine groups), which can enable further biomolecule grafting (e.g., ECM 
components, proteins and growth factors) and promote cell adhesion [7-9]. Therefore, this thesis 
aims at increasing compliance and endothelialization of VGs by combining 3D electrospun 
nanofiber matrices and bioactive coatings prepared by plasma-polymerization.  
Chapter 2 provides an overview of the literature addressing the clinical significance of 
cardiovascular disease (intimal hyperplasia (IH) & atherosclerosis) in small-diameter blood 
vessels. A review of coronary artery disease and treatments, including bypass grafting, 
angioplasty, and stenting are then presented. Clinically available synthetic vascular prostheses are 
presented and the limitations of commercial materials SDVGs is discussed. Then, a review of 
electrospinning and the polymer scaffold fabrication technique; including basic concept and 
process parameters optimization specifically for VG development, are reviewed. The 
requirements of engineered SVGDs and the motivation for using electrospun scaffolds are then 
presented. Surface modification techniques including immobilization of bioactive coatings to 
promote cell-adhesion, growth, survival and in-vitro endothelialization are also discussed in 
detail. Based on the literature review, hypotheses are made and specific objectives are defined for 
this thesis that are presented in Chapter 3. The next three chapters present the three papers 
forming the core of the thesis. Chapter 4 of this thesis (Paper 1, published in Macromolecular 
Bioscience [10]) deals with fabrication and characterization of morphological, physico-chemical, 
mechanical and biocompatibility properties of random electrospun nanofiber mats and the benefit 
of a plasma polymer coating. We showed that this combination led to finely controlled structural, 
mechanical, and surface properties that are required for confluent EC monolayer on VGs. EC-
adhesion, -growth, and -retention under shear-induced flow were characterized. 
Chapter 5 (Paper 2, published in Plasma Processes and Polymers [11]) focuses on the 
fabrication of the aligned scaffolds with large pore size for subsequent VSMC-seeding that 
possess optimal mechanical, morphological and surface-chemical properties in the media layer. 
The fabricated ePET nano-fibers are radially highly oriented; in order to bring their mechanical 
properties in line with those of natural blood vessels, a substantial reduction in Young’s modulus 
has to be attained. Therefore, in this research, electrospinning and plasma etching are combined 
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to fulfill those criteria. Three different plasma-etching techniques are investigated: (i) 
atmospheric pressure (“HP”) corona discharge in air, low-pressure (ii) radio-frequency (r.f.) 
discharge, and (iii) discharge in a microwave plasma asher. The best technique without visible 
damage to the fibers, changes in surface composition and improved wettability is chosen for 
further VSMC adhesion and growth experiments.  
Chapter 6 (Paper 3, published in Biomacromolecules [12]) aims to use biomolecules’ 
immobilization to further improve the cell adhesion, growth, survival and retention on the 
electrospun PET scaffolds for the luminal and media layers. As previously shown in our team, 
grafting bioactive coatings including chondroitin sulfate on nitrogen-rich plasma coating prevents 
platelet adhesion while promoting HUVEC adhesion and growth on the flat surfaces [13]. We 
therefore hypothesize that these bioactive coatings on electrospun PET mats can enhance 
HUVEC adhesion, growth, and their resistance to detachment. In addition, EC alignment in the 
direction of blood flow in the natural arteries is known to increase the cells capability to resist 
detachment under shear stress. This is typically achieved by a long and resource consuming 
method involving in vitro fluid flow preconditioning in a bioreactor prior to implantation. But, a 
recent study has shown an improvement in EC retention by tuning the topography (e.g., 
orientation) of electrospun fibers [14]. Therefore, we also investigate EC resistance to shear stress 
by tuning electrospun alignment and immobilization of bioactive coatings. 
In Chapter 7, the general discussion, including the recommendations and limitations are 
presented, followed by the conclusion. 
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CHAPTER 2 LITERATURE REVIEW 
2.1 Clinical Significance of Intimal Hyperplasia & Atherosclerosis 
Cardiovascular diseases (CVDs) are the leading cause of death worldwide [1]. An estimated 85.6 
million American adults (>1 in 3) have more than one type of CVD. Of these, 43.7 million are 
estimated to be ≥60 years of age. Small-diameter vessels (below 6 mm) in the body, including 
fine arteries of the heart and limbs have high prevalence of occlusion. This is caused by intimal 
hyperplasia (IH), which usually precedes atherosclerosis and eventually leads to distal tissue 
ischemia such as infarction in the case of coronary disease [15], as shown in Figure 2.1. There 
can be significant variability in which size of arteries and locations are affected in individual 
patients, although atherosclerosis is often a systemic disease. IH gradually happens by formation 
of the multi-layer of the cells on the elastic membrane of the arterial wall and expressing α-
smooth-muscle actin [16]. The pathology of small-vessels disease (e.g., coronary) comprises a 
number of distinct features such as IH, appearance of foam cells/macrophages and cholesterol 
buildup, platelet aggregation and thrombogenesis, inflammation, etc. These features often overlap 
and enhance each other. IH usually refers to the cellular morphogenesis caused by a cell 
proliferation/differentiation process [17].  
 
 
Figure 2.1 Schematic of atherosclerosis disease 
from: https://stanfordhealthcare.org 
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2.2 Current Therapies and Limitations 
Treatment options for coronary artery disease (CAD) depend on various factors, including 
severity and extent of the disease, type of symptoms such as chest pain and shortness of breath, 
overall heart function, other medical conditions such as diabetes, peripheral artery disease, and 
prior stroke or heart attack. Drug therapy has been used for decades to combat IH and 
atherosclerosis. Overall, it has not been satisfactory. Therefore, several approaches have been 
proposed to treat CAD, including angioplasty, stenting and bypass grafting.  
 
2.2.1 Balloon Angioplasty  
Angioplasty-also known as percutaneous coronary intervention (PCI)- is a minimally invasive 
procedure with a low risk of complication. Angioplasty may especially be recommended if the 
chest discomforts (angina) due to reduced blood flow have not responded to medication and 
lifestyle changes. During the procedure shown in Figure 2.2, a catheter containing a small 
balloon on its tip is inserted at the site of the blockage and is expanded to widen the narrowed 
artery by compressing or flattening the atherosclerotic plaque.  
 
2.2.2 Stenting  
Most of the time, to keep the artery open and reduce the risk of renewed narrowing, a small metal 
coil (stent) is implanted in the clogged artery, as illustrated in Figure 2.2. Stenting, like 
angioplasty, is a minimally invasive procedure. Even with stenting, it is still possible for the 
coronary artery to narrow again. With bare-metal stents, such restenosis occurs in as many as 
15% to 30% of patients depending on the type of stent. This percentage is much lower in patients 
who receive drug-eluting stents [18]. If restenosis occurs, patients may require another balloon 
angioplasty, stent procedure, or bypass surgery. Although stents have proven to be a safe and 
effective treatment, their use may, on rare occasions, result in what is known as stent thrombosis 
which may cause a heart attack. 
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Figure 2.2 Schematic of balloon angioplasty and stenting 
from: http://www.keyword-suggestions.com 
 
2.2.3 Coronary Artery Bypass Graft (CABG) 
Bypass grafts from the patients’ own veins or arteries constitute another therapeutic approach if 
interventional procedures (balloon angioplasty and stenting, used in cases of less than 70% 
occlusion  [19]) are not feasible or successful.  In CABG (Figure 2.3), which is performed in 
cases with a greater degree of occlusion, autologous veins or arteries from the patient are grafted 
to bypass partially or completely occluded coronary artery, thereby improving myocardial 
oxygenated blood supply and preventing infarction.  
Different autologous vessels may be employed to establish cardiac revascularization. The use of 
arterial grafts for replacing the left anterior descending (LAD, a coronary artery) was established 
before [20], the left internal mammary artery (LIMA) being the vessel of first choice for this 
procedure. IMAs are usually patent for many years postoperatively (10-year patency >90%) [21, 
22] because of the fact that <4% of IMAs develop atherosclerosis, and only 1% have 
atherosclerotic stenoses of hemodynamic significance [23]. 
Reversed saphenous vein grafts (SVGs) are commonly used in patients undergoing CABG. Their 
disadvantage is a declining patency with time: 10% to 25% of them occlude within 1 year of 
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CABG [24]; an additional 1% to 2% occlude each year during the 1 to 5 years after surgery; and 
4% to 5% occlude each year between 6 and 10 years postoperatively. Therefore, 10 years after 
CABG, 50% to 60% of SVGs are patent, only half of which have no angiographic evidence of 
atherosclerosis [25]. 
In general, autologous graft shows great promise in CABG procedure since it has the natural 
architecture. It is also a living, non-thrombogenic endothelium, is biocompatible, and has 
encouraging surgical handling characteristics. SVs have shown structural and functional changes 
leading to thrombosis, calcification and premature occlusion of the graft, while an autologous 
artery is more robust and longer-lasting.  
A recent trial comparing CABG and PCI, reviewed the records of nearly 190,000 patients 65 
years or older with multi-vessels disease. 86,244 underwent CABG and 103,549 underwent 
PCI. The median follow-up period was 2.67 years. At 1 year, there was no significant difference 
in mortality between the groups (6.24% CABG versus 6.55% PCI; risk ratio, 0.95). At 4 years, 
there was lower mortality with CABG than with PCI (16.4% versus 20.8%; risk ratio, 0.79) [26]. 
A major obstacle in bypass grafts is that many patients (5-30%) cannot provide veins or arteries 
suitable for grafting, due to previous surgery or antecedent vascular disease. Consequently, 
considering the mentioned limitations for the above VG alternatives and to address this vital 
demand, the development of prosthetic VGs has been a rapidly growing area of research [27]. 
 
Figure 2.3 Schematic of the commonly used saphenous vein and internal mammary artery graft 
for CABG; from: http://biology-forums.com 
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2.3 Clinically Available Synthetic Vascular Prostheses 
There have been growing investigations to find alternate sources to mimic the structural and 
mechanical performance of native blood vessels, due to the high demand for bypass graft 
operations. Prosthetic materials that are currently used clinically are woven or knitted 
poly(ethylene terephthalate) (PET, Dacron®), expanded poly(tetrafluoroethylene) (ePTFE, 
Teflon®)  as VGs for arteries with an inner diameter of more than 6 mm [28]. These materials 
have been validated as successful grafts for large-diameter arteries in which high flow and low 
resistance leads to low rates of thrombosis and excellent rates of long-term patency. However, in 
the long term, several complications may happen for smaller size, depending on the diameter, 
including thrombosis and IH. Therefore, the graft success rate (high patency in the long run) is 
highly dependent on internal diameter, and it falls steadily as the diameter becomes smaller [29].  
The mechanisms involved in the development of IH have been largely established. In humans IH 
develops as early as 6 weeks after grafting and leads to narrowing of the vessel lumen. Generally, 
in the case of large grafts, the occlusion mechanism is well-stablished in the literature. They 
trigger immune responses initiated first by plasma protein, followed by platelet adhesion, and the 
migration of ECs and SMCs [30]. These initially cause static aggregation of lipid and blood 
factors (thrombosis), surrounded by ECM and followed by a continuous excessive SMC in-
growth and plasma protein deposits in the chronic phase, which is covered by a fibrous cap (IH).  
ePTFE exhibits a 5-year patency rate of 91 to 95% when implanted as an aortic graft [31]. 
Similar to Teflon®, Dacron® also shows low patency rate of 56% in young patients with 
premature atherosclerosis over 10 years [32].  
 
2.4 Challenges of Prosthetic Grafts as Small-Diameter VGs 
(SDVGs) 
Small-diameter blood vessels experience low blood flow and high shear compared to medium 
and large diameter ones. This makes the synthetic SDVGs (< 6 mm i.d.) more prone to thrombus 
formation and IH. This phenomenon is more acute in SDVGs for the coronary, renal, and carotid 
arteries: especially after increased contact time of blood components with grafts, and the 
increased activation of blood coagulation, this would result in high rates of thrombosis and low 
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patency in SDVGs [33]. So far, a primary reason for the failure of SDVGs made from synthetic 
materials has been their thrombogenic characteristics, but clinical observation also comes up with 
possible evidence that the patency rates of small grafts are improved by matching the elastic 
properties (compliance) of the graft to that of natural artery. Although there is still controversy 
that ‘elastic mismatch’ per se is the cause of IH, it is generally accepted that mechanical factors 
are important in its genesis. These include disturbed flow at the anastomosis, leading to 
fluctuations in shear stress at the endothelium, injury due to suturing and stress concentration at 
the anastomosis [34]. 
For example, Hehrlein et al. [35] compared the patency of ePTFE (3-5 mm i.d.) and SV grafts 
and concluded that 86% of SV grafts, while only 59% of ePTFE grafts were patent after 1-year 
follow-up. Dacron SDVGs (3-4 mm i.d.) have not shown encouraging performance, as evidenced 
by low medium-term patency rates [35]. 
Researchers have been investigating strategies to minimize thrombosis in small grafts, and to 
ensure appropriate mechanical (compliance) properties similar to those of natural blood vessels. 
While many different approaches can be used to tackle the current issues for SDVGs, two are 
most commonly used: (1) endothelialization; and (2) tuning the mechanical (compliance) 
properties of the grafts [36]. 
 
2.5 Importance of VG Endothelialization 
Figure 2.4 presents the structure of native blood vessels: The inner layer named intima, is 
composed of a monolayer of endothelial cells, ECs. The endothelium is a continuous semi-
permeable, non- thrombogenic protective barrier in the blood vessel wall, which controls blood 
flow and vessel tone, platelet activation, adhesion and aggregation, leukocyte adhesion and SMC 
migration and proliferation [37].  
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Figure 2.4 Structure of native blood vessels [38]. 
 
Unfortunately, it has been shown that VGs do not spontaneously endothelialize in situ/in vivo due 
to low initial EC attachment, spreading and growth.  
The EC monolayer formed on synthetic VGs was observed to be less than 10% of physiological 
levels, compared with EC of native vessels [39]. ECs possess limited capacity for regeneration. 
After about 70 cell cycles, ECs can no divide and therefore, currently available VGs implanted 
into humans manifest limited EC ingrowth, typically not extending beyond 1-2 cm of the 
anastomoses [36]. 
This can also be explained by poor cell-adhesive properties as well as the structure and 
morphology of the grafts.. Therefore, graft patency is very limited for SDVGs below 6 mm, due 
to resulting thrombosis: Adhesion and agglomeration of platelets occur on the impaired 
endothelialized grafts, which is the main reason for thrombosis. Thus, it is necessary to accelerate 
EC attachment and proliferation on the internal surface, especially under blood flow conditions, 
to establish good long-term patency [40]. 
A promising method to improve the anti-thrombogenic properties of VGs is to seed ECs or 
capture endothelial progenitor cells (EPC) so as to form a complete monolayer on the lumen of 
VGs [41, 42]. Seeding of ECs provides an interface between the blood flow and the underlying 
VG, one that improves resistance of VGs to thrombosis and IH. Two approaches can be 
proposed: 1) in vitro pre-seeding prior to implantation; 2) promoting in vivo endothelialization 
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EC monolayer formation by in-vitro cell seeding comprises EC-adhesion to the graft surface, 
which takes place over a period of weeks; preferably within a shorter time, EC-growth or -
proliferation leads to confluent EC layer formation [43]. Several studies showed that in vitro 
endothelialization of grafts prior to implantation decreases thrombogenic complications and 
improves long-term patency [42]. These techniques and their limitations are described in more 
details in the next section. 
 
2.5.1 EC Seeding and Maturation Techniques  
Three main techniques have been employed by researchers for seeding and maturation of the 
grafts: (1) a single-stage procedure, (2) a two-stage procedure, and (3) pre-conditioning in a 
bioreactor.  
In (1), developed by Herring et al. [44], the ECs are harvested and then immediately seeded on 
grafts. In order to assure a successful outcome, the harvested cell density should be high. In 
subsequent randomized clinical trials, EC-seeded ePTFE resulted in increased patency rates of 
arterial bypass grafts up to 9 year follow-up [45]. A major obstacle for single-stage seeding is the 
weak adhesion and possible detachment (70%) of ECs from the lumen when exposed to shear 
force and cyclic strain due to blood circulation a few minutes or hours after exposure to pulsatile 
flow [46].  
In (2), ECs are extracted from the patient’s vein, artery, subcutaneous fat, or blood as progenitor 
cells. They are then cultured for a prolonged period in order to increase the number of cells, 
before seeding on the lumen, where they proliferate until confluency for 2-4 weeks in static 
culture before implantation [47]. In a clinical study, seeding of 4mm precoated Gore-Tex 
coronary with fibrin glue, including 5 ng/mL Human Basic Fibroblast Growth Factor (hbFGF), 
showed a 90% graft patency rate after 52 weeks post-implantation [48]. However, this procedure 
is time-consuming and labor-intensive, has the risk of contamination and infection within the cell 
culture medium, and risk of  inefficient proliferation of the cells with time [40]. These render it 
impractical in emergency situations in clinical settings. Moreover, the EC-adhesion and -
resistance to flow-induced shear are impaired once the bare or unmodified graft is implanted in-
vivo, leading to probable cell-detachment [14]. 
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To promote EC attachment and high retention rate under physiological condition, shear stress 
preconditioning has been used for decades [49]. In this procedure, cells are gradually subjected to 
low shear stress in a bioreactor in order to mature the EC layer. This stategy has shown 
significant impact on EC cell retention after in-vivo implantation [49]. In all cases, however, 
limited cell retention can be at least partly explained by inertness of these biomaterials, which 
justifies the use of bioactive coatings as a possible solution. In addition, the graft morphology has 
a large impact on the formation of a confluent EC monolayer. In that sense, small pores on the 
woven/non-woven structure of  grafts facilitate ECs to form an adherent monolayer on the top 
surface and ensures satisfactory endothelialization.  
 
2.6 Importance of Mechanical (Compliance) Properties 
Most commercial VGs (Dacron® and Teflon®) suffer from unsatisfactory mechanical properties 
including low compliance, and high stiffness or rigidity [27]. To simplify a complicated physical 
phenomenon in a clinical setting, the “compliance” of a tube has been defined to express a 
change of diameter with changing pressure. In general, it has been found that as compliance 
mismatch increases, graft patency decreases [50]. Compliance mismatch prevents a synthetic 
graft from stretching at the surgically-made connection between it and the native blood vessel -  
the so-called “anastomosis region”. This causes the frequency of the pulsatile blood flow to be 
dampened, leading to an increase in the flow velocity, a concomitant increase in wave reflection 
and energy loss. The extent to which the pulse amplitude is dampened depends upon the length of 
the rigid portion [51], its lack of elasticity causing turbulence and shear stress, which in turn 
produce inconsistent blood flow profiles and damage to ECs. On the other hand, reduced shear 
stress can cause flow stagnation in affected areas, increasing the interaction between platelets and 
the vessel wall, and accumulation of chemokine factors. This promotes thrombosis and severe IH, 
hence eventual occlusion of the graft [50].  
To prevent this scenario from occurring, a VG should closely match the compliance of the 
adjacent native blood vessel. Beside matching compliance, VGs should also have sufficient 
tensile stiffness to withstand forces related to vessel contraction and physiological blood pressure 
[52]. Therefore, the fabrication of synthetic VGs with mechanical properties similar to those of 
native blood vessels remains a challenge, and it has become a fast-growing area of research.  
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2.7 The Limitations of Commercial Materials as SDVGs 
To develop “ideal” SDVGs with good patency rates, it is crucial to design a structure that mimics 
the native blood vessel ECM, and that matches its mechanical compliance (see above). Another 
key factor, also described earlier, is thrombo-resistance of the surface, which can be obtained via 
a complete, stable monolayer of ECs.  Woven or knitted Dacron® (PET) fabrics with differing 
degrees of porosity have been tested as SDVGs in some animal studies. Woven grafts are 
typically much less porous than knit ones, but all exhibit higher stiffness than native small blood 
vessels. To improve their bioactivity, different coatings have been investigated, for example 
gelatin, collagen, heparin, fibrin, and growth factors [53, 54]. The outcomes of those studies 
showed no significant reduction in thrombus formation, and impaired in-vivo endothelialization 
even with functional coatings [55, 56]. Expanded PTFE (ePTFE) with pore sizes between ca. 
30µm and 100µm were developed by paste extrusion, followed by solvent evaporation, biaxial 
stretching and high-temperature sintering, but ePTFE is also less compliant than natural arteries 
and veins [50]. Despite its mechanical mismatch, ePTFE has gained some acceptance for 
peripheral vessel bypass, particularly for the femoropopliteal artery. Indeed, there have been 
debates about the superiority of ePTFE over Dacron®, and this controversy still persists. Bio-
functionalization of ePTFE grafts has been attempted in order to improve their patency, for 
example fibrin / growth factor combinations [57, 58], but surprisingly no improvement was found 
in the animal models studied. As such, no solid conclusions could be drawn.  
To overcome compliance mismatch of the above-described conventional materials, a less stiff, 
more elastic material has been sought, for example polyurethane (PU) [59, 60]. Polyester-based 
PU (PEU) grafts such as Estane® were used in an animal study, but with discouraging results due 
to its instability by hydrolysis or to enzymatic attack, or both [61]. Mitrathane®, a polyether PU 
(PEEU) graft is more stable under both acidic and alkaline conditions, but this graft is prone to 
the enzymatic stress cracking after implantation [62]. 
Vascugraft® polycarbonate urethane (PCU), using a spray technique to resolve the instability of 
PEU and PEEU, produces microporous fibers with inter-connected pores. However, this graft 
also showed disappointing clinical results in a 15-patient study caused by early occlusion [63]. 
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Therefore, there still exists an unmet need of a material to mimic the structural and mechanical 
performance of native blood vessels. The 3D network of blood vessels ECM has a fibrous 
structure [64]; woven and knitted Dacron and ePTFE are far from that fibrillar morphology, 
therefore they are inadequate to form an endothelial monolayer (Figure 2.5).   
 
Figure 2.5 Morphological structure of woven (A); knitted (B) PET;  
ePTFE grafts (C) from [65]. 
 
There have been a growing number of studies to design VGs with hierarchical structures having 
more ‘biomimetic’ topography and mechanical interactions of the native ECM. To this aim, 
scaffolds based on different techniques have been considered, generally by electrospinning, self-
assembly, and phase separation [66, 67]. In the following, we shall focus on electrospinning.  
 
2.8 Electrospinning  
2.8.1 Principle 
Electrospinning, a versatile technique for fabricating nano/micro fibers, has great potential for 
developing a microenvironment that mimics natural ECM [68, 69]. It is simpler and more 
efficient than other competing techniques like self-assembly or phase separation, being able to 
A B 
C 
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produce a highly porous (>70% porosity) network of continuous ultrafine fibers ranging from 
nanometer to micrometer diameters. The first patent about electrospinning had already described 
an apparatus for producing polymer filaments that took advantage of electrostatic repulsions 
between surface charges [70]. In the early 1990s, that since-forgotten technology was 
reintroduced to fabricate thin fibers of various organic polymer [71]. By applying an electric 
field, polymer solution or melt is drawn from a spinneret to a collector. A high voltage is required 
to overcome surface tension. A so-called “Taylor cone” is formed, in which the narrow jet is 
accelerated towards the grounded or oppositely-charged collecting target, while the solvent 
evaporates [67]. For producing VGs, a rapidly-rotating cylindrical mandrel can be used as the 
target / collector, to produce a tubular scaffold. At low rotational speed, fibers organize 
randomly, while at high speed the fibers will align near-perpendicularly to the axis of rotation 
[72]. Figure 2.6 shows a schematic of the electrospinning process, and a SEM micrograph of 
electrospun nanofibers. Different fiber morphologies such as beaded-, ribbon-, porous fibers and 
core-shells, can also be fabricated [67]. A broad range of polymers and co-polymers with 
sufficiently high molecular weights can be employed, yielding fiber diameters ranging from 
several nanometers to micrometers. Electrospun nanofiber mats form non-woven, random or 
aligned sheets or arrays [73]. 
 
 
Figure 2.6 a) Schematic diagram of the electrospinning process; 
from http://www.people.vcu.edu/~glbowlin; 
b) SEM images of PET electrospun nanofibers 
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The fibers’ properties depend on many parameters like processing conditions, polymer solution, 
and ambient conditions. Solution characteristics include the molecular weight of the polymer, its 
concentration, its viscosity and surface tension, charge density, conductivity, and dielectric 
constant. Process variables include flow-rate, applied voltage, distance between needle-tip and 
collector, and the collector composition and geometry. Ambient conditions include temperature, 
humidity, and pressure [73]. Good understanding of these variables allows one to reproducibly 
fabricate defect-free nanofibers with controllable morphology. 
2.8.1.1 Effect of Electrospinning Parameters on Structure and Morphology 
As just mentioned, structure and morphology of electrospun fibers are determined by a synergetic 
interaction between those various sets of parameters [74]. For example, viscosity influences fiber 
diameter. It can initiate bead-like shape, and influences jet trajectory [75]. There is an optimal 
viscosity for obtaining continuous fibers, and a higher viscosity produces larger diameters and 
pore sizes [75]. A minimum solution concentration is required to form a bead-free fiber; below a 
critical concentration, a mixture of beads and fibers results [75].  
Solution conductivity, another key player, mainly depends on polymer type and solvent. 
Increased electrical conductivity results in a reduced nano-fiber diameter [76]. Molecular weight 
of the polymer plays an important role in electrical and rheological properties [77], with high 
values producing larger fiber diameters and pore sizes, while lower ones favor bead formation 
rather than smooth fibers [78]. Polymer jet velocity is obviously influenced by flow rate. Tuning 
the latter governs the solvent evaporation time, hence the formation of smooth, uniform fibers 
[79].   
Applied voltage plays an important role in stability of the Taylor cone. For example, increased 
voltage results in higher jet velocity and reduced fiber diameter, which eventually leads to beaded 
fibers [75].  Distance between needle-tip and collector changes fiber diameter and morphology of 
the final mat. A minimum distance is required to allow fibers to properly dry before depositing 
on the collector, but increasing distance reduces the fiber diameter and eventually leads to bead 
formation [75].  
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Ambient conditions also influence fiber diameter and morphology. For example, as temperature 
increases, solution viscosity decreases, resulting in smaller fiber diameters and pore sizes, while 
high humidity forms circular pores on the fibers [80].  
2.8.1.2 Effect of Electrospinning Parameters on Mechanical Properties 
Recent studies have shown strong correlation between mechanical properties of a VG and IH. 
The reader is reminded that compliance, the measure of VG diameter change with pressure, is 
one of the key factors to success or failure [50]. Despite high burst pressures and suture retention 
strengths, compliance values of PET and ePTFE are much below native vessel values [81]. As a 
result, the compliant natural artery will expand and contract to maintain constant wall shear 
stress, whereas a stiff synthetic graft resists those changes in diameter. As also explained earlier, 
this compliance mismatch perturbs blood flow, results in zones of recirculation, flow separation, 
and low wall shear stress at the endothelium [34] that, along with cell-biological factors, 
stimulate IH [29]. Therefore, a VG that closely matches native artery compliance can greatly 
improve long-term clinical success.  
Native blood vessels consist of alternating layers of elastin and collagen, which provide both high 
burst pressure and high compliance (respectively 1680 ± 307 mmHg  and 4.4 ±0.8%/mmHg  10-4 
for the saphenous vein) [50, 82]. Reproducing these in synthetic VGs is very challenging, given 
that they are often inversely related. The hierarchical structure of alternating elastin / collagen in 
arteries provides for a low tensile modulus with high elastic recovery, accompanied by strong 
strain hardening response at higher strains [83]. A synthetic material that can mimic this stress-
strain behavior will obviously better match the required compliance properties and thereby 
reduce danger of IH. For example, electrospun fiber diameter and alignment, both of which can 
readily be “tuned”, are known to influence mechanical properties [84-86].  
Electrospun nanofiber mats exhibit unusual, and unique mechanical properties compared with 
macroscopic film structures [87]. Figure 2.7 shows that the stress-strain curve of an electrospun 
mat does not manifest “necking”, contrary to an injection-molded bulk polymer sample [86, 88].  
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 (c) 
Figure 2.7 Typical stress-strain curve of the electrospun mats (a), the bulk polymer sample (b) 
and ePTFE VGs (c). 
(a): authors’ result on random ePET mat; (b) from (http://www.hardiepolymers.com); (c): from 
[89]. 
 
In electrospun fibers, crystallinity and molecular orientation play important roles in determining 
the physical and mechanical properties of resulting mats [90]. For example, the amorphous 
fraction influences strength and elastic modulus of fibers, while the crystalline phase imparts 
dimensional stability. Therefore, both phases combine to govern the overall mechanical 
properties of fibers [86], while the tensile properties of mats also depend on the properties of 
individual fibers, as well as their mutual interactions and arrangements within the mats. 
Therefore, those properties are not easily explained [87]. For example, deformation of a single 
fiber depends on its diameter: below a critical value, tensile strength is observed to increase 
exponentially, while large fibers show bulk-like properties [86]. This can be explained by gradual 
ordering of the macromolecular chains and increased crystallinity [90].  
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Other key factors which affect mechanical properties are the degree of fiber alignment within the 
mat, their entanglement, and interface properties where there is fiber-fiber contact. Tensile 
properties of random electrospun mats are generally lower than those of aligned ones, due to the 
fact that during tensile testing only fibers oriented along the loading direction are solicited, while 
perpendicularly oriented ones experience little if any force [91]. In the non-linear region of a 
typical stress-strain curve, fibers tend to align in the loading direction until they become highly 
oriented (ultimate tensile strength), eventually breaking at several locations (elongation at break).  
2.8.1.3 Effect of Electrospinning Parameters on Cell Adhesion, Growth and Infiltration 
Morphology and topography can regulate cell-adhesion, spreading, orientation, proliferation and 
infiltration through the phenomenon of contact guidance. The effect of fiber diameter on cellular 
activity has been extensively studied [92-94], but the results are not conclusive due to synergetic 
effects of porosity, pore size and fiber diameter. For example, Chen et al. [95] investigated fiber 
diameter (0.1-1.6 μm) in highly porous (pore size > 50 μm) electrospun polycaprolactone (PCL) 
scaffolds, observing initial surface proliferation and subsequent depth penetration of cells with 
increasing culture time. They concluded that fiber diameter < 1 μm improved cell-proliferation 
due to higher surface area and protein adsorption that promoted cell-adhesion. This was 
confirmed by Whited et al. [14], using random and aligned electrospun PCL/collagen fibers of 
different diameters (100 nm, 300 nm and 1200 nm). HUVEC-adhesion and growth were seen to 
be greater on sub-µm random and aligned scaffolds (100 nm, 300 nm) compared with the 1200 
nm one.  
Lowery et al. [92] observed that peak pore diameter related linearly with fiber diameter by a 
factor of 3.44 (R2 = 0.97). This demonstrates that randomly aligned electrospun fibers of 1 µm 
diameter create a fabric having a peak pore diameter of 3.44 µm, smaller than the average 
rounded cell diameter of 5–20 µm. Other studies implanted VGs in animal models with fiber 
diameter less than 1 µm and confirmed that these VGs inhibit cellular penetration [96-98].  
 
2.8.1.3.1 Effect of Fiber Orientation 
The effect of topography and orientation on cell morphology and alignment has been 
controversial in the literature. Whited et al. [14] investigated electrospun random, semi-aligned 
and fully-aligned polycaprolactone (PCL)/collagen fibers with different diameters (100 nm, 300 
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nm and 1200 nm). They concluded that the fiber orientation had a significant influence on 
HUVEC orientation at 1200 nm, but no significant influence for smaller diameters. Gaharwar et 
al. [99] observed that anisotropic mats of electrospun fibers promote EC proliferation and led to 
highly organized endothelial constructs. Further, the metabolic activity of HUVECs seeded on 
aligned PGS-PCL scaffolds was higher than on random ones [99]. On the other hand, HUVECs 
seeded on random hexyl methacrylate (HMA)/methyl methacrylate (MMA)/ methacrylic acid 
(MAA) scaffolds with small pore size exhibited a significantly higher growth compared with 
aligned ones [100]. 
 
2.8.1.3.2 Effect of Porosity and Pore size  
The “ideal” VG scaffold should have adequate porosity and pore size to fulfill the requirements 
of each particular layer [101]. For example, small pore size enables adherence and localization of 
ECs on the topmost surface and formation of the confluent monolayer, while large pore size 
allows VSMCs to migrate into the wall [10, 11, 102].  
Research indicates that electrospun fiber mats behave differently from more rigid porous 
materials. For example, in a rat model it was shown that cells could penetrate into electrospun 
PGA mats with fiber diameters as low as 0.22 μm and pores of only 1.5 μm, much smaller than 
the assumed minimum of 10 μm. This was explained by the ability of cells to push aside 
individual fibers [103]. Ju et al. [104] demonstrated that fiber diameters < 1.0 µm inhibited 
infiltration of SMCs. De Valence et al. [96] investigated bilayered PCL mats featuring a less 
porous (fiber diameters 0.83 µm) and a more porous layer (diameters of 2.21 µm); after 
implantation, they noted reduced infiltration when the adventitial layer was less porous, but 
neither case affected the rate of endothelialization [96, 105]. 
Thus, there is an apparent paradox that fibers with < 1 µm diameter and lower porosity inhibit 
cellular infiltration. To address this, methods for producing increased pore size but without 
increasing fiber diameter have been investigated, based on bi-layers, salt leaching, sacrificial 
fibers, air-flow impedance, and cryogenic spinning [106-108].  
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2.8.2 Advantages of Electrospinning for VG 
Electrospinning is a very promising technique for VG since it can be used to create nano/micro-
fibrous scaffolds that mimic the structure and mechanical properties of natural blood vessels 
[109].  
Nano/micro-fibrous constructs can assure mechanical strength, cell-attachment, and reservoirs of 
biomolecules just like natural fibrous components of the ECM. They can also allow seeded cells 
to bridge voids, attach at multiple sites and control cellular functions, such as phenotype, ECM 
deposition, and infiltration into pores [92]. Other desired features for engineered VGs include 
high porosity for infiltration and tissue in-growth, high surface-to-volume ratio, tunable 
mechanical properties, capability of surface modification, and ability to load drugs or genes 
[110].  
A nano/micro-fibrous scaffold is often very strong:  Electrospinning enables one to tune strength 
and elasticity through different fabrication parameters, including fiber alignment, crystallinity, 
porosity, thickness, and others. However, mechanical properties tend to be material-dependent. 
Although numerous studies have attempted to increase compliance of electrospun scaffolds, it is 
still an ongoing challenge to meet the compliance of the natural blood vessels in order to achieve 
optimal therapeutic value [111]. 
Most important for in vivo application, an electrospun VG should possess anti-thrombogenic 
properties, for the reasons explained earlier. Next, it should facilitate infiltration of cells to 
achieve adequate new tissue formation. Analyzing and understanding reported in vivo studies 
enables one to understand benefits and challenges of electrospun VGs, and sheds light on design 
criteria. 
AVflo™ (Nicast) was the first commercially available large-diameter electrospun PU vascular 
access graft for hemodialysis [112]. Nanovessel IV™ (Nanofiber Solutions) is a synthetic nano-
fibrous veterinary blood vessel for enhancing vein and artery formation. Although electrospun 
nanofibers have great potential to replace occluded blood vessels in humans, limited studies have 
been performed on animal models. Furthermore, they do not apply to clinical trials in humans 
since they did not sufficiently address mechanical performance under dynamic conditions, or 
regulatory issues like sterility, stability, and quality control [113].  
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2.9 Surface Modification of Nanofiber Scaffolds to Improve Bio-
functionality  
2.9.1 Rationale 
As described before, the patency rates of VGs depend upon their ability to inhibit thrombosis and 
IH: inadequate endothelialization is presently the most important limitation. In situ andin vitro 
endothelialization show promise to enhance patency rates after implantation. Strategies for 
minimizing thrombosis include thrombo-resistant scaffold materials, anti-coagulant or anti-
platelet drug eluting polymers, chemical modification of the luminal surface, and expediting 
development of a confluent endothelial layer. 
In all cases, understanding cell interactions with scaffolds is key for choosing the best strategy 
towards endothelium formation on VGs. Cells interact via integrin receptors on their membranes 
with their corresponding ligands on ECM such as collagen, fibronectin, vitronectin, laminin, etc. 
[114, 115]. The same mechanism is applicable on biomaterials surfaces in vitro: After initial 
contact with cell culture medium or body fluid, proteins adsorb on the biomaterial surface, 
mediating its interaction with living cells.  
The interaction of adsorbed proteins with adhesion receptors, such as integrin on inflammatory 
cells, plays a crucial role in the recognition of biomaterials [116]. The presence of adsorbed 
proteins (albumin, fibrinogen, fibronectin, vitronectin, γ-globulin, and others) modulates host 
inflammatory cell interactions and adhesion, and they are thus linked to subsequent inflammatory 
and wound-healing responses. Natural polymers generally induce cell-ECM interactions, but they 
do not possess satisfactory mechanical properties. In contrast, most synthetic polymers used as 
biomaterials and scaffolds, despite being mechanically strong and chemically stable, generally 
possess chemically and biologically inert hydrophobic surfaces (low surface energy), leading to 
inadequate cell attachment, -spreading and -proliferation [117]. Thus, surface modification has 
been widely studied [118-120], including physico-chemical methods (surface roughness, -energy, 
and/or chemical composition), or by immobilizing bioactive molecules.   
Thus, surface modification can be categorized into: i) physical patterning / modification [121], 
inducing specific topographical features to physically control cell behavior; ii) chemical 
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treatments, which introduce functional groups that improve cell affinity through enhanced 
wettability; and iii) bio-functionalization with bioactive molecules like ECM proteins [Collagen 
(Types I to XXVIII), fibronectin and gelatin], peptides [Arg–Gly–Asp (RGD)], 
glycoaminoglycans (GAGS),  and growth factors, through physical adsorption or chemical 
immobilization [122-124]. Candidates for these include irradiation by γ-rays [125], electron 
beams [126], lasers [127], ultraviolet photons (UV) [128], and plasma treatment [129], but also 
wet-chemical treatments with NaOH [130], hydrogen peroxide (H2O2) [131], or graft 
polymerization [132]. Wet chemistry is the one most frequently encountered in the literature [6]. 
For example, in the case of PET, OH- hydrolyses the ester groups and breaks the polymer chain, 
forming carboxylic acid and hydroxyl groups at the end of the two new chains. It was shown to 
increase surface roughness of PET fibers, cell adhesion and -proliferation [133]. Another 
technique, to introduce amine functional groups on PET surfaces and to thereby promote cell 
affinity, is aminolysis [134]. However, although wet chemistry is easy, it is also harsh and causes 
undesirable loss of mechanical properties and irregular surface etching. Furthermore, it tends to 
entrain problems of toxicity and environmental impact [117]. In contrast, a particularly powerful 
dry technique is non-thermal plasma treatment, which can produce unique surface properties, 
such as chemical cues and/or roughness without changing favorable bulk properties of the 
substrate; examples of resulting surface-near functionalities are primary amines, carboxylic or 
hydroxyl groups, among others, all known to promote cell adhesion and/or to enable 
immobilization of biomolecules [135]. Due to these advantages, plasma surface modification 
demonstrates great potential and will therefore be reviewed next. 
 
2.9.2 Surface Modification by Plasma  
2.9.2.1 Basic Concepts 
Plasma, the “4th state of matter”, can occur when there exists a source of energy that exceeds the 
ionization potential of gas molecules. The resulting dissociation and ionization of a neutral gas 
leads to an equal number of negative and positive charges: electrically quasi-neutral, plasma is a 
highly reactive multi-component system containing charged particles (electrons, negative and 
positive ions), excited atoms and molecules, reactive atoms and radicals, and UV photons [136]. 
Thermal plasmas, in thermodynamic equilibrium, have gas temperatures of several thousand 
24 
degrees. They are so destructive that they cannot be employed for surface modification of heat-
sensitive materials such as polymers [136]. On the other hand, “cold” (non-equilibrium) plasmas 
have low gas temperature, but high-temperature electrons: temperature of the gas, that of neutrals 
and ions, is approximately room temperature. Therefore, non-destructive, it can be utilized for 
surface modification of heat-sensitive materials like polymers. In this research, we always refer to 
cold plasmas [136]. 
In order to generate plasma, energy for ionization must be continuously supplied by an external 
source, such electrical energy [136]. The most common and convenient source is alternating 
current (AC), which can be applied at low (line) frequency of 60 Hz, audio frequency (for 
example, 20 kHz), radio- (13.56 MHz) or microwave frequency (2.45 GHz).  
 
2.9.2.2 Plasma Processes  
The surface of a polymer in contact with plasma undergoes reactions with highly reactive species 
that include ions, atoms and molecular free radicals. Breakage of covalent bonds at the polymer 
surface and reaction with above-named species changes the polymer’s surface properties while 
the bulk remains unaffected. Several parameters dictate the type of the reactions that take place, 
including the gas (composition, and flow rate), power, time of exposure, among others. Process 
types can include etching, surface functionalization, and deposition of a plasma-generated coating 
[137].  
 
2.9.2.2.1 Surface Functionalization 
In this process, hydrogen atoms or chain fragments on the polymer are removed by the plasma 
and replaced by oxygen- or nitrogen-bearing radicals, leading to the formation of polar 
hydrophilic groups such as hydroxyl, carbonyl, carboxyl, primary amine groups, etc. on the 
surface [138]. Therefore, selection of the reagent gas for example oxygen, air, ammonia, is 
important in determining the type(s) of functional groups [139]. Surface functionalization is 
mostly aimed to increase the surface energy (wettability). However, this property is not 
permanent because such surfaces tend to undergo so-called “hydrophobic recovery” [140]. 
Plasma modification of 3D fibrous structures occurs because the plasma species penetrate readily 
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inside the porous structures, but most characterization techniques only permit access to the 
outside surface [141]. Many studies have investigated cell interactions with plasma-modified 
fibrous structures or fabrics after immobilization of various bioactive molecules including 
proteins such as gelatin, collagen, laminin, fibronectin, etc. [142-147]. For instance, electrospun 
nanofibers composed of biodegradable polymers such as PGA, PLLA, or PLGA were modified 
using oxygen and acrylic acid plasma treatment to promote fibroblast adhesion and proliferation, 
without significant change in mechanical properties [148-150]. Air or argon plasma treatment has 
also been extensively used to incorporate carboxylic acid groups on the electrospun nanofibers, 
leading to enhanced cellular activity [151, 152].  
 
 
2.9.2.2.2 Grafting 
Free radicals on a polymer surface can react with a monomer, to initiate polymerization on the 
surface. This may take place in the plasma chamber by directly introducing the monomer, or by 
post-reaction of the monomer with reactive groups (Figure 2.8) [7].  Unlike plasma modification, 
grafting tends to be permanent. Surface graft polymerization not only can improve hydrophilicity, 
but also can introduce functional groups for subsequent covalent immobilization of biomolecules 
to promote cell adhesion, proliferation, and differentiation [153]. For example, graft 
polymerization of hydrophilic methacrylic acid (MAA) monomer was initiated on hydrophobic 
porous PU scaffolds, resulting in improved endothelialization [154]. In another example, gelatin 
was covalently attached on PMAA-grafted PET nano-fibrous scaffolds using water-soluble 
carbodiimide chemistry, leading to significant increase in EC-adhesion and growth [155]. 
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Figure 2.8 Surface modification techniques of electrospun nanofibers: (A) Plasma treatment or 
wet chemical method; (B) Surface graft polymerization from [156]. 
 
2.9.2.2.3 Etching  
Physical sputtering occurs when energetic ions bombard the topmost layer of a polymer surface 
[157].  To improve the efficiency of physical etching by non-reactive (inert) gases such as argon 
or helium, oxygen and/or fluorine-containing gases such as SF6 and CF4 can be introduced so as 
to add more rapid chemical etching, whereby the polymer bulk again remains unchanged. Unlike 
wet-chemical etching, plasma etching is a controllable and selective dry process [158].   
 
2.9.2.2.4 Plasma-Induced Deposition of Polymer-Like Coatings (Plasma Polymerization) 
In this laboratory, plasma-assisted deposition is done in a capacitively-coupled parallel-plate 
radio-frequency (r.f.) plasma reactor (Figure 2.9), utilizing precursor gases or vapors at low 
pressure (usually <20 Pa) that fragment under electron-bombardment and undergo plasma-
polymerization via free radical reactions. When the process gas consists wholly or in part of an 
organic compound, for example a hydrocarbon, the resulting free radical fragments give rise to a 
“plasma polymerization” process, the plasma polymer film being deposited on any solid substrate 
surface placed within the plasma chamber, including the chamber walls. Even methane, ethane 
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and others which have no unsaturated bonds can form plasma polymers, contrary to conventional 
polymerization. Due to the complex fragmentation and recombination processes, the resulting 
films’ structures are unlike conventional polymers. The structures of plasma polymers can even 
be varied by including “co-monomers”, for example by introducing oxygen, nitrogen, ammonia, 
SO2, or other heteroatom-containing gases into the process gas, thereby introducing functional 
groups such as hydroxyl, carboxyl, carbonyl, amine-, etc. Therefore, plasma polymerization is an 
important method to modify inert surfaces like PTFE, PE, PET or others for biomedical 
applications. It must again be underlined that the substrate’s physical (e.g., mechanical) 
properties are not appreciably influenced by this very thin coating [159]. Numerous articles and 
reviews in the literature have demonstrated the great interest in amine- (–NH2) containing organic 
surfaces for biotechnological applications, either to directly foster cell adhesion or to immobilize 
biomolecules [118, 160]. It is particularly clear that nitrogen-(N)-containing groups are excellent, 
most specifically the primary amine (–NH2) functionality, among others [161, 162].  
 
 
 
Figure 2.9 A schematic diagram of a capacitively coupled plasma reactor [160]. 
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2.9.3 Previous Related Plasma Polymerization Work in This Laboratory   
In  previous collaborations, the teams developed low-pressure plasma-polymerized ethylene 
doped with nitrogen (L-PPE:N / LP) coatings, which were deposited on PET and PTFE surfaces 
to improve EC attachment and resistance to shear flow [163]. The results showed that cell 
adhesion and adhesion rate, spreading, focal adhesion, and resistance to flow-induced shear were 
improved, compared with bare and gelatin-coated PET and PTFE. Therefore, L-PPE:N appears to 
be a promising candidate for improving the endothelialization of VGs [163]. In other similar 
studies of our group, we showed similar performance for VSMCs, fibroblasts and mesenchymal 
stem cells (MSC), namely to adhere and proliferate on L-PPE:N-coated surfaces [164, 165]. 
Moreover, L-PPE:N has several other advantages over plasma-induced grafting pre-treatment, for 
example different nitrogen- ([N]) and primary amine ([–NH2]) concentrations [162, 164]. In 
contrast to coatings made from pre-adsorbed proteins, plasma polymer is firmly adherent on 
substrates. One drawback is slow partial conversion of primary amines to amides, due to 
oxidation by atmospheric oxygen [166]. Finally L-PPE:N can be used to immobilize selected 
biomolecules through reactions with their carboxylic acid groups.  
 
2.9.4 Plasma Polymerized Coating for Electrospun Mats 
Plasma polymerized coating on electrospun nano-fiber mats has been discussed in several recent 
studies, for example plasma-polymerizd allylamine (PPAAm) was used to coat the fiber surfaces 
of electrospun non-woven poly(L-lactide-co-D,L-lactide). In vitro cell experiments using human 
osteoblasts confirmed improved cell spreading on the positively-charged, amino group-
containing PPAAm surfaces already after 1 h of incubation, and the rapid formation of filopodia 
along and between the electrospun polylactide fibers [167].  
In another recently published study, plasma-polymerizd oxygen-functionalized hydrocarbon 
coatings were applied on synthetic fibrous PCL substrates. The authors showed that these 
scaffolds were suitable for in vitro development of muscle tissue, especially for cellular 
alignment and myotube formation [168]. Allylamine was plasma-polymerized on electrospun 
PLGA mats, resulting in highly hydrophilic substrates containing amine groups. To further 
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improve bioactivity, heparan sulfate was immobilized on the plasma-polymer and it was shown 
to support embryonic stem cell culture and differentiation [169].  
 
2.10 Bioactive Coatings for VGs 
In this section, we will summarize the different strategies employed by the researchers in order to 
tackle the issues of IH and thrombosis in SDVGs, and prolong the graft patency.  
First, coatings have been developed to decrease risks of thrombosis in VG using various 
anticoagulants (heparin), antiplatelet factors (glycoprotein inhibitors), and antiproliferating agents 
(rapamycin) [170]. However, it is now generally recognized that the efficacy of this approach is 
limited in time, and that the best non-thrombogenic surface is a complete monolayer of ECs. 
Therefore, bioactive coatings have been created to foster either in vitro or in situ pre-
endothelialization. Since in vitro endothelialization is time-consuming and costly, in situ 
endothelialization has been recently experimented extensively to find highly desirable and fast 
methods [171]. In vivo circulating ECs could potentially be captured onto a functionalized graft 
for in situ endothelialization [172]. Unlike in vitro endothelialization, in situ endothelialization 
includes some advantages such as fast availably upon demand, simpler surgical procedures and 
more stable endothelium formation in vivo. However, the challenge is to develop a coating which 
captures and homes ECs.  
 
2.10.1 Bioactive Coatings for in-vitro or in-situ Endothelialization  
The main challenge in endothelialization is to find a more specific and selective biomolecule to 
capture cells. Once it is selected, the bioactive molecule can be immobilized on the biomaterial’s 
surface via physical adsorption or chemical conjugation [173]. To resist the shear stress of the 
blood flow in vivo, chemical conjugation has shown the greater promise by establishing an 
anchor-like binding mechanism leading to longer stability and controllability of the biomolecules. 
Usually, functional groups including primary amines (-NH2), carboxyl (-COOH), hydroxyl (-OH) 
or thiol (-SH) groups induced on the surface of the biomaterials using the previously described 
methods, can be used as a binding site for the bioactive molecules [54, 173].  
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Biomolecule immobilization demonstrated great promise due to more durability and stability 
resulting in enhanced and continuous cell response [174]. Moreover, in the case of GFs, lower 
quantities of immobilized GFs are required to stimulate cellular function when compared to 
diffusible form where large amounts are required by a sustainable source (either medium renewal 
in vitro or controlled release). Covalent immobilization provides long term availability and strong 
attachment leading to an irreversible and durable binding of functional groups [175].  
Due to the promising anti-platelet adhesion property of GAGs, several groups including our 
team, have explored the use of GAG molecules to modify the surfaces of cardiovascular devices. 
To prevent platelet adhesion, chondroitin sulfate (CS) and hyaluronic acid (HA) are used for the 
luminal surface coating of VGs [176-179]. Because GAG coating provides a low adhesion layer 
mimicking the EC surface, further studies are needed to verify the biological function in vivo. 
GAGs are also key intermediaries of growth factor binding, and they have been shown to 
influence the bio-activities of different GFs through interaction via their glycosaminoglycan 
moieties as well as their core proteins [180, 181]. GAGs immobilization strategies have included 
physisorption, electrostatic deposition, and covalent bonding to surfaces [182, 183]. For example, 
cross-linked collagen surfaces have been used for the covalent immobilization of heparin to 
improve blood compatibility, but the use of highly thrombogenic materials such as collagen for 
VGs may be problematic [4,10]. 
Our team has been working on bioactive coatings combining L-PPE:N / LP coatings, CS and GF 
immobilization (e.g. Epidermal Growth Factor (EGF) and Vascular Endothelial Growth Factor 
(VEGF)) to promote ECs and VSMC adhesion, growth, and survival, as well as vascular repair 
around vascular implants [13, 184-187]. 
CS, a glycosaminoglycan naturally encountered in blood vessels, has demonstrated anti-apoptotic 
properties in rat and human VSMC as well as in fibroblasts [184, 188-190].  
Similar to in vitro endothelialization, non-selective cell adhesive proteins or peptide motifs such 
as collagen [191], fibronectin [192], gelatin [171] and RGD peptides [193] have been used to 
recruit EPCs from blood circulation. However, these bioactive coatings are not selective for ECs 
and other circulating cells, because platelets, leukocytes and SMCs can also be captured and 
homed on the lumen, leading to IH. For example, in a clinical study, gelatin-coated grafts resulted 
in significant inflammation [194], rendering this technique undesirable.  
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Several growth factors and biomolecules have been studied as promising candidates for 
promoting cellular activities of ECs and ECPs. Growth factors (GFs) are naturally occurring 
components that can influence cellular activity in the body in soluble form, or they can be ECM-
incorporated stimulators for the cells. Therefore, there have been many attempts to incorporate 
GFs into scaffolds in order to take advantage of their intrinsic regenerative properties through 
sustained release or surface immobilization on different constructs [195, 196].  
VEGF with very high EC specificity and without mitogenicity for other cell types, is a secreted 
protein ligand that activates transmembrane receptors on ECs. The activation of VEGF receptors 
(VEGFR-1(flt-1) and VEGFR-2(KDR/flk-1)) provokes different cell signaling pathways leading 
to EC survival, proliferation and vascular organization [197]. Covalently immobilized VEGF was 
shown to improve endothelialization by increasing EC adhesion, proliferation and migration in 
vitro [198]. It also has potential to promote EPC differentiation to the endothelial lineage under 
shear-induced flow [199], but burst release of VEGF from a device surface or secreted from 
monocytes may lead to tumor development [200].  
EGF, a 6-kDa mitogenic polypeptide, has been shown to possess anti-apoptotic properties and to 
enhance VSMC growth. Our team has recently developed bioactive coatings for vascular 
implants, ones that combine CS and covalently immobilized EGF, to favor vascular cell growth 
and resistance to apoptosis [184, 189].  
Heparin, an anti-coagulant, has also been widely employed in VG engineering. Its effect in 
promoting EC-adhesion, -proliferation and -growth has been observed in-vitro and in-vivo [201, 
202]. 
Selective cell-capturing biomolecules including antibodies, peptides and aptamers could target 
specific surface molecules of ECs. To take advantage of their capabilities, scaffolds could be 
functionalized with these biomolecules for in-situ endothelialization. 
Cell-specific binding peptides including YIGSR and REDV, more specific to ECs, are 
respectively derived from laminin and fibronectin. Some studies have investigated their potential 
for promoting cellular activity of ECs compared to SMCs, and for preventing platelet adhesion 
[203-206].  
The key factor influencing bioactivity of immobilized biomolecules includes its final 
conformation on biomaterials, whereby the active side of the biomolecule should be easily 
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accessible by the receptors of cells [207, 208]. A spacer can be incorporated onto the short 
peptide motifs to make them more readily accessible. On the other hand, to further enhance 
bioactivity and binding affinity of antibodies, and considering their “Y” configuration, tuning 
their spatial orientation is a critical factor in surface engineering [209]. Several studies have noted 
that oriented antibodies, as opposed to random ones, orienting significantly increased the capture 
efficiency [207]. Generally, random orientation involves primary amine groups, which are 
distributed throughout the antibodies. However, in order to orient them on a biomaterial surface, 
various site-selective techniques using specific moieties on the antibodies have been proposed 
[210, 211].  
Other strategies to maintain GF bioactivity are to employ ECM binding tags that can be 
genetically fused to the GF, or pairs of high affinity peptides with variable stabilities in which 
one is bound to the substrate of interest while the other is fused to a GF by genetic engineering 
[212]. Our team has investigated the bioactivity of random covalent and oriented tethered EGF 
for VSMC survival. The results demonstrated that random covalent EGF immobilization are not 
an optimal strategy to take the full advantage of protein bioactivity due to inappropriate 
conformation and/or epitope inactivation, thus inhibiting optimal communications with cells 
[213]. An innovative oriented immobilization strategy for GFs based on two high-affinity 
peptides including Ecoil and Kcoil with high specificity that bind to each other to form stable 
coiled-coil structures, was developed [214].  Ecoil-tagged EGF (Ecoil-EGF) was produced in 
human embryonic kidney (HEK) 293 cells and its bioactivity was confirmed on human 
epidermoid carcinoma (A-431) and human corneal epithelial (HCE-2) cell lines [215]. Therefore, 
the bioactivity and protein surface density of EGF on the film-like scaffolds are significantly 
promoted by utilizing oriented EGF immobilization strategy, where all immobilized EGF 
molecules are attached via a tag added to a specific EGF region in order to allow immobilization 
without epitope inactivation [185]. 
In a very recent study in our group [186], the synergetic effect of co-immobilized EGF and 
VEGF on the CS-grafted film-like scaffolds on in vitro cellular activity was investigated. CS 
layer has shown to promote cell adhesion but reduces nonspecific adsorption of plasma proteins 
[13]. In in vivo environment, GFs show collective or complementary effects on wound healing or 
angiogenesis. There is an unmet need of research to illuminate the potential synergies existing 
between GF that could be utilized to promote VGs bioactivity. The results showed the feasibility 
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of the controlled combination of EGF and VEGF with pro-survival properties for ECs and 
VSMCs compared to each GF captured alone, demonstrating a collaborative effect of these GFs 
[186]. 
 
Figure 2.10 Schematic illustration of the grafting steps for the oriented EGF immobilization on 
CS and CMD. The grafting of CS or CMD layers on aminated surfaces was followed by the 
chemical grafting of cysteine-tagged Kcoil peptides using EMCH as heterobifunctional linker. 
Remaining EMCH thiol-reactive groups were deactivated using cysteine molecules. Ecoil-tagged 
EGF proteins were captured on the surface via the reversible E/K coiled–coil interaction [185]. 
 
One of the challenges which the bioactive immobilized biomaterials face in the in vivo 
environment is the issue with non-specific protein adsorption. For example, once a biomaterial is 
implanted inside the body, proteins in the blood such as fibrinogen is adsorbed on its surface 
leading to mask the bioactive coatings. There are few studies addressing this issue by utilizing an 
anti-fouling PEG layer, with the longer PEG chain length which showed to reduce fibrinogen 
adsorption [13]. Our team has also investigated utilizing star PEG grafting and CS to create 
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nonfouling and nonthrombogenic surfaces. The outcome of these studies showed that CS is as 
effective as PEG in reducing fibrinogen adsorption (~90% reduction) and nonthrombogenicity. 
Furthermore, CS significantly promoted HUVEC adhesion and growth compared to PEG-grafted 
and bare scaffolds [13, 216]. In another study [217], Anti-CD34 Ab, randomly immobilized onto 
the PEG layer, as expected, resulted in a slight increase in fibrinogen adsorption. However, 
platelet adhesion was somehow similar and EPC adhesion was greater than the control scaffold 
before antibody immobilization.  
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CHAPTER 3 HYPOTHESES & OBJECTIVES 
As seen in the literature review, conventional prosthetic VGs (ePTFE, PET) have proven 
unsatisfactory for small-diameter vessels (below 6 mm) due to poor endothelialization and 
compliance mismatch, which lead to thrombogenesis and consequently the lack of patency. In 
this thesis, we hypothesize that combination of electrospinning and surface modifications can 
provide adequate scaffolds for luminal and media layers of SDVGs. Bioactive coatings are 
particularly interesting since they can be applied to any kind of surface (versatile approach). 
 
The specific hypotheses of this thesis are:  
Hypothesis 1: Electrospinning of PET can create nanofibrous structures that are more compliant 
and favor the formation of an EC monolayer compared to conventional woven PET or ePTFE 
structures; 
Hypothesis 2: Plasma coating can improve the biological properties (EC attachment and growth) 
of electrospun mats; 
Hypothesis 3: Plasma etching techniques can help optimize the compliance of the structure 
without damage to the fibers; 
Hypothesis 4: Bioactive coating made of CS and GFs can further optimize the biofunctionality 
of the structure to promote envisaged cell adhesion, growth, survival and infiltration.   
 
The general objective of this thesis is: 1) to create scaffolds for subsequent cell-seeding in the 
luminal and media layers, by fine tuning properties of 3D electrospun scaffolds by plasma-
assisted coating and/or etching accompanied by bioactive coatings (e.g. CS and/or oriented 
tethered EEGF) for VG applications; and 2) to evaluate these in regards to their morphology, 
physico-chemical, mechanical properties, as well as their ability to favor cell adhesion, growth, 
survival and resistance to shear. 
 
 
36 
The rationale and specific objectives of the three papers are described below:  
Paper 1 
3D nanofibrous mats are excellent candidates as scaffolds that provide mechanical compliance, 
morphology and surface area that mimic those of natural blood vessels. Electrospun PET appears 
to be an excellent candidate for small-diameter grafts in regards to mechanical properties, 
stability, biocompatibility, and low cost, but foremost due to the fact that PET VGs have already 
been FDA-approved and clinically used for a few decades. However, the synthetic polymers are 
generally chemically quite inert; this doesn’t favor endothelialization and could also lead to 
thrombus formation. Plasma-polymerization of thin coating on the inner surface is an interesting 
method to promote biomolecules immobilization via carbodiimide chemistry and eventually to 
enhance directly EC adhesion and growth 
Therefore, we hypothesized that 3D electrospun nanofiber mats combined with nitrogen-rich 
plasma-polymerized coating can provide scaffolds that are morphologically suitable, 
mechanically compliant and biocompatible for optimum EC-adhesion, -growth, and -shear 
resistance properties. 
The specific objectives of the first paper were thus to create 3D electrospun random nano-
fibrous PET scaffolds for the luminal side of VG, to combine them with optimized nitrogen-
rich L-PPE:N (or LP) coatings, and to evaluate these in regards to their composition, 
morphology, mechanical properties, as well as their ability to favor HUVEC adhesion, 
growth, and resistance to flow-induced shear. 
 
Paper 2 
In this paper, we focused on the medial layer of VG.  Aligned electrospun fibrous scaffolds have 
been investigated to mimic circumferentially aligned orientation similar to that in the media layer 
in natural vessels. Yet, it was shown that tensile properties, including Young's modulus, of 
random and aligned ePET mats are higher than those of natural arteries. Therefore, we 
hypothesized that etching techniques can help optimize the mechanical properties of electrospun 
mats in order to provide scaffolds that are morphologically suitable for VSMC infiltration and 
guidance, and mechanically compliant for VG application. 
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The specific objective of the second paper was thus to compare the effect of various low- 
and high (atmospheric-) pressure plasma-etching on mechanical, morphological, chemical, 
and biocompatibility properties of aligned ePET mat scaffolds, specifically destined for the 
media layer of VG. 
 
Paper 3 
In our first objective of this research, we showed that random electrospun nanofiber mats coated 
by primary-amine rich plasma polymer coating (LP) lead to finely controlled structural and 
surface properties that are required for confluent EC monolayer on VGs. EC adhesion, -growth, 
and -retention under shear-induced flow stress were shown to be increased by L-PPE:N coating. 
However, cell retention is still not ideal. Moreover, this underlying L-PPE:N-coated substrate is 
thrombogenic. Our team recently demonstrated that grafting CS on LP plasma coating prevents 
platelet adhesion while promoting HUVEC adhesion and growth.  
We therefore hypothesized that grafting CS on LP coated electrospun mats can enhance HUVEC 
adhesion, growth and their resistance to detachment.  
In addition, EC alignment in the direction of blood flow in the natural arteries is known to 
increase the cell capability to resist detachment under shear stress. This is typically achieved by a 
long and resource-consuming method involving in vitro fluid flow preconditioning in a bioreactor 
prior to implantation. Our second hypothesis was therefore that EC resistance to shear stress may 
be further improved if they can be directed by tuning electrospun alignment.  
Furthermore, bioactive coatings comprising CS-grafted surfaces with EGF in an oriented manner 
have shown by our team to enhance VSMC adhesion, growth and survival on the film-like 
structure.  
Therefore, we hypothesized that bioactive coatings (LP+CS+oriented tethered EGF) with aligned 
mats having larger pore-size for the media layer can favor VSMC adhesion, growth, survival and 
infiltration. 
The objective of this study is thus to immobilize CS on plasma-coated random (R) and aligned 
(A) electrospun nanofiber mats and to evaluate their bioactivity and ability to favour EC 
adhesion, growth and resistance to shear-induced flow. In addition, it is also to investigate 
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simultaneous VSMC survival and infiltration and circumferential alignment under the guidance 
of grafts with circumferentially oriented fibers. The specific objectives of the third paper were 
thus to:  
 
1- investigate electrospun mats with bioactive coatings that improve cell behavior, said 
coatings being based on LP coating and CS, with or without EGF.  
2- investigate the effect of immobilized CS on random or aligned mats with small pores 
on HUVEC adhesion and growth under flow for the lumen side of the VGs.  
3- investigate the effect of a CS-EGF coating on aligned scaffolds with large pores in 
regards to increased VSMC survival and infiltration into the pores.   
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Abstract  
In the quest to reduce risk of thrombosis in vascular grafts, it is essential to provide a surface with 
morphological and mechanical properties close to those of the extracellular matrix beneath the 
luminal endothelium, and to favor the growth of a confluent, stable monolayer of endothelial 
cells.  This is accomplished here by combining electrospun poly(ethylene terephthalate) (PET) 
mats with an amine-rich thin plasma-polymerized coating, designated “L-PPE:N”. Its deposition 
does not modify the open, highly porous mats and leads only to small changes in mechanical 
properties. L-PPE:N  significantly improves the adhesion and growth of human umbilical vein 
endothelial cells (HUVEC)  and their resistance to flow-induced shear stress. These properties 
favor the formation of desired confluent HUVEC monolayers on the topmost surface, unlike 
conventional vascular grafts (ePTFE or woven PET), where cells migrate inside the material.  
This combination is therefore highly advantageous for the pre-endothelialization of the luminal 
side of small-diameter vascular prostheses. 
 
Keywords: electrospinning, plasma polymerization, mechanical property, surface chemistry, 
endothelialization. 
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4.1 Introduction  
Cardiovascular diseases are the leading cause of premature death worldwide, occlusion of blood 
vessels being a major problem [218]. Autologous grafts from patients’ own veins or arteries can 
provide a solution when angioplasty or stenting are not feasible, but not when treatment is 
impeded by previous surgery or antecedent vascular disease. In such circumstances, synthetic 
vascular grafts constitute the only option [219]. Current commercial grafts are made from 
synthetic polymers, expanded poly(tetrafluoroethylene) (ePTFE) or Dacron® [woven 
poly(ethylene terephthalate), PET], but they are used clinically only as large-diameter vessels, > 
6 mm [219] since their patency rate is poor as smaller-diameter vessels. This is mainly due to 
inadequate endothelialization and to mechanical compliance mismatch, which lead to occlusion 
on account of thrombosis and intimal hyperplasia [220]. Therefore, synthetic scaffolds are 
required that simulate the mechanical and 3D nano-fibrous morphological properties of the 
extracellular matrix (ECM) beneath endothelial cells (ECs) [221]. Electrospinning is the ideal 
technique for producing such micro-/nano-fibrous interconnected network scaffolds of high 
porosity and large surface area; hence it is an excellent candidate for producing vascular graft 
scaffolds. Fabrication parameters such as polymer solution and processing conditions can be fine-
tuned for particular applications [111]. 
In recent years, several prototypes of electrospun prosthetic vascular grafts have been reported 
[222, 223] for tissue engineering purposes, including ones comprising biodegradable polymers, 
with variable degradation rates, ranging from weeks to years [224-228]. However, their 
mechanical properties are still not ideal. Moreover, biodegradable scaffolds face some important 
challenges such as the difficulty to predict and match the degradation rate with vascular tissue 
growth, and possible cytotoxic degradation products [229, 230]. In addition, the stability of the 
endothelium may be impaired on a biodegradable scaffold. Therefore, there exists a need for 
permanent scaffolds with appropriate physical and biological properties. Electrospun PET 
appears to be an excellent candidate for small-diameter grafts in regards to mechanical properties, 
stability, biocompatibility and low cost, but foremost due to the fact that PET vascular grafts 
have already been FDA-approved and clinically used for a few decades [231, 232]. Several 
researchers, including some of us [231-235], recently reported studies of electrospun PET mats 
with controllable characteristics such as fiber diameters, -orientations and mechanical properties, 
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achieved by varying process parameters. However, literature data suggest that achieving good 
coverage of ECs on such PET scaffolds may be problematic [219]. The reason is the polymer’s 
surface inertness: EC adhesion, growth and resistance to flow-induced shear stress has proven to 
be limited on PET [232, 236]. This might be overcome by a suitable treatment to increase surface 
roughness, surface energy, or by grafting bioactive molecules. Candidates for these include dry 
processes such as irradiation by γ-rays [237], electron beams [238], lasers [239], ultraviolet 
photons (UV) [240], and plasma treatment [241], but also wet-chemical treatments with NaOH 
[130], hydrogen peroxide (H2O2) [131], or graft polymerization [132]. Wet chemistry is the one 
most frequently encountered in the literature [242-244]; for example, NaOH was shown to 
increase surface roughness, hence cell adhesion and –proliferation [133]. However, wet-chemical 
treatments also tend to entrain problems of toxicity and environmental impact [245].  
A particularly powerful alternative technique, developed among others by members of this team 
[162], is the deposition of a plasma-polymerized (PP) coating containing suitable functional 
groups; examples are primary amines (–NH2), or carboxylic groups, known to promote cell 
adhesion and/or to enable immobilization of biomolecules [7, 162]. Thanks to the high density 
and stability of functional groups they can incorporate, PP coatings are more effective than mere 
plasma-induced grafting of surface-near groups [7]. Oxygen-containing PP coatings on fibrous 
PCL substrates were reported to be suitable for in vitro muscle tissue development, especially for 
cellular alignment and myotube formation [168]. Numerous articles have also demonstrated the 
particular effectiveness of nitrogen-, particularly of amine-containing PP coatings [7, 160, 168]. 
For example, N-rich plasma-polymerized ethylene (L-PPE:N) coatings deposited on PET and 
PTFE films showed that EC adhesion rate, spreading, focal adhesion, and resistance to flow-
induced shear were greatly improved, compared with bare and gelatin-coated PET and PTFE 
[246]. In other words, L-PPE:N appears to be a particularly promising candidate for the 
endothelialization of vascular grafts [246]. 
Therefore, the objective of this study has been to combine optimized nitrogen-rich L-PPE:N 
coatings with electrospun random nano-fibrous PET scaffolds, and to evaluate these in regards to 
their composition, morphology, mechanical properties, as well as  their ability to favor HUVEC 
adhesion, growth and resistance to flow-induced shear.  
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4.2 Experimental Section 
4.2.1 Fabrication of PET Nano-Fibre Scaffolds 
4.2.1.1 Electrospinning 
PET scaffolds (ePET) were fabricated by electrospinning; since the details have been described 
earlier [231], we repeat only the essential aspects here. Briefly, 9 % wt/vol polymer solution was 
prepared by dissolving PET pellets (DuPont selar PT 7086, intrinsic viscosity of 1) in 1:1 mixture 
of analytical grade dichloromethane (CH2Cl2) / trifluoro-acetic acid (TFA) (both from Sigma 
Aldrich), and gently stirring for 24 h. Two (2) ml of polymer solution was electrospun at a rate of 
0.5 ml/h for 4 hrs with the aid of a syringe pump, in an enclosure with controlled ambient 
humidity (RH: 8-25%) and temperature (20-25 °C). The power supply provided a constant 
voltage of 15-17 kV between the tip of the grounded spinneret needle (size 22G) and the rotating 
collector. The latter, a drum rotating at 1.6 m/s (the diameter, 20 cm, and speed differed from 
those in ref. [231]), was placed at a distance of 15 cm from the needle tip. The actual nano-fibre 
mat was collected on an aluminum foil wrapped around the metal drum. Electrospun mats were 
first dried in ambient air for ca. 3 days, then cut into pieces and carefully peeled from the 
aluminum foil for subsequent experiments. The pieces of scaffolds were stored in a desiccator 
until further use. 
 
4.2.1.2 Plasma-Polymerization 
Here, too, we merely present the essentials, because details have been described earlier [160, 
247]. L-PPE:N coatings  were deposited on the surface of nano-fibre mats in a low-pressure (“L”) 
capacitively coupled radio-frequency (r.f., 13.56 MHz) glow discharge plasma reactor, using 
ethylene (C2H4) / ammonia (NH3) gas mixtures (C2H4:  99.5%; NH3: 99.99%; Air Liquide Canada 
Ltd., Montreal, QC). The coatings were deposited at 600 milliTorr (80 Pa) pressure in the 
cylindrical aluminum/steel reactor chamber, flows of the high-purity feed gases being controlled 
using electronic flow meter/controllers (Vacuum General Inc., San Diego, CA), and admitted into 
the chamber via a shower-head gas distributor of 10 cm diameter. The flow rates of C2H4 
“monomer” and of NH3, FC2H4 and FNH3, were kept constant at 20 standard cubic centimeters per 
minute (sccm) and 15 sccm, respectively, resulting in a mixture ratio R = FNH3/ FC2H4 = 0.75. The 
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deposition was performed under mild plasma conditions (power, P = 10 W, negative d.c. bias 
voltage, VB = - 40 V) for a duration of 15 min. These conditions were previously shown to yield a 
thin layer, ~100 nm, of L-PPE:N on a glass microscope slide [247],  with adequate nitrogen and 
amine concentrations, [N] and [NH2], and minimal solubility in cell-culture media [247, 248].  
As will be shown later, commercial woven PET samples (“wPET”, Dacron®, Medtronic 
Vascular, Santa Rosa, CA), both bare and L-PPE:N-coated, were also investigated as control 
materials, mainly in regard to their cell-biological characteristics. 
 
4.2.2 Materials Characterization  
4.2.2.1 Scanning Electron Microscopy (SEM)  
Selected samples were examined by field-emission scanning electron-microscopy (FE-SEM) 
using a JEOL model JSM-7600 TFE instrument (JEOL Ltd., Tokyo, Japan) at a voltage of 0.5 kV 
and a working distance of 4 mm, at different magnifications. Nano-fiber mat surfaces were 
sputter-coated under vacuum with a thin layer of gold in a dedicated coater for 20 seconds, and 
were then mounted on a suitable sample holder using double-sided tape. The diameters of 100 
randomly-selected fibers (at least two experiments with triplicate samples of both pristine and L-
PPE:N-coated mats) were examined by SEM; Dacron® samples were also examined, both coated 
and uncoated. Micrographs were analyzed using image analysis software (NIH Image software).  
 
4.2.2.2 Mercury Intrusion Porosimetry (MIP) 
Porosity and pore size of nano-fiber mats were determined using an AutoPore IV 9500 
instrument (Micromeritics Instrument Corporation, U.S.A.) with a 15-ml penetrometer. The mats 
were cut into 1.5×3 cm2 rectangles and weighed. A sample was then placed into the cup of the 
penetrometer, which was closed by tightening the cap. The penetrometer and sample was 
transferred into the pressure chamber of the porosimeter for measurement to take place. Working 
pressures were in the range 0.015-220 MPa. The determination of porosity is based on the 
relationship between the applied pressure and the pore diameter into which mercury intrudes, 
according to the Washburn equation [249]: 
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                                                                                        (1) 
where PL is the pressure of the liquid, D is the pore diameter, γ is the surface tension of mercury 
(484 mNm-1), and θ is the contact angle, taken to be 140° between mercury and the pore wall at 
ambient temperature [249]. The measured intrusion was corrected for expansion of the 
penetrometer. The experiment was performed on four nominally identical samples of both bare 
and L-PPE:N-coated mats. 
 
4.2.2.3 Mat Thickness  
The mats’ thicknesses were measured using a digital gauge (Film Master, Qualitest, designed for 
film thickness measurements with better than 10 μm resolution). To minimize possible error 
resulting from compression of the mats during measurements, they were sandwiched between 
two rigid PET films.  
 
4.2.2.4 Tensile Testing (Dry and Wet) 
Tensile properties of the mats were evaluated using a uniaxial tensile testing machine (Instron, 
ElectroPuls™ E3000). Samples were prepared by cutting mats into 0.5 cm x 2 cm strips; a given 
sample was then inserted into the Instron’s jaws, the distance between the upper and the lower 
jaw being set at 1.5 cm. The tensile test was performed using a 250 N load cell, at a speed of 10 
mm/min. Young’s modulus, yield strength, yield strain, tensile strength and elongation at break 
were calculated manually using Stress-Strain curves. Samples were tested in the “dry” state (in 
ambient air) or in the “wet” state. In the latter case, to better mimic physiological conditions in 
the body, samples were first immersed in phosphate buffered saline (PBS) solution at 37 °C for 
24 h, then cleared from excess liquid using tissue paper and immediately tested as described 
above. Experiments were repeated three times; at least 12 samples were used in each experiment 
to test reproducibility. 
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4.2.2.5 Surface-Chemical (XPS) Analyses  
X-Ray photoelectron spectroscopy (XPS) analyses were performed in a VG ESCALAB 3MkII 
instrument, using non-monochromatic Mg Kα radiation [160, 247, 248]. The size of the analyzed 
area was about 1 mm2, and the sampling depth was in the 1-5 nm range on account of the fibers’ 
geometries. Spectra were acquired at 0° emission angles (normal to the mat surface), and 
charging was corrected by referencing all peaks to the carbon (C1s) peak at binding energy, BE = 
285.0 eV. The X-ray source was operated at 15 kV, 20 mA. Quantification of data was performed 
using Avantage v4.12 software (Thermo Electron Corporation) by integrating the area under a 
specific peak after a Shirley-type background subtraction, and using sensitivity factors from the 
Wagner table.  
For the case of L-PPE:N-coated mats, the near-surface-concentrations of primary amine groups, 
[NH2], were determined using the highly-selective derivatization reaction of 4-(trifluoromethyl) 
benzaldehyde (TFBA, 98%, Aldrich) vapor with NH2 groups [250]. By this reaction TFBA is 
covalently linked via imine bonds, whereby [NH2] values could readily be deduced from the 
ﬂuorine concentrations, [F], at the surface, determined by XPS, as described in detail in earlier 
work from these laboratories [160, 247, 248]. The reader is referred to those articles for any 
additional information required. Data acquired by XPS survey spectra of both derivatized and 
pristine samples were combined to calculate [N], [NH2], and other quantities of interest. 
 
4.2.2.6 Chemical Aging after Immersion, and Depth Analysis 
Possible changes in [N] and [NH2] of L-PPE:N-coated mats after water immersion were 
measured by XPS, as also reported earlier by Ruiz et al. [247]. After immersion in Milli-Q water 
for 1, 3 and 7 days after deposition of L-PPE:N, XPS measurements were performed on dried 
samples with and without derivatization, to study possible chemical “ageing” effects, mostly 
changes in [NH2]. To assess possible chemical composition gradients across the thickness of a 
mat, a 2-layer sample of similar thickness was prepared by electrospinning 1 ml of PET solution 
for 2 h, followed by overnight drying; then, a second layer was electrospun for 2 h on top of the 
former, after which the composite sample was coated with L-PPE:N from one side. XPS analyses 
were performed on the top, bottom and mid-plane locations of this special composite sample by 
the same procedure as that described above. 
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4.2.3 Biological Testing 
4.2.3.1 Cell Culture and Seeding 
HUVECs (Cell Applications Inc., 200p-05n, lot 2729) were cultured in 1% gelatin-coated flasks, 
in complete medium EGM-2 bullet Kit (Lonza, CC-3162), and used at passage # 3-5.  Samples 
were cut into 1×1 cm2 squares, placed into 24-well polystyrene culture plates, four samples of 
each: bare and L-PPE:N-coated electrospun mats; bare and L-PPE:N-coated woven PET 
(Dacron®, Medtronic Vascular, Santa Rosa, CA) and sterilized in 500 µL of 70% ethanol for 5 
min, followed by a rinse with sterile water. Samples were dried overnight under a laminar hood. 
The next day, cloning glass cylinders (0.8 cm inner diameter; 1 cm height) were placed on the 
samples to prevent their movement after cell seeding, and to prevent cell adhesion outside the 
sample. HUVECs were detached with 0.05% trypsin/EDTA (Invitrogen, 25300-054), counted 
and diluted to obtain a cell suspension of 100,000 cells/ml. 200 µL of this solution (20,000 cells) 
was added to each well. As control, cells were also cultured directly on polystyrene culture plates 
coated with 1% gelatin (hereafter “PCP”). After a 4h adhesion period, cloning cylinders and 
medium were removed, wells were rinsed with PBS to remove non-adherent cells, and 500 µL of 
complete medium was added to each well. The plates were incubated for 1, 7, 14 and 21 days, the 
culture medium being changed every 2 days.  
 
4.2.3.2 Cell Adhesion and Growth  
4.2.3.2.1 AlamarBlue Assay 
Cell adhesion and growth was assessed using AlamarBlue reduction assay (Cedarlane, 30025-
1(BT)), during which cell metabolic activity reduces resazurin dye (blue) to resoruﬁn (pink). At 
days 1, 7, 14 and 21, culture medium was removed and 500 µL of complete medium plus 50 µL 
of AlamarBlue were added to each well and incubated for 4 h at 37 °C, 5% CO2. After 4 h, 150-
µL aliquots were pipetted into 96-well plates (Corning) in triplicate, and the plates were 
examined at excitation/emission wavelengths of 560/590 nm in a fluorescence plate reader 
(BioTek, Synergy 4).  The experiment was repeated three times to assure reproducibility. To 
confirm these data, the density and homogeneity of cells on the mats were directly observed after 
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staining cells by crystal violet solution (0.075% w/v in a 3% v/v acetic acid solution) for 15 min, 
rinsed 3 times with Milli-Q water and air-dried prior to capture by microscopy (not shown here).  
 
4.2.3.2.2 Immunofluorescence Analysis (“Live / Dead” Assay) 
To estimate cell survival and distribution on or inside the various mats, HUVEC grown for 1, 7 
and 21 days were stained by calcein-AM (2 µM) and ethidium homodimer-1 (5.5 µM) 
(Invitrogen) in serum-free medium for 45 min at 37 ºC in the dark, before rinsing with D-PBS. 
The polyanionic dye, calcein, produces intense uniform green fluorescence in living cells 
(excitation/emission, 495 /515 nm). Ethidium homodimer-1 (EthD-1) enters cells with damaged 
membranes and produces a bright red fluorescence upon binding to nucleic acids in dead cells. 
The samples were transferred onto microscope slides and green (live) or red (dead) cells were 
imaged with Olympus FV10-MSASW software under a Laser Confocal Scanning Microscope 
(Olympus multiphoton FV-1000 MER, Olympus, Canada). Both planar and Z-stack images 
(images of planes at various depths within the sample) were taken. 
 
4.2.3.2.3 Scanning Electron Microscopy (SEM) 
To visualize cell morphology on controls and modified scaffolds, some samples with cells grown 
for 7 and 21 days were fixed at room temperature for 1 hr with 3% glutaraldehyde (diluted in 
PBS), before rinsing twice with PBS.  Thereafter, they were dehydrated in successive ethanol 
solutions of different concentrations (30, 50, 70, 95 and twice 100%; 10 min each). Samples were 
air-dried under a hood overnight, then mounted and gold- coated (Coater: Emitech, K550X) for 2 
min for SEM (Hitachi, S-3600N).  
 
4.2.3.3 Cell Resistance to Laminar Shear Stress 
To study the HUVECs’ resistance to shear when on mats, the following procedure was used: 
Samples from the two types of electrospun mats (L-PPE:N coated and uncoated) were cut (10 
mm x 22.5 mm), placed in 6-well polystyrene culture plates, sterilized in 2 ml of ethanol (70%, in 
MilliQ water) for 5 min, and then left to dry under the hood overnight. Next, perforated press-to-
seal silicone isolators (5 mm x 20 mm x 2.5 mm; Cat. S5560, Sigma-Aldrich, Canada) were 
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placed on the mats to constrain cell seeding.  Mats were then seeded with HUVECs (250 μL in 
complete medium, passage # 3-5, 106 cells/mat), which were left to adhere during 48 hrs to 
obtain a confluent monolayer of cells. Following this, the cell-populated mats were subjected to 
laminar flow-induced shear stress for one hour in a parallel-flow chamber (Glycotech, C 31-001, 
Gaithersburg MD, USA). This setup consists of a peristaltic pump to produce laminar flow; a 
coiled heat exchanger to maintain the medium’s temperature; and the actual flow chamber, 
comprising a stack on the gasket (5 mm x 20 mm x 0.25 mm), assembled as specified by the 
manufacturer. The pump was run at 6 mL min-1, to obtain a shear stress of ca. 15 dynes cm-2 
(similar to an actual physiological value [251, 252]) in the flow chamber, and maintained for 1 hr. 
Since cell detachment generally occurs during the first 30-45 min, the 1 hr duration was felt to 
suffice in order to assess the cells’ adhesion strength [246, 253]. The numbers of cells retained on 
the mats after shear stress tests were compared with those on similar surfaces that had not been 
tested, by measuring the cells’ metabolic activity by AlamarBlue assay (Cedarlane, 30025-
1(BT)). The morphology and distribution of the cells was also inspected by SEM (Hitachi, S-
3600N) after sample preparation, as described above.  
 
4.2.4 Statistical Analysis 
All data are expressed as means ± SD. Statistical analysis was carried out using ANOVA with 
Bonferroni-Holm’s post hoc analysis, or by independent t-test when comparing 2 groups only 
(pristine vs L-PPE:N-coated). Values of p lower than 0.05 were considered significant for all 
tests.  
 
4.3 Results and Discussion 
4.3.1 Physical Properties of Pristine and of L-PPE:N-Coated Mat Samples 
4.3.1.1 Scanning Electron Microscopy (SEM) 
Figure 4.1 shows a SEM micrograph of a typical electrospun (“ePET”) mat after L-PPE:N 
deposition, thin enough not to lead to perceptible differences between bare and plasma-coated 
samples (bare and coated Dacron® samples are not shown here). The micrograph clearly 
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illustrates the randomly interconnected web structure of the electrospun PET nano-fibers, which 
display smooth surfaces devoid of “beads” (spherical defects). This confirms favorable 
processing conditions. Nano-fiber diameters could readily be obtained from micrographs like 
Figure 4.1, and values were found to be in the range from 200 to 800 nm, see Figure 4.2. Mean 
values of 551  91 nm and 567  111 nm were found for untreated and plasma-coated mats, 
respectively, with a mean increase of only 16 nm (n = 200, p = 0.2868). This is much less than 
the nominal ~100 nm deposit thickness expected, based on values measured on flat surfaces. 
While the large variability in fiber diameters (see Figure 4.2) may obscure variations due to 
coating, several other factors explain why electrospun mats have thinner coatings than flat 
substrates. First, the high porosity of the mat greatly increases the surface area to be coated and, 
second, fibers deep within the mats are less readily accessible to the plasma’s active precursor 
species.  
 
Figure 4.1 SEM micrograph of  a plasma-coated electrospun PET nano-fiber mat; no distinction 
was possible between pristine (bare) and plasma-coated materials (scale bar: 1 µm). 
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Figure 4.2 Distributions of fiber diameters, as-prepared (ePET); after deposition of L-PPE:N 
(ePET-LPPE:N). 
 
The results of mat thickness measurements show significant variation from the center to the 
edges (50-90 µm). Therefore, samples for later experiments, for example tensile tests, SEM, 
biological tests, and others, were taken exclusively from the central portions. 
 
4.3.1.2 Mercury Intrusion Porosimetry (MIP) 
Mercury intrusion porosimetry results are shown in Figure 4.3 and Table 4.1. Properties such as 
porosity, pore dimension and volume directly influence successful use of a given scaffold. The 
overall porosity of the present mats, 87%, is highly desirable for the intended application, 
vascular grafts, by readily permitting the transport of nutrients, metabolic wastes and gases [46]. 
Moreover, as seen later in this text, the pore size is low enough to avoid EC intrusion into the 
scaffold. As expected, the porosity did not change significantly after plasma coating, also in 
agreement with SEM analysis (Figure 4.1). On the other hand, the total intrusion volume and 
average pore diameter (4V/A) tend to be slightly decreased after plasma-coating (Table 4.1), 
although the number of samples investigated was too small for statistical analysis. 
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Figure 4.3 Pore-size distributions of pristine (bare) and L-PPE:N coated electrospun PET 
nanofiber mats (n=4). 
 
Table 4.1 Porosity and pore properties of electrospun mats, bare and L-PPE:N-coated (n=4). 
Sample 
 
Intrusion 
(ml/g sample) 
Porosity 
(%) 
Average Pore Diameter 
(4V/A) (µm) 
Bare mat 5.3±0.4 87±1 3.2±0.5 
Coated mat 4.7±0.4 86±1 2.5±0.9 
 
4.3.1.3 Mechanical Properties 
The tensile properties of pristine (bare) and plasma-coated mats were measured in the length 
direction of the 0.5 cm x 2 cm sample strips. Knowledge of stress-strain behavior of nano-fiber 
mats facilitates understanding their performance under dynamic stress encountered in use. 
Tensile properties under dry and wet conditions are summarized in Table 4.2, while Figure 4.4 
shows a typical stress-strain plot; bare and L-PPE:N-coated mats led to nearly indistinguishable 
curves. The PET mats were seen to exhibit elastic (linear) behavior up to about 1 MPa, followed 
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by further deformation and rupture at about 250% of elongation. In the presence of the L-PPE:N 
coating, the ultimate tensile stress was found to be slightly increased while maximal strain was 
reduced (p < 0.05). Young’s moduli of the coated mats were also somewhat higher (34 ± 7 vs 20 
± 6 Mpa; p < 0.05), confirming that coated electrospun mats are slightly stiffer, indicative of an 
eventual graft’s overall mildly reduced compliance. This may be due to the fact that L-PPE:N 
tends to “glue” nano-fibers together, thereby impeding their ready displacement under applied 
load. No statistical differences were found between dry and wet mats, both bare and coated.   
The Young’s moduli of ePET mats, bare or L-PPE:N-coated, are still above those of natural 
arteries (see Table 4.2) but they can be advantageous in comparison to ePTFE and woven 
structures of highly oriented PET; furthermore, the characteristics can be adjusted by chemical 
means [130], or by plasma etching (to be published), if required. Tensile strength is similar to 
published values for various arteries and veins, indicating that the burst pressure would also be in 
the same range. Elongation at break was found to be greater than that of arteries in all cases, but 
not believed to be problematic. However, while uni-axial tensile tests allow one to estimate 
elastic properties of the fabricated scaffolds, they do not directly provide their compliance (a 
multi-axial property). Therefore, further tests would be desirable, in particular ones designed to 
assess compliance and fatigue resistance of tubular multilayered grafts; this is the subject of 
future work.   
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Table 4.2 Mechanical properties of bare and L-PPE:N-coated electro-spun PET mats under dry 
and wet conditions (three experiments, at least 12 samples in each experiment). Young’s modulus 
was calculated in the linear portion of the stress-strain curve. Data are presented in comparison 
with values from the literature. 
Sample 
Young's 
Modulus 
(MPa) 
Yield 
Strength 
(MPa) 
Yield 
Strain 
(%) 
Tensile 
Strength 
(MPa) 
Elongation 
at 
Break (%) 
ePET  (dry) 20±6(*) 0.85±0.1(*) 7±2(*) 1.7±0.2(*) 247±88(*) 
ePET- L-PPE:N (dry) 34±7(*) 1.2±0.2(*) 5±1.1(*) 2.1±0.3(*) 164±39(*) 
ePET (wet) 21±8 1.0±0.3 6.2±2.2 1.9±0.5 211±27 
ePET- L-PPE:N (wet) 28±9 1.1±0.3 4±0.7 1.9±0.4 139±23 
Human Saphenous Vein [254] 15 - - 1 - 
Human Femoral Artery [255] 9-12 - - 1-2 63-76 
Human Coronary Artery [89] - - - 1.4–11 55-99 
* Significant difference at the 0.05 level between two mat-types (bare and L-PPE:N-coated) 
 
 
Figure 4.4 Typical tensile test (stress-strain) results for a nano-fibre mat; curves corresponding to 
bare and L-PPE:N-coated samples had very similar characteristics. 
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4.3.1.4 Chemical Properties of Bare and L-PPE:N-Coated Mat Samples 
4.3.1.4.1 Chemical Composition and Its Depth-Dependence  
Using the special L-PPE:N-coated 2-layer mat sample described earlier, XPS measurements were 
carried out on top ([a]: 0 µm), in the middle ([b]: 45 µm) and on bottom ([c]: 90 µm) positions, 
respectively (n = 3). Respective values of [N] in each of those three locations were as follows: 
[a]: 13 %; [b]: 5 %; [c]: 5 %. Although [N] is seen to have decreased with increasing depth, it 
was clearly non-zero in positions [b] and [c], several tens of micrometers below the surface of the 
mat during its exposure to the plasma. This reveals beyond doubt that active species from the 
plasma penetrated through the mat’s porous structure. 
 
4.3.1.4.2 Ageing under Wet Conditions 
Figure 4.5 shows ageing behavior (surface-chemical changes) of L-PPE:N-coated mats following 
immersion in Milli-Q water for 1, 3 and 7 days: We first note an appreciable increase in [O], 
accompanied by a decrease in [N] during the first 3 days, after which changes became smaller; as 
expected, [NH2] also decreased somewhat during immersion. The latter is due to reactivity of 
primary amines with oxygen and humidity; amides, ketones and aldehydes are the likely main 
reaction products, as revealed by earlier research in these laboratories [247, 248]. Despite this 
small decrease, [NH2] remained at a relatively high value (above 4 %) compared to other 
functionalization techniques, for example by plasma modification [256, 257]. This is of key 
importance, because [NH2] plays an essential role in promoting cell-adhesion. 
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Figure 4.5 Ageing of L-PPE:N-coated mats after immersion in Milli-Q water for various 
durations, namely 1, 3, and 7 days (XPS; n=3). 
 
4.3.2 Cell Adhesion, Viability and Proliferation on Bare and L-PPE:N-Coated 
Mat Substrates 
HUVEC response to the electrospun mat scaffolds (ePET), to woven PET (Dacron®, “wPET”), 
and to PCP (as positive control) was investigated by measuring the ability of cells to adhere and 
proliferate on the various materials, both bare and L-PPE:N-coated, see Figure 4.6. Adhesion 
after 24h (day 1) on the bare mat (ePET) was significantly less than on PCP.  ePET-LPPE:N 
significantly increased adhesion (p < 0.05), to the point of being the same as on PCP. In other 
words, plasma-coating of the electrospun mat resulted in a much greater population density of 
adhering cells. This was presumably due the much enhanced surface activity of L-PPE:N 
resulting from its primary amine groups, also evidenced by previously published research from 
these and other laboratories [167, 168, 246, 248].  
HUVEC growth at days 4, 7, 14 and 21 was also found to be significantly (p < 0.05) higher on 
the plasma-coated mat than on the bare one (compare data “ePET” and “ePET-LPPE:N”). In 
actual fact, AlamarBlue reduction induced by cells on a bare mat was observed to even decrease 
between days 1 and 7, but it then rose on days 14 and 21; Ma et al. [155] reported similar 
behavior for human coronary artery endothelial cells on electrospun PET nano-fibrous mats with 
57 
and without gelatin-coating. Here, however, L-PPE:N coating enhanced HUVEC density during 
the entire culture period, days 1 to 21 (see “ePET-LPPE:N”). Adhesion was even higher than on 
the positive control, gelatin-coated PCP. The higher values obtained with PCP at days 14 and 21 
should not be taken into consideration, because in PCP wells cells could migrate during the 
growth period and cover a larger area, ~1.9 cm2, compared with only ~1 cm2 in the case of ePET 
mats. 
  
Figure 4.6 Growth of HUVECs on different bare and L-PPE:N-coated substrate surfaces, after 
different culture times (PCP: tissue-culture polystyrene; ePET: electrospun mats; wPET: woven 
Dacron® fabric; LPPE:N: L-PPE:N-coated) (n= 9 for each) 
* Significant difference between bare and L-PPE:N-coated ePET (p<0.05) 
 
In comparison with ePET, the bare and plasma-coated Dacron® exhibited even higher cell 
numbers at each time point (except day 1) (p < 0.05). This was not unexpected, because this 
material’s large pores enabled cell migration into those, as observed here by confocal and 
scanning electron microscopy. In contrast, the smaller (2.5 - 3.5 µm) pores of electrospun mats 
restrain cells to the topmost surface, an important advantage for forming a confluent monolayer 
of endothelial cells on the lumen side of a graft. Confocal microscopy images are presented in 
Figure 4.7, where the upper portion portrays planar views of cell populations on the different 
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substrates, on days 1, 7 and 21.  On each of the surfaces the numbers of dead cells (red) was very 
small. Both the planar (upper) and the Z-stack (lower portion of Figure 7) images confirmed that 
on Dacron® (wPET), the cells penetrated inside the scaffold, while on ePET, where they 
remained confined at the surface, fluorescence is seen to have remained concentrated on a surface 
layer of ca. 10 µm thickness. This was also confirmed by SEM images, which show a near-
confluent monolayer of endothelial cells on the coated electrospun mat at day 21 (Figure 4.8): 
Figure 4.8(a,b) clearly reveals the flat, spread morphologies of HUVECs after 21 days on the 
pristine [8(a)] and L-PPE:N-coated [8(b)] electrospun PET mats, respectively. Fewer cells are 
observed on the bare mat (ePET) than on its coated counterpart, ePET-LPPE:N, in qualitative 
agreement with earlier-mentioned results by others. [133, 155, 258] Figure 4.8(c,d) shows that 
HUVEC  penetrated inside the voids of bare (wPET) and coated Dacron® (wPET-LPPE:N), as 
already pointed out while discussing Figure 4.7.  
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Figure 4.7 Confocal microscopy images of immunofluorescence-stained HUVECs on the various 
substrates identified at the top; different rows represent days 1, 7 and 21 of culture (scale bar: 200 
µm). The bottom row shows Z-stack images after 21 days. 
 
 
 
Figure 4.8 SEM micrographs of electrospun nanofiber mats with HUVECs after 21 days of 
growth: a) bare mat (ePET);  b) mat after L-PPE:N coating; c) bare woven PET (wPET, 
Dacron®); d) woven PET after L-PPE:N coating (scale bar: 100µm) 
 
a b 
d c 
a 
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Together, these results therefore tend to confirm our hypothesis that electrospun nanofiber 
scaffolds can provide a structure akin to the base-membrane of natural arteries [89, 258, 259]. 
However, while cell adhesion, viability and proliferation allow one to estimate the 
biocompatibility and non-cytotoxicity of the fabricated scaffold, more detailed studies would be 
desirable to evaluate its efficacy as a graft material. 
 
4.3.3 Cell Resistance to Laminar Shear Stress 
HUVEC retention on bare and L-PPE:N-coated ePET mats was investigated using the parallel-
flow chamber with a typical physiological shear stress value of 15 dynes cm-2, for 1 hr. Figure 
4.9 shows AlamarBlue results after 48 hrs of adhesion and growth,  subjected or not to shear. Cell 
retention was found to be promising for L-PPE:N-coated mats, with approximately 70 ± 4%  and 
30 ± 10% of the cells remaining on coated and bare mats, respectively (p < 0.05). Once again, in 
this experiment L-PPE:N coating was also found to have increased the initial adhesion and 48 hrs 
growth of cells under static conditions. However, the difference with bare ePET was less marked, 
probably due to the fact that large numbers of cells were seeded, 106 cells per mat. It has been 
reported [260] that the influence of the substrate on cell adhesion can be reduced when cell 
density is very high, possibly due to cell-cell interactions that may dominate over those with the 
substrate. After exposure to shear, cell densities were significantly greater on ePET-LPPE:N than 
on bare (ePET) samples (p < 0.05), as also confirmed by SEM observation (Figure 4.10). This 
agrees with earlier-published results from these laboratories [184, 246], which showed strong 
adhesion and retention of endothelial cells on L-PPE:N coated flat substrates. 
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Figure 4.9 HUVECs’ resistance to laminar shear stress (15 dynes/cm2, 1h), evaluated by 
AlamarBlue assay (n= 12 for each mat). * Significant difference at the 0.05 level between ePET 
mats under static and shear conditions. + Significant difference at the 0.05 level between bare  
and L-PPE:N-coated ePET mats under shear condition. 
 
 
Figure 4.10 SEM micrographs of bare (a,c) and L-PPE:N-coated (b,d) electrospun nanofiber 
(ePET) mats: a,b) under static conditions; c,d) under shear (scale bar: 100µm) 
b 
c d 
a 
62 
 
4.4 General Discussion and Conclusion 
The primary requirements for a synthetic functional vascular graft (VG) are biocompatibility, 
bioactivity, and favorable mechanical properties [229]. The current generation of VGs is mainly 
limited by inadequate mechanical properties that lead to mismatch and intimal hyperplasia, and 
by lacking spontaneous endothelialization of the lumen surface. Pre-endothelialization of the 
lumen has shown promise as a strategy to improve small-diameter VGs, but it is still handicapped 
by poor adhesion and retention of endothelial cells (ECs) [261, 262].  
In the present study two well-documented techniques, electrospinning and plasma polymerization 
(PP) of an amine-rich coating, were combined to address the issues mentioned above, that is, to 
create an effective scaffold for subsequent EC-seeding. Electrospun 3D PET mats (ePET) with 
random fiber orientation were prepared, PET being chosen because it is stable, cost-effective and 
cytocompatible, with tunable properties and because several PET-based vascular implants have 
already received FDA-approval [263]. Electrospun PET exhibits relatively low stiffness and 
favorable strength that can be of interest for VG applications, its tensile properties being 
comparable to those of natural arteries [130, 133, 231, 264].   
Although further investigation is warranted, present results reveal no deleterious effect of L-
PPE:N coating on the properties of ePET mats, thanks to the mild plasma conditions employed 
(low power, 10 W; pressure, 600 mTorr; and temperature, ~300 K).  
The morphology of our electrospun PET 3D nanofibre network proved suitable for forming a 
near-confluent endothelial cell (EC) monolayer lining, see Figure 8b and 10. Indeed, the 
fabrication conditions yielded high porosity and small pore size (Figure 1) that enable exchange 
of nutrients and gas molecules, while restricting EC growth to the topmost (eventual lumen) 
surface [265]. This is greatly advantageous compared with presently used ePTFE and woven PET 
grafts, where cells penetrate and do not readily form such a complete EC monolayer (see Figure 7 
and 8d).  
Cell adhesion, -growth and -retention under flow-induced shear stress were shown to be limited 
on bare ePET mats, but L-PPE:N coating helped overcome this limitation to a large extent. 
Earlier work in these laboratories had already proven L-PPE:N to be highly effective, 
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reproducible and sufficiently stable over time for cell culture applications [164, 247, 266]. Here, 
the greatly-enhanced cell density on L-PPE:N-coated scaffolds compared with bare samples (see 
Figure 6) confirmed the coating as an excellent pre-treatment for the requisite HUVEC response; 
this was not surprising in view of similar observations we reported for HUVEC, but also for 
vascular smooth muscle cells (VSMCs), fibroblasts and mesenchymal stem cells (MSC) [164, 
165, 189, 246]. It also agrees with other groups’ findings that functionalized PP coatings can 
enhance cell adhesion, growth and proliferation on diverse electrospun substrates [7, 267]. PP 
with appropriate chemical functionalities, primary amine (-NH2) groups in the case of L-PPE:N, 
rapidly attract and bind proteins in bio-fluids or culture media; integrin receptors on cells’ outer 
membrane surfaces, in turn, “recognize” and bind to certain of these proteins. In aqueous solution 
at physiological pH values, the protonated amine group possesses a localised positive charge 
which helps attract the negatively-charged biomolecules (proteins) and cells [268]. Because L-
PPE:N promotes the attachment of many different cell types,  pre-seeding with endothelial cells 
should precede in-vivo implantation. On the other hand, it can also serve to create complete 
tissue-engineered vascular grafts (TEVG). 
There have recently been several reported efforts to create TEVGs based on electrospining, for 
example bilayered scaffolds or hybrid scaffolds made by combining natural and synthetic 
polymer mats. Let us mention bilayered scaffolds of PCL-collagen blend [104], elastin, type I 
collagen and poly (D,L-lactide-co-glycolide) (PLGA) [269], multi-layered type I collagen, 
gelatin, segmented polyurethane and poly(ethylene oxide) [270], and collagen/ 
chitosan/thermoplastic polyurethane nanofibrous scaffolds [271]. Although collagen is known to 
increase cell adhesion, its possible immunogenic effects, rapid degradation, and cost of synthetic 
collagen constitute important challenges [272]. L-PPE:N can be deposited on any type of surface 
and could be used with other electrospun material, resorbable or not. As a logical future step, the 
combination presented here (electrospinning + PP) will be used to add a more porous electrospun 
outer layer, either of PET or of a biodegradable polymer, to favor growth of a thick VSMC layer 
and obtain a complete scaffold for TEVG.  
In conclusion, the combination of electrospinning and primary-amine rich plasma polymer 
coating proposed in this research can provide an adequate scaffold for the luminal side of small-
diameter vascular prostheses; more precisely, it enables finely-controlled structural, mechanical 
and surface properties that are required for confluent, flow-stable pre-endothelialization of VGs 
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or TEVG. These improvements may help overcome the clinical complications encountered when 
using current generations of off-the-shelf VG prostheses. 
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Abstract  
Aligned electrospun poly(ethylene terephthalate) (ePET) nanofiber mats that mimic the media 
layer of arteries have been fabricated. In order to bring their mechanical and surface properties in 
line with those of natural blood vessels, we have used three different plasma etching techniques: 
(i) atmospheric pressure (“HP”) corona discharge in air; low-pressure (ii) radio-frequency 
discharge (“LP”) and (iii) discharge in a microwave plasma asher, the latter two in pure oxygen 
(O2) gas, or O2 mixture with Ar or CF4. Substantial reduction in Young’s modulus has been 
attained after as little as 5 min. treatment in (iii), without visible damage to the fibers. Changes in 
surface composition and drastic improvement in surface wettability / wicking have also been 
observed, which resulted in promoting adhesion and growth of smooth muscle cells (SMCs). 
 
Keywords: Nanofibers, Electrospinning, Plasma-etching, Poly(ethylene terephthalate), 
Mechanical property, Surface chemistry, Vascular graft 
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5.1 Introduction 
The quest for improved functional small-diameter vascular grafts is great and growing. Currently, 
the use of autologous grafts from the patient is considered the gold-standard, especially for small-
diameter blood vessels. However, their availability has in practice been a limiting factor due to 
insufficient or defective donor tissue and danger of patient morbidity associated with harvest 
surgery [27]. Synthetic grafts such as woven poly(ethylene terephthalate) (PET, DacronR) and 
expanded poly(tetrafluoroethylene) (ePTFE) have been widely used to replace large-diameter 
vessels. However, these have shown limited patency when applied to small-diameter (< 6 mm) 
vessels due to the mechanical and compliance mismatch that lead to intimal hyperplasia [27, 
273].  
The native artery wall is composed of three distinct layers: the intima, media, and adventitia 
[274] [275]. Each layer contributes its own biomechanical role, while being subjected to axial, 
circumferential and torsion forces. The extracellular matrix (ECM), comprising a basement 
membrane and a complex, chemically and physically cross-linked network of proteins, 
glycosaminoglycans, collagen and elastin fibers with nanoscale features, plays an important role 
in controlling cell behavior in living systems [274, 275]. It is known that the media layer, which 
contains smooth muscle cells (SMCs), collagen fibrils and elastic lamellae, comprises long, 
parallel and circumferentially aligned fibers. These are essential for arterial contraction and 
dilation and they facilitate the control of blood pressure and tissue homeostasis [276].  
Primary requirements for a functional synthetic vascular graft (VG) are biocompatibility, 
bioactivity and, most important, favorable mechanical properties [27, 229]. The current 
generation of VGs is limited by (i) inadequate (excessive) mechanical stiffness that leads to 
compliance mismatch and intimal hyperplasia; and by (ii) lack of spontaneous endothelialization 
of the lumen surface [277]. Therefore, fine-tuning of the mechanical properties will directly 
affect the performance of an engineered VG after implantation.  
Electrospinning has the potential to produce fiber-based scaffolds similar to the protein fibers of 
the ECM, with diameters that can range from 50-5000 nm, and consisting of a 3D structure with 
high porosity and large surface area; this technique uses polymer solutions or -melts under high 
electric field [278, 279]. An important challenge in attempting to engineer a synthetic vascular 
graft is to achieve optimum morphological, mechanical and biological properties in each layer. 
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Regarding the media layer, the versatility of electrospinning allows one to organize and orient 
fibers so that they can guide the migration and elongation of cells [229]. 
Aligned fibrous mat-scaffolds from selected natural and/or synthetic polymers are under 
investigation to mimic the media layer, by directing SMCs in a circumferentially aligned 
orientation similar to that in natural vessels. In addition, aligned fibers can provide the requisite 
mechanical strength to resist the high pressure encountered in-vivo [279-284]. Electrospun PET 
(ePET) is an excellent candidate, because it is non-toxic, has good mechanical properties, bio-
durability, biocompatibility and low cost; however, most important is the fact that PET vascular 
grafts have already been FDA-approved and clinically used for several decades. Therefore, a 
number of research groups, including the present authors, have elected to use PET as their 
vascular biomaterial [10, 133, 235, 285, 286]. 
We have recently shown that tensile properties, including Young’s modulus, of random ePET 
mats are higher than those of natural arteries, but that they can be better than ePTFE, woven or 
knitted PET in the present context.[10] Moreover, those characteristics can be modified by wet-
chemical [130] or dry (plasma-based) etching, if desired. Wet-chemical treatment (e.g. hydrolysis 
with concentrated NaOH, among others) has so far been the only method proposed in the 
literature for this purpose [130, 287-289], but it generally entrains problems of toxicity, 
environmental impact, and associated costs, among others [290]. Furthermore, macroscopic 
damage can result to fibers in contact with NaOH, when the ester linkage of PET is broken 
(leading to formation of a sodium carbonate salt and ethane1, 2diol) [291, 292]. 
On the contrary, rapid, clean, highly reproducible and environmentally benign plasma etching 
may offer an attractive alternative to fine-tune the mechanical and surface-chemical properties of 
ePET fibers. This can be accomplished by controlling treatment parameters such as gas type and 
flow, power, pressure and treatment time. Cold plasma treatments, both at low- and atmospheric 
pressure are widely used to modify the inert surfaces of polymers so as to enhance their 
wettability, roughness and biocompatibility, for example, and to adapt them for biomaterials 
applications, generally without changing their bulk properties [293-297]. Keller et al. reported a 
comprehensive study of plasma-based and wet-chemical removal of manufacturing residuals 
from PET multifilament fibers, concluding that radio-frequency plasma in He/O2 is the best 
option for various reasons [298]. Verdonck et al. used SEM to investigate the influence of O2 
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plasma etching on the morphological properties and fiber diameter distribution of electrospun 
polyacrylonitrile (PAN) fibers, including etch mechanisms in the reactive-ion etching (RIE) 
mode. They concluded that etching was more rapid in the presence of ion bombardment and for 
smaller-diameter nanofibers [299]. Zandén et al. also used O2 plasma treatments of electrospun 
polyurethane (PU), for durations up to 7 minutes, to investigate changes in surface morphology, 
chemistry and wettability. They observed fiber diameter reduction, increased porosity and 
modified fiber surface texture, accompanied by structural degradation after longer exposure 
times. The initially hydrophobic membranes were observed to become hydrophilic and water-
absorbing, but the authors found that neither pristine nor plasma-modified samples had an effect 
on the shape of red blood cells (RBC), the function of which remained intact [300]. Finally, a 
very recent study by Jeon et al. reported O2 plasma-based creation of sub-micrometer sized 
surface patterns, with the aid of special templates, on mats of electrospun poly(e-caprolactone) 
(PCL) fibers. The authors showed SEM images corresponding to plasma exposures up to 120 
minutes. Stress-strain tests revealed weakening (decrease in Young’s modulus, strength and 
elongation at break), attributed to the fibers’ roughened surfaces. Finally, they described 
enhanced attachment and proliferation of (MG63) osteoblast-like cells, claiming the materials’ 
suitability for tissue engineering applications [301].   
Clearly, some of the above-cited work has utilized O2 plasma to etch or surface-modify various 
electrospun fibrous mats for cell-biological purposes. However, none of the authors have 
specifically mentioned plasma-etching as a potential process to fine-tune the mechanical 
properties of electrospun fiber mats, certainly not in the context of vascular grafts. Therefore, the 
objective of the present study has been to investigate the effects of low- and high (atmospheric-) 
pressure plasma-etching on mechanical, morphological, chemical and biocompatibility properties 
of partially aligned electrospun PET mat scaffolds, specifically destined for VG applications. 
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5.2 Experimental Part 
5.2.1 Fabrication of Aligned Nanoﬁbrous PET Scaffolds 
5.2.1.1 Electrospinning 
Partially aligned nanoﬁbrous PET mats (ePET) were prepared by electrospinning of 12.5 
wt/vol% polymer solution [231]. The polymer solution was prepared by dissolving PET pellets 
(DuPont selar PT 7086, intrinsic viscosity of 1) in a 1:1 mixture of analytical grade 
dichloromethane (CH2Cl2) / trifluoro-acetic acid (TFA) (both from Sigma Aldrich), and gently 
stirring for 24 h. Two (2) ml of polymer solution was electrospun at a rate of 10 ml/h with the aid 
of a syringe pump, in an enclosure with controlled ambient humidity and temperature. The power 
supply provided a constant voltage, 30 kV, between the tip of the grounded spinneret needle (size 
18G) and the rotating collector. The latter, a drum rotating at 1000 RPM, was placed at a distance 
of 13 cm from the needle tip. The actual nano-fibre mat was collected on a non-stick aluminum 
foil wrapped around the metal drum. Electrospun mats were first dried in ambient air for ca. 3 
days, then cut into pieces and carefully peeled from the aluminum foil for subsequent 
experiments. The pieces of scaffolds were stored in a desiccator until further use. Process 
conditions are summarized in Table 5.1. 
 
Table 5.1 Process conditions used to produce the present electrospun aligned PET mats. 
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5.2.1.2 Plasma Etching 
5.2.1.2.1 Low-Pressure  
Nano-fibre mats were etched in a low-pressure (“LP”) capacitively coupled radio-frequency (r.f., 
13.56 MHz) glow discharge plasma reactor[162], using (i) Argon (Ar) / 10% Oxygen (O2) gas 
mixture, or (ii) pure oxygen (O2) (both from Air Liquide Canada Ltd., Montreal, QC). Etch 
treatments were performed at 100 milliTorr (13.3 Pa) pressure in the cylindrical aluminum/steel 
reactor chamber, flows of the feed gases being controlled using electronic flow meter/controllers 
(Vacuum General Inc., San Diego, CA), and admitted into the chamber via a shower-head gas 
distributor of 10 cm diameter. The flow rate of gas was kept constant at 20 standard cubic 
centimeters per minute (sccm) for both cases (i) and (ii) above. The treatment was performed at 
constant power, P = 50 W (corresponding d.c. bias voltage, VB = - 40 V), for different durations, 
namely 3, 6, 12, and 15 minutes, samples being placed on the (10 cm diameter) powered 
electrode. Clearly, the maximum energy of ions impinging on the samples’ surfaces, a key 
parameter in plasma etching, did not exceed some tens of eV, as indicated by the above-cited 
value of VB. In reference 18 we pointed out that at this low pressure, active plasma species can 
penetrate through the entire depth of the highly porous mats. 
 
5.2.1.2.2 Atmospheric Pressure  
The high-(“HP”, atmospheric)-pressure dielectric barrier discharge (DBD) apparatus was 
described and illustrated earlier, and it was operated in atmospheric air in the so-called corona 
mode [302, 303]. Briefly, the system comprised a cylindrical, dielectric-coated stainless steel 
high-voltage (HV) electrode and a grounded, planar Al electrode on which reposed a 300 × 240 
mm2, 2 mm-thick glass plate that served both as substrate and as a second dielectric layer (the 
gap between the two was typically 1 mm). The lower (planar) electrode and glass plate were 
moved back and forth under the HV electrode at precisely controlled speed, depending on the 
desired treatment (etching) time. The roughly 1 cm wide plasma (filamentary corona) zone was 
generated with a commercial power source and transformer (Enercon Industries, model LM2727-
03, 450 kVA maximum output) at a typical frequency of 10 kHz and peak-to-peak voltage of 18 
kV.  
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5.2.1.2.3 Plasma Asher  
A low-pressure microwave plasma ashing system (GIGAbatch 360 M, PVA TePla A.G., 
Germany), designed to remove organic photoresist during the manufacture of integrated circuits, 
was also used here to etch nanofibrous PET mats. The density of microwave plasma, ca. 1011 
cm−3, is much greater than that of its r.f. counterpart, typically 109 cm−3, resulting in a greatly 
increased etch rate [304, 305]. As in earlier work [304, 305] (i) a mixture of O2 / 20% CF4, but 
also (ii) pure O2 were used at 1000 mTorr (133.3 Pa) pressure, and at 200 W of microwave power 
for 1 min and 5 min, respectively. The optimal etching conditions, ones presumably leading to 
highest yields of O and F atoms, were taken from previously published research by this 
laboratory [305]. 
 
5.2.2 Materials Characterization  
5.2.2.1 Scanning Electron Microscopy (SEM)  
Selected samples were examined by field-emission scanning electron-microscopy (FE-SEM) 
using a JEOL model JSM-7600 TFE instrument (JEOL Ltd., Tokyo, Japan) at a voltage of 1 kV 
and a working distance of 13.3 mm, at different magnifications. Nano-fiber mat surfaces were 
sputter-coated under vacuum with a thin layer of gold in a dedicated coater for 50 seconds, and 
were then mounted on a suitable sample holder using double-sided tape. The diameters and 
diameter distributions of 400 randomly-selected fibers (at least two experiments with triplicate 
samples of both pristine and etched mats) were examined by SEM. Micrographs were analyzed 
using image analysis software (NIH Image software).  
 
5.2.2.2 Mat Thickness  
The mats’ thicknesses were measured using a digital gauge (Film Master, Qualitest, designed for 
film thickness measurements with better than 10 μm resolution). To minimize possible error 
resulting from compression of the mats during measurements, they were sandwiched between 
two rigid PET films.  
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5.2.2.3 Quantification of Fiber Alignment  
Fast Fourier Transform (FFT) was used to characterize the alignment of the fibers. Here, we 
merely present the essentials, because details have been described elsewhere [270, 306]. The FFT 
function converts spatial information into an optical data image in a mathematically defined 
frequency domain. The resulting FFT output image reflects the degree of fiber alignment present 
in the selected area. A square region of 512 × 512 pixels on the SEM image was randomly 
selected and processed for FFT using image analysis software (NIH Image software) supported 
by an oval profile plug-in. All FFT data was normalized to a baseline value of 0 and plotted in 
arbitrary units, allowing different data sets to be directly compared. 
 
5.2.2.4 Porosity  
Porosity properties of nanofiber mats were determined using a liquid (ethanol) intrusion method 
[96, 131]. Dry mats were weighed before being immersed in 100% ethanol overnight for 
complete wetting. Mats were then gently wiped to remove excess ethanol and weighed again. 
Porosity is defined as the volume of the ethanol entrapped in the pores divided by the total 
volume of the wet mats (ethanol + mat).  In our previous study,[10] we also measured porosity of 
mats by two other alternative methods, namely gravimetric and mercury intrusion porosimetry. It 
is worth noting that they gave similar results, with no significant difference compared with the 
liquid (ethanol) intrusion method. 
 
5.2.2.5 X-Ray Photoelectron Spectroscopy 
X-Ray photoelectron spectroscopy (XPS) analyses were performed in a VG ESCALAB 3MkII 
instrument, using non-monochromatic Mg Kα radiation. The size of the analyzed area was about 
1 mm2, the sampling depth being in the 1-5 nm range on account of the fibers’ geometries. 
Spectra were acquired at 0° emission angles (normal to the mat surface), and charging was 
corrected by referencing all peaks to the carbon (C1s) peak at binding energy, BE = 285.0 eV. 
The X-ray source was operated at 15 kV, 20 mA. Quantification of data was performed using 
Avantage v4.12 software (Thermo Electron Corporation) by integrating the area under a specific 
peak after a Shirley-type background subtraction, and using sensitivity factors from the Wagner 
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table. Data acquired by XPS survey spectra were combined to calculate [O], [O]/[C], and other 
quantities of interest. 
 
5.2.2.6 Static Contact Angle (SCA) Measurements 
Static contact angle (SCA) of water was measured using a VCA Optima Surface Analysis System 
(AST Products, Billerica, MA) at room temperature (approximately 23°C). The sample was fixed 
on a glass slide, a 2 µL drop of MilliQ water was placed on the sample surface using a micro-
syringe, and SCA was measured using the VCA software provided by the manufacturer. The 
measurement was repeated at five different locations on selected samples; each experiment was 
carried out in triplicate to ensure reproducibility, the values were averaged, and the standard 
deviation was calculated.  
 
5.2.2.7 Wicking Properties  
Since the nanofiber mats possess irregular structure with high porosity, it is difficult to precisely 
measure the wetting properties by contact angle measurements. As an alternative, wicking 
behavior of the mats can provide sufficiently accurate information about the wetting behaviour. 
According to the ISO9073-6 standard test method, wicking can be expressed as the height of 
capillary rise measured for a predetermined time, or the time required for a liquid to reach a 
predetermined height. We measured the time of capillary rise to 2 cm height in a vertically 
suspended specimen strip (2 cm × 1 cm) along the fiber direction, while the lower end was 
dipped into water colored with methylene blue.  
 
5.2.2.8 Tensile Testing  
Tensile properties of the mats were evaluated using a uniaxial tensile testing machine (Instron, 
ElectroPuls™ E3000). Samples were prepared by cutting mats into 0.5 cm x 2 cm strips; a given 
sample was then inserted into the Instron’s jaws, the distance between the upper and the lower 
jaw being set at 1 cm. The tensile test was performed using a 250 N load cell, at a controlled rate 
of 10 mm/min. Young’s modulus, yield strength, yield strain, tensile strength and elongation at 
break were calculated manually using Stress-Strain curves. Samples were tested in the “dry” state 
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(in ambient air). Experiments were repeated three times; at least 12 samples were used in each 
experiment to test reproducibility. 
 
5.2.2.9 Low-cycle Strain-controlled Accelerated Fatigue Testing  
In addition, low-cycle strain-controlled fatigue testing was carried out on the samples which had 
the closest mechanical properties to those of natural arteries (ePET-Asher-O2-5min, see further 
below). Pristine and plasma-etched samples were cut into strips (6 mm × 20 mm), and placed 
between the grips of a uniaxial tensile tester (Bose, Electroforce 3200 instrument, 22 N load cell). 
Cyclic uniaxial tensile testing was performed in the elastic domain with a strain-controlled 
loading (initial linear part of the stress–strain curve, see below). Mat-samples were stretched 
using a cross-head speed of 0.17 mm/s to an initial strain of 0.25% (pre-conditioning), and were 
then subjected to 1,000,000 continuous sinusoidal cycles at 10 Hz, in strain ranges of ±1%, 
whereby the maximum strain, εmax, did not exceed the yield strain.  
 
5.2.2.10 Intrinsic Viscosity and Molecular Weight 
Solution viscosity measurements were performed with pristine and plasma-etched ePET samples, 
to determine their intrinsic viscosity and molecular weight [307, 308]. In accordance with 
ASTM-D 4603, a Cannon-Ubbelohde viscometer was used for this purpose: A solvent mixture of 
phenol / 1,1,2,2-tetrachloroethane (60/40 w/w) was employed to dissolve 0.125 g of the PET 
samples in 25 mL of solvent at 110 °C for 1 hr. Once the samples were completely dissolved, the 
solutions were first filtered, then tested at 30 °C in a water bath, as follows: From the flow times 
of the pure solvent mixture (t0) and the polymer solutions (t, at least three measurements), 
inherent and intrinsic viscosities were determined from the following equations: 
                              (1), 
where:  
: inherent viscosity at 30°C and at polymer concentration of 0.5 g/dL 
 : relative viscosity = t/t0 
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t: average solution flow time, s 
t0: average solvent flow time, s 
C: polymer solution concentration, g/dL 
The intrinsic viscosity was calculated by using the Billmeyer relationship: 
                (2), 
By means of the Mark-Houwink equation, it is possible to determine the viscosity molecular 
weight, Mv, from the above-calculated intrinsic viscosity: 
                                               (3), 
where the constants “K” and “a” at 30 °C are 2.37 × 10–4 and 0.73, respectively [308]. 
 
5.2.2.11 Differential Scanning Calorimetry (DSC) 
Melting and crystallization behaviors of pristine and plasma-etched samples were carried out in 
pure nitrogen atmosphere using a differential scanning calorimeter (Model Q2000, TA 
Instruments Co., New Castle, DE, USA) equipped with a universal analysis 2000 program 
(Model Q1000, TA Instruments). About 10 mg of polymer was weighed and crimped into an 
aluminum pan; then, a heat-cool-heat programming protocol was used with a rate of 10°C min-1 
over the temperature range from 30°C to 300°C, that was expected to include crystallization, 
melting and glass transitions of all samples. Heat flow and temperature were calibrated using an 
indium metal standard. 
 
5.2.3 Biological Testing 
5.2.3.1 Cell Culture and Seeding 
Vascular smooth muscle cells (VSMCs) from rat embryonic thoracic aorta (a7r5 cell line, ATCC, 
Manassas, VA) cultured in Dulbecco’s Modified Eagle’s Medium/ Nutrient Mixture F-12 Ham’s 
Media (DMEM/F12; Invitrogen, Burlington, ON) supplemented with 10% fetal bovine serum 
(FBS; Medicorp, Montreal, QC) were used between passages 4 to 15.  Samples from pristine and 
plasma-etched electrospun mats (Asher-O2; 5 min; n=6 each) were cut into disks with a punch (D 
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= 1 cm), placed into 48-well polystyrene culture plates, sterilized in 70% ethanol for 5 min, 
followed by a rinse with sterile water. Samples were dried overnight under a laminar hood.  Next 
day, cloning glass cylinders (0.8 cm inner diameter; 1 cm height) were placed on the samples to 
prevent cell adhesion on the outside. VSMCs were detached with 0.05% trypsin/EDTA 
(Invitrogen, 25300-054), counted and diluted to obtain a suspension of 100,000 cells/ml. Next, 
200 µL of this suspension (20,000 cells) was added to each well. As control, cells were also 
cultured directly on polystyrene culture plates (hereafter “PCP”). After a 24h culture period, 
cloning cylinders and medium were removed, and 500 µL of fresh complete medium was added 
to each well. The plates were incubated for 1 and 7 days, the culture medium (DMEM/F12 
supplemented with 1% penicillin–streptomycin (Pen–Strep; Invitrogen) being changed every 2 
days.  
 
5.2.3.2 Cell Adhesion and Growth  
5.2.3.2.1 AlamarBlue Assay 
Cell adhesion and growth was assessed using AlamarBlue reduction assay (Cedarlane, 30025-
1(BT)), during which cell metabolic activity reduces resazurin dye (blue) to resoruﬁn (pink). At 
days 1 and 7, culture medium was removed and 500 µL of complete medium plus 50 µL of 
AlamarBlue were added to each well and incubated for 4 h at 37 °C, 5% CO2. After 4 h, 150-µL 
aliquots were pipetted into 96-well plates (Corning) in triplicate, and the plates were examined at 
excitation/emission wavelengths of 560/590 nm in a fluorescence plate reader (BioTek, Synergy 
4). The experiment was repeated three times to assure reproducibility. To confirm these data, the 
density and homogeneity of cells on the mats were directly observed after staining cells by crystal 
violet solution (0.075% w/v in a 3% v/v acetic acid solution) for 15 min, rinsed 3 times with 
Milli-Q water and air-dried prior to capture by microscopy (not shown here).  
 
5.2.3.2.2 Scanning Electron Microscopy (SEM) 
To visualize cell morphology on controls and plasma-etched scaffolds, some samples with cells 
grown for 7 days were fixed at room temperature for 1 hr with 3% glutaraldehyde (diluted in 
PBS), before rinsing twice with PBS. Thereafter, they were dehydrated in successive ethanol 
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solutions of different concentrations (30, 50, 70, 95 and twice 100%; 10 min each). Samples were 
air-dried under a hood overnight, then gold-coated (Coater: Emitech, K550X) for 2 min for SEM 
observation (Hitachi, S-3600N).  
 
5.2.4 Statistical Analysis 
All data are expressed as mean values ± SD. Statistical analysis was carried out using 
independent t-test when comparing two groups only (for example, pristine versus plasma-etched). 
Values of p lower than 0.05 were considered significant for all tests.  
 
5.3 Results and Discussion 
5.3.1 Physical Properties of Pristine and of Etched Samples 
5.3.1.1 Fiber Alignment and Mat Thickness 
Partially aligned nanoﬁbrous PET mats were prepared by electrospinning, the mandrel being 
rotated at 1000 rpm. The height and shape of the 2D FFT plot derived from an SEM micrograph 
of a pristine mat bear witness to a high degree of fiber alignment (Figure 5.1 A,B): The higher 
and narrower the peak, the more precisely aligned are the fibers along a single direction. The 
frequency plot, Figure 5.1C, shows greatest intensity in the direction of fiber orientation on the 
micrograph, while sharp peaks near 90° and 270° confirm that the vast majority of fibers were 
preferentially oriented in the direction of mandrel rotation, that is, perpendicular to the axis of 
rotation.  
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Figure 5.1 Two-dimensional FFT analysis of scaffold anisotropy; (A) SEM micrograph of 
pristine aligned electrospun nanofiber sample; (B) Image frequency plot; (C) 2D FFT alignment 
plot for the corresponding SEM micrograph. 
 
Mat thickness measurements revealed significant variation from the center to the edges (70-100 
µm). Therefore, samples for later experiments were taken exclusively from the central portions. 
 
5.3.1.2 Measurements of Pore Parameters and Porosity  
Porosity results from pristine and plasma-etched samples (Table 5.2) were obtained by ethanol 
intrusion porosimetry. The high porosity of pristine mats, 78%, is highly desirable for the 
intended media layer of vascular grafts, readily enabling the transport of nutrients, metabolic 
wastes and gases. Moreover, the pore size is large enough to allow SMC penetration into the 
scaffold. As expected, the porosity was seen not to change significantly after plasma etching.  
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Table 5.2 Average fiber diameter and porosity of electrospun mats, pristine and plasma-etched. 
 
 
5.3.1.3 Scanning Electron Microscopy (SEM) 
SEM micrographs of untreated and plasma-etched samples are shown in Figure 5.2; all are seen 
to possess structures with large open spaces. The pristine mats clearly show smooth fibers with 
diameters ranging between 400 and 2000 nm, the average value being 890±350 nm. Average 
fiber diameters for plasma-etched samples are shown in Table 5.2: After O2 and Ar /10% O2 
“LP”-type plasma etching, one notes reduced diameters accompanied by progressively rougher 
surface features for shorter treatment times (up to12 min), while longer-duration (15 min) 
exposure caused degradation of the fiber structure and increased friability of the mats. In the case 
of “HP” (corona) discharge, surface roughening in the form of tiny pits and micro-cracks 
accompanied a reduction in the average fiber diameter after 15 min. exposure (Table 5.2). For 
both “LP” and “HP”-treated samples the density, depths and sizes of pits and micro-cracks 
increased with rising exposure time. In the case of “LP”, vacuum ultraviolet (VUV) radiation (λ < 
200 nm) and ion bombardment may have contributed, in addition to erosion by reactive oxygen 
species. Somewhat surprisingly, the plasma-asher was found not to significantly alter the fibers’ 
morphology, while nevertheless significantly reducing the average fiber diameter (Table 5.2). 
We did not investigate longer treatment durations with the plasma asher, because 1 or 5 min of 
exposure was sufficient to adequately reduce the mechanical properties (see below). 
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The influence of plasma etching on porosity is only minor, but etching clearly leads to fiber 
diameter reduction, changes to fiber texture and to network morphology. It is worth pointing out 
that some similar observations had already been reported in earlier literature, notably preferential 
etching of small-diameter fibers [298], and surface roughening [298-300].  
 
 
Figure 5.2 SEM micrographs of electrospun aligned PET nano-fiber mats; effects of different 
plasma-etch treatment processes: (A) O2 “LP”-type plasma etching; (B) Ar/10% O2 “LP”-type 
plasma etching; (C) “HP” corona discharge; D) Plasma-asher (scale bar: 1 µm). 
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5.3.2 Surface-Chemical (XPS) Analyses 
The surface-chemical compositions of pristine and plasma-treated mats were obtained by XPS 
analyses, Table 5.3 Surface-near C and O concentrations of pristine samples were 70.5 % and 
29.5 %, respectively, but plasma-etched ones displayed higher O/C ratios, as expected. “LP”-type 
O2 plasma etching led to higher O/C than its Ar-10% O2 counterpart, while “HP” corona created 
mostly O-containing groups, but some N- containing ones, as well. Plasma ashing, on the other 
hand, resulted in the highest O/C ratio. This is presumably caused by very high atomic oxygen 
content in the microwave-excited plasma. Plasma-ashing with the O2 / 20% CF4 mixture was 
found to result in low F concentration at the surface. 
 
Table 5.3 Surface-chemical compositions of pristine and plasma-etched electrospun mats. 
 
 
5.3.3 Contact Angle (SCA) Measurements  
The water SCA results are summarized in Table 5.4. It can be clearly seen that plasma etching 
dramatically changes the surface response from hydrophobic to fully hydrophilic (~ 0°). The 
water droplets spread and immediately penetrated into all plasma-etched mats once they were 
placed on the surfaces. This can be due to capillary effects, surface roughness, porosity and high 
surface oxygen content as seen from XPS data (Table 5.3), which can be mainly assigned to 
polar carbonyl and carboxyl groups. 
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5.3.3.1 Wicking Properties 
As explained earlier, SCA measurements alone do not enable one to fully understand the 
hydrophilicity of nanofibrous materials. Therefore, wicking was proposed as a complementary 
method of investigation. Wicking is the spontaneous uptake of a liquid into a porous substrate, 
driven by capillary forces. Table 5.4 presents the wicking time for a 2 cm liquid rise in plasma-
etched ePET mats, compared with the pristine “non-wetting” one, for which no capillary rise was 
observed. This supports SCA measurements, which showed that plasma etching significantly 
increased the wettability of electrospun PET mats. 
 
Table 5.4 Static contact angle and wicking time of pristine and plasma-etched electrospun mats. 
 
 
5.3.4 Tensile Tests  
The tensile properties of pristine and plasma-etched mats were measured in the length direction 
of the 0.5 cm x 2 cm sample strips. The effects of plasma etching by “LP, “HP” and asher at 
different treatment times are depicted in Figure 5.3 and Figure 5.4; the latter also shows selected 
literature data for ePET after NaOH wet-chemical etching [133], and for femoral artery [309], for 
comparison. Young’s modulus, tensile strength and elongation at break were all found to 
decrease significantly with rising treatment time (Figure 5.3). Interestingly, shorter treatment 
times sufficed for the plasma asher to achieve similar reduction in Young’s modulus as with LP 
and HP plasma (Figure 5.4). For this reason, no longer treatment duration was investigated with 
plasma asher. We had noted earlier that LP and HP plasma etching both introduced micro-pit 
surface defects, and that they led to fiber degradation after longer exposure times (see Figure 
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5.2). Thus, observed decreases in tensile properties with rising treatment times are not 
unexpected. Surprisingly, as also noted earlier, micro-pits and -cracks were not observed on 
fibers treated in the plasma asher, even though the PET erosion rate was high [304, 305], 
especially for O2-CF4 etch (Table 5.2). Here too, plasma etching resulted in significant decrease 
in Young’s modulus, tensile strength and elongation at break. These might be due to more intense 
short-wavelength VUV irradiation in the microwave plasma, resulting in more chain scissions. 
This may be particularly significant for the present highly porous nano-fibrous mats, because 
plasma can be sustained inside the pores and VUV can affect a significant fraction of the fibers’ 
volume in spite of its shallow penetration depth (a few tens of nm [141, 295, 310, 311]). To 
further examine possible chain scission effects, intrinsic viscosity and molecular weight 
measurements were carried out; the results are discussed in the following section. 
Young’s modulus was calculated from the linear portion of the stress-strain curve, and data are 
presented in comparison with values from the literature. Young’s moduli and tensile strengths of 
plasma-etched PET mats are comparable to those of natural arteries (see Figure 5.4). On the 
other hand, elongation at break was found to be less than that of arteries in all cases. However, 
even though uni-axial tensile testing allows one to assess elastic properties of the fabricated 
scaffolds, it does not provide a direct measure of compliance (a multi-axial property). Therefore, 
further tests are desirable, particularly ones designed to evaluate compliance and fatigue 
resistance of tubular multilayered graft prototypes; this is the subject of ongoing work. 
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Figure 5.3 Effect of etch duration on mechanical properties of pristine and plasma-etched aligned 
ePET mats (three experiments, at least 12 samples in each experiment). (A) Young's modulus; 
(B) tensile strength; (C) elongation at break. 
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Figure 5.4 Mechanical properties of pristine and plasma-etched aligned ePET mats (three 
experiments, at least 12 samples in each experiment). (A) Young's modulus; (B) tensile strength; 
(C) elongation at break; (D) yield strength. Yield strain did not change significantly for plasma-
etched samples compared with pristine ones. 
 
5.3.4.1 Low-cycle Strain-controlled Accelerated Fatigue Testing  
For further experiments, an asher-etched ePET mat (Asher-O2, 5min) was chosen, because it 
provides similar reduction of Yong Modulus as other etch treatments, but for short treatment 
duration, no significant alteration of the fibers’ morphology and no F content. Stress-strain curves 
(N=1; 1,000,000 cycles) of pristine ePET and of mats etched with the plasma-asher (Asher-O2) 
are depicted in Figure 5.5. The loading / unloading curves did not change with increasing 
numbers of cycles. Therefore, after a large number of 10 Hz cycles the samples’ mechanical 
properties were unchanged, which is of course highly desirable for the application considered in 
this study. In addition, some minor hysteresis (a possible difference between loading and 
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unloading, which represents energy loss in the system) did not significantly change with the 
number of cycles at this frequency, as evidenced by the constant area between loading and 
unloading curves. No signs of sample damage (buckling and deformation) were observed during 
experiments. However, while fatigue testing of planar mats does allow one to assess fatigue 
behavior, more detailed studies on tubular multilayered prototype grafts will be desirable to 
understand their behavior in the real applications. 
 
 
Figure 5.5 Strain-stress diagrams (loading and unloading) for pristine and plasma-etched aligned 
ePET mats, at cycle numbers 1 and 1 000 000. 
 
5.3.4.2 Intrinsic Viscosity and Molecular Weight  
In the preceding section, we postulated that plasma etching might entrain chain scissions, 
leading to lower average chain lengths (reduced molecular weight). This might originate from 
both ion bombardment (LP-type plasma) and VUV irradiation, for example the 130 nm emission 
from atomic oxygen [168, 305] and /or energetic photons from excited argon or fluorine in 
certain LP and plasma-asher treatments. Such effects are greatly enhanced when the samples’ 
surface-to-volume ratio is large, clearly the case for electrospun material. 
Table 5.5 shows significant reductions in intrinsic viscosities and viscosity Mv values for the 
cases of plasma-etched mats after different plasma-etching procedures. These results agree with 
SEM images of the treated mats, where surface degradation was observed for samples etched by 
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LP-plasma in O2 and Ar+O2 mixture. Decreases are also seen to be appreciable for HP- and 
asher-etched samples, compared with the pristine sample values. This would therefore confirm 
that the nanofibrous polymer was indeed subject to chain scissions, resulting in reduced average 
chain lengths and lower values of elastic modulus [168, 297, 312]. 
 
Table 5.5 Inherent and intrinsic viscosities and viscosity molecular weights for pristine and 
plasma-etched mats 
 
 
5.3.5 Differential Scanning Calorimetry (DSC) 
DSC measurements were performed on all samples. Presumably, the glass transition (Tg), cold 
crystallization and melting point temperatures correspond to the three peaks on the DSC 
thermograms (Figure 5.6), in order of rising T, all for first heating runs. Cold crystallization and 
melting peaks occurred at 127 °C and 252 °C in the thermograms of both pristine and etched 
nanoﬁbers, but no cold crystallization peak was observed for the case of a PET pellet since it was 
already partially crystalline. However, the melting temperature (252 °C) of the pellet and ePET 
were the same. Hence, no major differences in thermal properties were observed between pristine 
and plasma-etched samples, suggesting that crystallinity did not change appreciably in the course 
of plasma exposure. Differences between PET mats and pellets (particularly Tg) are probably due 
to very rapid solidification during solvent evaporation while electrospinning: this presumably 
does not allow enough time for macromolecular ordering. 
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Figure 5.6 DSC thermograms for PET pellet, pristine and plasma-etched ePET mats, during first 
heating. 
 
5.3.6 Cell Adhesion, Viability and Proliferation on Pristine and Plasma-
Etched Substrates 
5.3.6.1 Cell Adhesion and Growth 
Cell adhesion and -growth was observed on both pristine and plasma-etched mats (Asher-O2, 5 
min) using the AlamarBlue assay. As already pointed out above, asher-etched ePET mat (O2, 5 
min) was chosen because its mechanical properties are comparable to those of natural arteries, 
and because the fibers’ surface morphology was unchanged (see Table 5.3). No significant 
difference in cell adhesion was observed between pristine and plasma-etched samples, which 
showed similar results as control PCP 24h after seeding (Figure 5.7). 
Cell growth after 7 days was quite limited on pristine ePET, but significantly (p <0.05) greater on 
the plasma-etched mat (Figure 7). Even more cells were found on PCP (p <0.05) on day 7, but 
this should not be taken into account, because cells could migrate in PCP wells during the growth 
period and cover all areas of the well. In contrast, ePET mats were transferred to new wells 
before the Alamar-Blue assay, to prevent counting cells which migrated and grew on the bottoms 
of wells. The observed high cell count on plasma-etched mats was expected, because a similar 
increase had already been observed following wet-chemical or plasma treatments in O2, CO2 or 
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air, for the case of both polymer films and electrospun mats [133, 153, 313]. It is probably due to 
their different surface properties (hydrophilicity, O-containing functional groups, and somewhat 
increased surface roughness). These may improve cell adhesion and growth via increased 
adsorption of proteins from the culture medium or from cell secretions, in agreement with other 
studies [133, 301]. 
 
 
Figure 5.7 Adhesion 24 h and growth 7 d of VSMCs on pristine and plasma-etched substrate 
(PCP: tissue-culture polystyrene; ePET: electrospun mats; e-PET-Asher: plasma-etched mats) 
(n = 8 for each). * Significant difference between pristine and plasma-etched ePET at day 7 
(p < 0.05). 
 
5.3.6.2 Cell Morphology 
Cell morphology was visualized on the pristine and plasma-etched mats at day 7 by SEM (Figure 
5.8). Cells spread on both mats and oriented along or bridged between neighboring fibers. Also, 
they displayed a spindle-like contractile phenotype and multicellular network, and they 
penetrated inside the voids of both types of mats. This observation agrees with other studies that 
show cell migration towards the inside of nano- or micro-fibrous matrices with large pore sizes 
[284] [106, 133, 314]. However, SEM images merely allow one to observe cell infiltration into 
the very top layers of the mats; additional study by confocal microscopy is required to evaluate 
their deeper penetration. 
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Figure 5.8 SEM micrographs of electrospun nanofiber mats with VSMCs after 7 d of growth: (A) 
pristine mat (ePET); (B) mat after plasma-etching (scale bar: 50 µm). 
 
5.4 General Discussion and Conclusions 
Mimicking the mechanical properties and structure of the media layer of blood vessels  plays a 
key role in the clinical outcomes of engineered vascular graft (VG). Fabrication of a 
biocompatible, compliant matrix with defined structure that enables the growth of 
circumferentially-oriented smooth muscle cells (SMCs) remains a challenge [275]. Orientation is 
the key requirement for SMCs, because they are spindle-shaped and circumferentially aligned 
[106]. 
In the present study, cost-effective and easily-implemented electrospinning with a high speed 
rotating mandrel was used to approximate morphology and mechanical properties of the VG’s 
SMC layer. Highly porous electrospun PET mats (ePET) were prepared with fibers well-aligned 
along the mandrel’s circumference, advantageous for SMC growth. PET was selected because it 
is stable, inexpensive and cytocompatible, with tunable properties, and because several PET-
based vascular implants already received FDA-approval [10, 133]. The main challenge has been 
excessively-high mechanical properties in the circumferential direction of the spin-aligned mats 
(most particularly, their high Young’s modulus). Therefore, an environmentally benign process, 
plasma-etching, was chosen to fine-tune the mats’ mechanical and surface-chemical properties.  
92 
Significant decreases in Young’s modulus were observed following LP-, HP-, and asher-induced 
plasma etching (Figure 5.4). Moreover, although there is a reduction in elongation at break, the 
obtained tensile strengths are similar to those of natural arteries. These changes could be related 
to the reduction in fiber diameters and to nano/micro-pit surface defects observed after extended 
LP and HP plasma treatments. Chain scissions and concomitant decreases in molecular weight 
were also observed with all three etching techniques, according to  intrinsic viscosity 
measurements (Figure 5.6). These can be attributed to reactive oxygen erosion, accompanied by 
ion bombardment and VUV-induced reactions. These are responsible for the majority of chemical 
alterations present, namely chain scissions accompanied by molecular weight reduction, cleavage 
of the polymer backbone, and possibly some cross-linking, along with surface oxidation. 
Prolonged etching duration could entrain deleterious effects on the ePET mats’ morphology, as 
shown in Figure 5.2 for LP- and HP-plasma etched samples. Interestingly and fortunately, short-
duration treatments in the plasma-asher enabled one to attain a similar decrease in Young’s 
modulus (Figure 5.4) without observable damage of the fibers, which remained smooth. In 
addition, the average fiber diameter was reduced (Table 5.2) accompanied by a sharp increase in 
concentration of O-bearing functional groups (Table 5.3). Therefore, plasma etching can offer 
good control for tuning mechanical, morphological and surface-chemical properties of 
electrospun fibrous mats [299, 300, 315].  The likely presence at etched surfaces of some low 
molecular weight oxidized residues is not considered problematic, because they occur in very low 
concentration, are unlikely to be cytotoxic and, in any event, dissolve upon immersion in 
(aqueous) cell-culture media. 
The morphology of the present aligned ePET mats (pristine and asher-etched (O2, 5 min)) proved 
to be suitable for deep inward penetration of SCMs, for them to spread between fibers and along 
their lengths, see Figure 5.8. Indeed, the fabrication conditions used yielded high porosity and a 
relatively large average fiber diameter (Figure 5.2 and Table 5.2). This, and the ability of plasma 
to be sustained deep within the porous mats facilitated the infiltration of SMCs; of course, the 
open structure also enables ready exchange of nutrients and gas molecules. In addition to changes 
in mechanical characteristics, which allow the present etched ePET mats to more closely mimic 
natural blood vessels, plasma etching was also shown to have a large effect on wettability, 
observed by SCA and wicking time of a dye solution (Table 5.4), turning the originally 
hydrophobic mats into hydrophilic ones [300, 316, 317]. Increased wettability is, of course, 
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favorable for cell adhesion and –growth: The polar chemical functionalities created by plasma-
etching, for example hydroxyl, carbonyl or carboxylic groups, are known to favor cell adhesion 
and growth through increased protein adsorption [318, 319], which integrin receptors on cells’ 
outer membrane, in turn, “recognize” and bind to. Moreover, microscopic or sub-micrometer 
surface roughness can also significantly affect the materials’ wettability and protein adsorption 
[300, 315]. These combined effects showed a strong influence on cell growth after 7 days, 
compared with the pristine ePET mats (Figure 5.7). Additional modification with bioactive 
factors can further improve the scaffolds for VG applications, and this is the subject of ongoing 
investigations.  
To conclude, in the present work LP- and HP-plasma etching, along with microwave plasma 
ashing, have been applied to fine-tune the mechanical and surface properties of aligned 
electrospun PET (ePET) mat scaffolds. The effects on morphology, mechanical properties, 
surface chemistry / wettability and bioactivity have been studied and reported here. Among the 
three etch techniques, the plasma asher (with pure oxygen) seems to be most advantageous in 
terms of rapidity, minimal apparent damage to fiber surfaces, along with efficacy in changing 
mechanical properties. Thus, the combination of electrospinning and appropriate plasma-etching 
can provide an adequate (3D) scaffold for the media layer of small-diameter vascular prostheses; 
more precisely, it enables one to achieve finely-controlled structural, mechanical and surface 
properties that are required for VG applications. 
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Abstract 
The patency of small-diameter (< 6 mm) synthetic vascular grafts (VGs) is still limited by the 
absence of a confluent, blood flow-resistant monolayer of endothelial cells (ECs) on the lumen, 
and of vascular smooth muscle cell (VSMC) growth into the media layer. In this research, 
electrospinning has been combined with bioactive coatings based on chondroitin sulfate (CS) to 
create scaffolds that possess optimal morphological and bioactive properties for subsequent cell 
seeding. We fabricated random and aligned electrospun poly(ethylene terephthalate), ePET, mats 
with small pores (3.2 ± 0.5 or 3.9 ± 0.3 µm,), then investigated the effects of topography and 
bioactive coatings on EC adhesion, growth and resistance to shear stress. Bioactive coatings were 
found to dominate the cell behavior, enabling creation of a near-confluent EC monolayer that 
resisted physiological shear-flow conditions. CS is particularly interesting since it prevents 
platelet adhesion, a key issue to avoid blood clot formation in case of an incomplete EC 
monolayer or partial cell detachment. Regarding the media layer, circumferentially oriented 
nano-fibers with larger pores (6.3 ± 0.5 µm) allowed growth, survival and inward penetration of 
VSMCs, especially when the CS was further coated with tethered, oriented epidermal growth 
factor (EGF). In summary, the techniques developed here can lead to adequate scaffolds for the 
luminal and media layers of small-diameter synthetic VGs. 
 
Keywords: electrospinning; vascular graft; bioactive coatings; chondroitin sulfate; EGF 
immobilization; endothelialization; shear-induced flow; VSMC survival 
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6.1 Introduction 
Primary requirements for functional synthetic small-diameter vascular grafts (VGs) or tissue 
engineered blood vessels for coronary or femoral artery bypass are favorable compliance and 
hemocompatibility [27]. To achieve long-term patency, a VG should thus possess a continuous 
and stable monolayer of endothelial cells (ECs) on its lumen, with significant resistance to 
physiological shear stress [320]. Yet, stable endothelialization of VGs remains a so-far unmet 
objective, in spite of great efforts during the past decade. In vitro seeding of autologous ECs or in 
situ capture of endothelial progenitor cells on the luminal layer of grafts have been tested [321], 
but due to weak EC adhesion the implanted grafts lacked adequate long-term patency. This is 
partly due to the inability of conventional VGs to reproduce the morphology and cell-matrix 
interactions of native tissues. In the extracellular matrix (ECM), topographical cell guidance is 
assured thanks to various combinations of pores, ridges and fibers at micro/nanoscale levels. 
Additionally, the ECM is known to orchestrate time- and spatially-controlled delivery of 
biochemical cues that trigger specific cell signaling pathways to finely tune tissue growth and 
homeostasis [322, 323].  
Electrospinning has been used to design highly porous scaffolds that mimic topological cues of 
the ECM within native arteries [14, 229, 324]. Nano/microfiber scaffolds with different degrees 
of fiber- alignment and -diameter have therefore been developed to optimize structural and 
mechanical properties of VGs in an effort to regulate cell adhesion, shape, spreading, and 
migration [99, 133, 325]. 
Our team has investigated how electrospun polyethylene terephthalate (ePET) mat properties 
such as fiber diameter, orientation and surface characteristics affect EC adhesion, spreading, 
infiltration and migration [10, 11, 133, 231]. PET was selected for its good mechanical 
properties, stability, biocompatibility, and low cost. Furthermore, large diameter woven PET VGs 
have already been FDA approved and clinically used for many years [10, 27, 231]. The results of 
above-cited studies demonstrated that mats with small diameter fibers were appropriate to form 
an EC monolayer on the lumen of a VG [133], but a completely confluent monolayer could not 
be achieved under shear stress [10, 14].  
A promising method to further enhance EC adhesion, growth and resistance to shear stress is to 
combine electrospun fibers with a bioactive coating [6]. We have recently shown that a primary 
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amine-rich, low-pressure plasma-polymerized coating (hereafter “LP”) was able to significantly 
increase EC growth and retention [10, 246], but that retention was still not entirely complete. 
Moreover, LP was found to promote platelet adhesion and aggregation, that is, increased risk of 
thrombosis if the endothelial lining partially detaches under shear [13]. Our team also 
demonstrated [13, 190] that chondroitin sulfate (CS), a sulfated glycosaminoglycan that is 
abundant in the ECM of native blood vessels [326], once grafted on  LP coating, also promotes 
EC adhesion and growth, but strongly reduces protein adsorption, platelet adhesion and 
aggregation [13]. Therefore, we propose here to combine electrospun mats with a bioactive 
coating that includes CS, in order to achieve a complete, stable endothelial lining.  
Electrospinning may also help to achieve a porous structure for constructing the media layer of a 
synthetic blood vessel, a layer which contains circumferentially-aligned fibres and the vascular 
smooth muscle cells (VSMC) responsible for contraction, dilation and blood pressure control 
[327, 328]. Therefore, the combination of an electrospun scaffold with a bioactive coating was 
also evaluated here as a mean to enhance VSMC growth and infiltration into porous mats. In 
addition to CS, epidermal growth factor (EGF), a 6-kDa mitogenic protein known to enhance 
VSMC growth, was also tethered on CS-grafted surfaces in an oriented manner, because this 
strategy is known to improve GF potency compared with random covalent binding [185, 189, 
329]. 
We here report the cooperative effects of topological and biochemical features (the degree of 
alignment of electrospun nano-fibers, and the use of bioactive coatings) using three-dimensional 
(3D) ePET nanofiber scaffolds, upon cell growth of luminal (EC) and media (VSMC) layers for 
VGs. First, we combined LP+CS coatings with smaller pore-size random (hereafter “RL”) and 
aligned (hereafter “AL”) ePET mats for the luminal layer, then evaluated their ability to favor 
human umbilical vein EC (HUVEC) adhesion, growth and resistance to shear-induced flow. 
Next, we combined bioactive coatings (LP+CS+oriented tethered EGF) with aligned mats having 
somewhat larger pore-size for the media layer (hereafter “AM”), and investigated their 
bioactivity and ability to favor VSMC adhesion, growth and infiltration. 
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6.2 Materials and Methods 
6.2.1 Materials 
 PET pellets were obtained from DuPont selar PT 7086 (intrinsic viscosity of 1), and ethylene 
(C2H4; 99.5%) and ammonia gas (NH3, 99.99%) from Air Liquide Canada Ltd. (Montreal, 
Canada).  Chondroitin sulfate (CS), bovine serum albumin (BSA, 66 kDa) were purchased from 
Sigma-Aldrich Canada Ltd; DuoSet ELISA kits were obtained from R&D Systems, Minneapolis, 
MN. When not mentioned otherwise, chemical products were purchased from Sigma-Aldrich 
Canada Ltd.  
 
6.2.2 Fabrication of Random and Aligned Bioactive Nano-fibrous Scaffolds 
6.2.2.1 Electrospinning 
Optimized ePET mats for luminal and medial layers of VGs were prepared on a rotating mandrel, 
using a homemade electrospinning set-up. As previously described [10, 11], PET pellets were 
dissolved in 1:1 mixture of analytical grade dichloromethane (CH2Cl2)/trifluoro-acetic acid 
(TFA), and gently stirred for 24 h at room temperature. Two milliliters (mL) of polymer solution 
were electrospun with the aid of a syringe pump, in an enclosure at ambient humidity and 
temperature. Electrospinning parameters (Table 6.1) were adjusted to fine-tune the morphology 
of the mats for HUVEC and VSMC culture, i.e. random and aligned ePET mats with smaller 
pores for the luminal layer (RL and AL), and aligned mat with larger pore-size for the media 
layer (AM). The mandrel velocity was increased to obtain more aligned fibers for the luminal 
layer. On the other hand, a partially aligned, larger-pore mat for the media layer was obtained 
using higher PET concentration, a larger needle and relatively high drum speed. The fabricated 
electrospun scaffolds were dried in ambient air for 3 days to remove any residual solvent.  
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Table 6.1 Process conditions used to produce the electrospun random and aligned ePET mats 
Mat type 
PET solution 
concentration 
(% w/v) 
Process parameters Collector 
Ambient 
conditions 
Needle 
size (G) 
Tip-
Collector 
distance 
(cm) 
Voltage 
(kV) 
Flow 
rate 
(mL/h) 
Mandrel 
velocity 
(RPM) 
RH 
(%) 
Temp (°C) 
RL 9 22 15 15-17 0.5 175 8-25 20-25 
AL 9 22 15 20 0.5 2000 8-25 20-25 
AM 12.5 18 13 30 10 1000 8-25 20-25 
RL: random mat for luminal layer; AL: aligned mat for luminal layer; AM: aligned mat for media 
layer 
6.2.2.2 Plasma-Polymerization 
 Primary-amine rich plasma polymer (LP) coatings were deposited on the surface of the nano-
fiber mats in a low-pressure (“L”) capacitively-coupled radio-frequency (r.f., 13.56 MHz) glow 
discharge plasma reactor, using ethylene (C2H4) / ammonia (NH3) gas mixture [160, 247]. The 
coatings were deposited under partial vacuum (p = 80 Pa) using constant flow rates of C2H4 
“monomer” and ammonia, NH3, FC2H4 and FNH3, with a mixture ratio R = FNH3/ FC2H4 = 0.75. The 
deposition was performed for 8 min duration under mild plasma conditions (power, P = 10 W, 
d.c. bias voltage, VB = - 40 V). These conditions were previously shown to provide high nitrogen 
and amine concentrations, [N] and [NH2], and good stability (insolubility) in aqueous solutions 
[247]. 
6.2.2.3 CS Grafting on the LP-coated Mats 
Circular samples (1 cm2) of the amine-rich LP-coated ePET mats were punched to fit into 48-well 
plates. CS was dissolved in Milli-Q water at 0.1 g.mL-1, and the resulting solution was filtered 
(200-µm PTFE filter) to remove aggregates. CS was covalently grafted on the mats by way of 
carbodiimide chemistry (NHS/EDC-based chemistry) [185]: The mats were incubated in 200 µL 
100 
of solution containing 0.01 g.mL-1 CS, 40% v/v EtOH, 50 mM MES, 22.8 mM EDC, 4.6 mM 
NHS for 1 h at room temperature, then finally rinsed once with PBS (10 mM, pH 7.4) and twice 
with Milli-Q water for 2 min in an ultrasonic bath. 
6.2.2.4 EGF Oriented Immobilization  
Oriented immobilization of EGF on CS-grafted surfaces was performed [185] using the Ecoil and 
Kcoil peptides that hetero-dimerize with high specificity and affinity [215, 329]. Cysteine-tagged 
Kcoil peptides were synthesized by the peptide facility at the University of Colorado (Denver, 
CO, USA). Ecoil-tagged EGF (E-EGF) was produced in human embryonic kidney (HEK) 293 
cells and purified [213]. Kcoil was grafted on CS-grafted mats using EMCH linker that reacts 
with the carboxyl groups of CS and the thiol group of the cysteine-terminated Kcoil [185]. Mats 
covered with covalently bound Kcoil were incubated overnight in a 10% solution of fetal bovine 
serum (FBS) in PBS to remove any unbound peptide. After rinsing with PBS, surfaces were 
incubated for 1 h with 200 µL of E-EGF solution at 22 nM concentration in 10 mM PBS 
containing 1% BSA. This concentration was chosen based on our previous experiments on PET 
film surfaces [185]. After capture of the Ecoil-tagged protein, mats were rinsed with PBS.   
 
6.2.3 Characterization of Bioactive Scaffolds  
6.2.3.1 Mat Morphology 
Electrospun nano-fiber structure and morphology were evaluated by scanning electron 
microscopy (SEM) using a JSM-7600 Field Emission instrument (JEOL Ltd., Tokyo, Japan) at 
0.5 kV. Mat surfaces were first sputter-coated with gold for 45 s; images were analyzed using 
ImageJ (NIH, USA) software, and diameters were calculated based on at least 100 fibers (at least 
two experiments with triplicate samples). The fiber alignment was characterized using the 
directional plugin of ImageJ to obtain Fast Fourier Transformation (FFT) of SEM images [11]. 
The porosity of nanofiber mats was determined using a liquid (ethanol) intrusion method [96]. In 
addition, the average pore size was evaluated by SEM with the ImageJ software, assuming 
elliptical pore shapes and taking an average of major and minor axes of the best-fitting ellipses. 
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6.2.3.2 Chemical Composition  
X-ray photoelectron spectroscopy (XPS) analyses of bare and modified mats were performed in a 
VG ESCALAB 3MkII instrument, using non-monochromatic Mg K radiation. To assess 
possible chemical composition gradients across the thickness of the mat, a two-layer scaffold was 
created by a two-step electrospinning approach. The first ply (ca. 50 µm, half of the final 
thickness) was fabricated and dried overnight; the second ply (approx. 50 µm) was then 
electrospun on top of the first. A LP+CS coating was created on top of the two-layer mat and 
XPS survey spectra were taken at different depths of this composite sample, namely, top ([a]: 0 
µm), mid-plane ([b]: 50 µm), and bottom ([c]: 100 µm). 
6.2.3.3 Protein Adsorption Measurements  
Since CS has low-fouling properties [13], CS grafting throughout the scaffold thickness was 
examined by protein adsorption using Texas Red fluorescent-labeled bovine serum albumin 
(BSA), using the two-layer mat described above. Briefly, the two layers were gently separated 
and immersed in labeled BSA (0.2 mg/mL in PBS) for 2 h under static ambient conditions in the 
dark. Fluorescence intensity was measured after thorough washing with PBS to remove unbound 
protein. Images were analyzed using ImageJ software and the background auto-fluorescence was 
subtracted for each sample. 
6.2.3.4 E-EGF Quantification by ELISA 
E-EGF immobilized on the mats was quantified by direct enzyme-linked immunosorbent assay 
(ELISA) according to the manufacturer’s instructions. The optical density (O.D.) was measured 
at 630 nm. The slopes corresponding to the initial O.D. variation in the wells over time were 
calculated, and the value obtained for a surface with no growth factor was subtracted from all 
signals.  
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6.2.4 Biological Testing 
6.2.4.1 HUVEC Adhesion and Growth  
HUVECs (Cell Applications Inc.) were cultured in 1% gelatin-coated flasks, in complete medium 
EGM-2 bullet Kit (Lonza, CC-3162) and used at passage 3 - 5.  Random and aligned 1 cm-
diameter disk samples from bare, LP-coated, and CS-grafted mats were placed in 48-well 
polystyrene culture plates (hereafter “PCP”) and sterilized in 70% ethanol for 5 min, rinsed with 
sterile water, then dried overnight under a laminar hood. Cloning glass cylinders (0.8 cm inner 
diameter, 1 cm height) were placed on the disk samples to prevent their movement after cell 
seeding and to prevent cell adhesion elsewhere. 200 µL of HUVEC suspension (20,000 cells) was 
added to each well; as positive controls, cells were also cultured directly on PCP coated with 1% 
gelatin. After a 4h period of adhesion, cloning cylinders and medium were removed, and cells 
were left to grow for 1, 7, 14 and 21 days in 500 µL of complete medium supplemented with 1% 
penicillin–streptomycin (Pen–Strep; Invitrogen). HUVEC adhesion and growth on the various 
surfaces was evaluated using AlamarBlue (10 %v/v) reduction assay (Cedarlane, 30025-1(BT), 
four samples each). The experiment was carried out in triplicate to ensure reproducibility. To 
assess cell viability and distribution in the 3D mats, Live-Dead assays were performed by 
incubating in calcein-AM (2 µM) and ethidium homodimer-1 (5.5 µM, Invitrogen) for 45 min at 
37 ºC in the dark, before rinsing with PBS and imaging under a Laser Confocal Scanning 
Microscope (Olympus multiphoton FV-1000 MER, Olympus, Canada). 
Immunostaining was performed to visualize actin microfilaments, focal adhesions and cell-cell 
contact points according to well-established procedures [186, 246]. Briefly, cells were fixed and 
permeabilized with 3.7% paraformaldehyde and 0.1% TRITON X-100 solution in PBS, 
respectively, then incubated with primary antibodies, namely anti-mouse vinculin (Millipore, 
MAB3574, diluted 1:100) and anti-mouse VE-cadherin (Millipore, diluted 1:100). Following 
this, the scaffolds were incubated with secondary antibody, goat anti-mouse Alexafluor 546 
(Invitrogen, A-11018, diluted 1:200), then with the corresponding Alexa (Molecular Probes) 
Phalloidin Alexa-488 anti-mouse (Invitrogen, A-11029, diluted 1:40). Finally, cell nuclei were 
stained with Draq5 (diluted 1:1000). Samples were examined using a Leica TCS SP2 confocal 
laser-scanning microscope (Leica Microsystems, Wetzlar, Germany). 
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6.2.4.2 Cell Alignment and Morphology 
Cell alignment was calculated from immunostained images using ImageJ software, based on the 
angle difference between the long axis of each nucleus (presumed elliptical) and the average fiber 
direction (100 nuclei in total), following which alignment angles were categorized in 10° 
increments. Cells with angles < 30° were considered aligned [330, 331]. In addition, the cell 
elongation was evaluated using ImageJ software by its shape index (circularity = 
4*π*area/perimeter2) for each cell on random and aligned scaffolds, shape index 1 corresponding 
to a perfect circle [332]. SEM was also used to visualize cell morphology on controls and 
modified scaffolds. 
6.2.4.3 HUVEC Resistance to Laminar Shear Stress 
To study HUVEC resistance to shear, cells (250 μL in complete medium, 106 cells/mat) were 
seeded and left to adhere on mats (10 mm×22.5 mm) for 48 h so as to obtain a confluent 
monolayer. They were then subjected to laminar flow-induced shear stress of ca. 15 dynes cm-2 
(similar to an actual physiological value [333]) for 1 h in a parallel-flow chamber (Glycotech, C 
31-001, Gaithersburg MD) [10]. The influence of fiber alignment (random vs. aligned mats) and 
surface composition (bare, LP and LP+CS-coated mats) on cell retention was studied by 
AlamarBlue and SEM.  
6.2.4.4 VSMC Adhesion, Growth and Survival  
VSMCs from rat embryonic thoracic aorta (a7r5 cell line, ATCC, VA, USA), cultured in 
Dulbecco’s Modified Eagle’s Medium/ Nutrient Mixture F-12 Ham’s Media (DMEM/F12; 
Invitrogen) supplemented with 10% fetal bovine serum (FBS; Medicorp, Quebec, Canada), were 
used between passages 4 to 15. For cell growth and survival experiments, 20,000 and 30,000 
cells/mat, respectively, were seeded in complete media on pristine and modified aligned mats 
(LP, LP+CS, LP+CS+EGF), as was done in the case of HUVECs. Cell growth was assessed in 
complete media and cell survival in serum-free medium (DMEM/F12; Invitrogen), both using 
AlamarBlue. The media was changed every other day. For conditions designated as ‘‘soluble 
EGF’’, 10 ng.mL-1 of EGF was supplemented in the culture medium. 
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6.2.4.5 Histology  
In order to evaluate cellular infiltration into the electrospun mats after 21 days of incubation, 
samples were rinsed with PBS and fixed with 10% neutral buffer formalin for 24h at room 
temperature. After embedding in paraffin, 6 µm thick microtomed sections were stained using 
Hematoxylin-Eosin (H&E) and imaged. 
6.2.5 Statistical Analysis  
Each experiment was carried out in triplicate to examine reproducibility. All data are expressed 
as mean values ± SD. Statistical analyses were carried out using ANOVA with Tukey’s post hoc 
analysis, or by independent t-test when comparing two groups only. Values of p < 0.05 were 
considered significant for all tests. 
 
6.3 Results and discussion  
6.3.1 Morphology of Random and Aligned Scaffolds for Lumen 
In blood vessels, ECs are well known to be aligned and elongated in the flow direction, which 
results in maximized cell retention under blood flow-induced shear stress [333]. To stimulate EC 
alignment by topographical cues, aligned scaffolds with small pore-size (AL) were compared 
with their random counterparts (RL) in regard to formation of an EC monolayer. SEM images 
(Figure 6.1A and B) confirm uniform, smooth fiber morphology with interconnected open 
structure, and average diameters of ca. 550 ± 90 nm and 500 ± 140 nm for random and aligned 
nanofibers, respectively (n=200). The overall porosity was similar (87%) in both cases, mean 
respective pore diameters being ca. 3.2 ± 0.5 and 3.9 ± 0.3 µm. The 2D FFT frequency images 
(Figure 6.1A and B, inset) show that only the aligned (AL) scaffolds exhibited an oriented 
structure. The fiber alignment was also quantified by the 2D FFT plot (see supplemental data 
Figure E1) which shows greatest intensity in the direction of fiber alignment on the micrograph, 
while sharp peaks at 90° and 270° confirm that the majority of fibers were oriented in a specific 
direction (perpendicular to the mandrel axis during electrospinning). 
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6.3.2 Morphology of Aligned Scaffolds for Medial Layer 
Aligned scaffolds (AM) with greater pore size were fabricated in order to mimic the media layer 
(Figure 6.1C), respective average fiber diameter, pore diameter and porosity being 890 ± 350 
nm, 6.3 ± 0.5 µm and 78%. Greater pore sizes were desirable in this case to allow SMC 
infiltration into the bulk of the scaffold. The 2D FFT frequency image (Figure 6.1C, inset) and 
quantified plot (supplemental data Figure E1) also confirm the fiber alignment.  
 
 
Figure 6.1 SEM and 2D FFT images (insets) of (A) random (RL), (B) aligned (AL) mat for the 
luminal layer; and (C) aligned (AM) mat for the media layer (scale bar: 10 µm). 
 
6.3.3 Surface Chemistry and Depth-Dependence 
XPS-based elemental composition of an AM mat after LP deposition and CS grafting is presented 
in Table 6.2. From our earlier work it is known that LP is stable and that it comprises high values 
of [N] and [NH2] [10, 334], reconfirmed here ([N] = 11.2%). The presence of sulfur (S) also 
confirmed successful grafting of CS on the LP-coated mats. Furthermore, the ability to coat fibers 
with LP and LP+CS in the sample bulk was examined using the two-layer mat sample, on top [a]: 
0 µm; in the middle, [b]: 50 µm; and at the bottom, [c]: 100 µm (n = 3, Table 6.2). Although [N] 
decreased with increasing depth, it was clearly measurable in cases [b] and [c], many tens of 
micrometers below the surface, confirming that active plasma species penetrated through the 
porous structure. After CS grafting, [N] decrease and [S] increase at each level of the mats are a 
first confirmation that CS was grafted across the mat thickness. 
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Table 6.2 XPS-based chemical compositions of bare and coated aligned mats for the media layer 
(AM) and their depth-dependence (n=3) 
2-layer AM bare mat 
Depth [a]: 0 µm [b]: 50 µm [c]: 100 µm 
Elements Avg. (%) ±SD Avg. (%) ±SD Avg. (%) ±SD 
C 70.5 70.5 70.5 
N 0 0 0 
O 29.5 29.5 29.5 
S 0 0 0 
2-layer AM+LP-coated mat 
C 84.3±1.4 74.4±1 74.5±0.8 
N 11.2±0.9 7.2±0.1 5.1±0.8 
O 4.6±2.4 18.4±1.1 20.4±0.0 
S 0 0 0 
2-layer AM+LP+CS grafted mat 
C 69.3±1.4 69.8±0.5 71.3±1.4 
N 8.7±1.2 5.8±0.1 4.4±0.3 
O 21.3±0.2 23.6±0.3 23.6±1.2 
S 0.7±0.1 0.8±0.0 0.8±0.1 
 
6.3.4 Protein Adsorption  
CS grafting throughout the thickness of the AM mats was confirmed by BSA adsorption on the 
same two-layer mats. Protein adsorption can serve as an indirect indicator for CS grafting thanks 
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to the earlier-demonstrated low-fouling properties of CS [13]. As shown in Figure 6.2, LP 
coating increased albumin adsorption compared with bare ePET mats, as previously 
demonstrated on film substrates [13], while CS grafting significantly decreased it. As expected, 
these effects are less pronounced at the bottom (case [c]), which confirms lower [NH2] after 
plasma (Table 6.2) and consequently less grafted CS.   
 
 
Figure 6.2 Fluorescence intensity of adsorbed Texas Red-BSA (0.2 mg/mL) on bare AM, 
AM+LP-, and AM+LP+CS-coated mats as a function of depth (n=10). 
 
6.3.5 Effect of Fiber Orientation and Bioactive Coatings on HUVECs  
 Figure 6.3 presents adhesion and growth results for HUVECs on the various surfaces, assessed 
by their metabolic activity. Adhesion and growth on bare RL and AL scaffolds were found to be 
similar at each time point (p > 0.05). Interestingly, metabolic activity was found to drop sharply 
at day 7, but then it increased again, a type of behavior reported before by our team [10] and 
another group [155]. LP coating significantly increased cell adhesion and growth on both 
scaffolds (p < 0.05), in agreement with previous studies on various 2D and 3D substrates [10, 13, 
246]. CS-grafted scaffolds showed similar initial adhesion as LP (p > 0.05), but more rapid 
growth thereafter, as shown by significantly higher values at day 7, 14 and 21 (Figure 6.3, 
Figure 6.4).  
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Figure 6.3 Adhesion (day 1) and growth (day 7, 14 and 21) of HUVECs on bare and coated 
random (RL) and aligned (AL) mats. Mean ± SD (n ≥ 6). 
(* p < 0.05 with bare surfaces; # p < 0.05 with LP-coated surfaces at the same time point). 
 
 
Figure 6.4 SEM images of HUVECs after 21 days of cell culture on a) bare and coated random 
(RL); b) bare and coated aligned (AL) ePET mats (scale bar: 100µm). 
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The z-stack confocal images in Figure 6.5a confirm a monolayer of endothelial cells on both RL 
and AL scaffolds, with no sign of cell penetration into the bulk. Moreover, at locations where 
confluency occurred, VE-cadherin protein expression is noted at cell-to-cell contact regions, 
indicating that neighboring cells interacted in a coherent manner (Figure 6.5d). This would 
confirm that these nano-fibrous structures are indeed well adapted for forming confluent 
monolayers of endothelial cells. 
Vinculin immunostaining showed no significant difference between the various mat 
morphologies. Even on the latter we observed only limited focal adhesion complexes, mostly at 
the polarized cell edges (Figure 6.5e). This agrees with other studies [335, 336], demonstrating 
weak focal points between cells and the electrospun nano- fibers. 
 
Figure 6.5 a) z-stack confocal micrograph of HUVECs grown (D21) on an AL mat (live cells in 
green); b, c) confocal micrographs of HUVEC adhered (at D1) on LP-coated (b) random (RL) 
and (c) aligned (AL) mats (cytoskeletal F-actin in green, nucleus in blue, electrospun fiber 
direction indicated by arrow); d) typical cell-cell interactions (VE-cadherin, in white); e) cell 
focal adhesion points (vinculin, in red) on LP-coated random (RL) mat at D7 (scale bar: 75 µm). 
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Finally, cell retention after shear stress was tested on bare and coated mats (Figure 6.6). The 
percentage of cells remaining after shear was very low on bare mats (25-30%), but much greater 
for LP and LP+CS coated ones, both random and aligned (LP+CS > LP > bare; p < 0.05). The 
performance was slightly (but not significantly) better on the aligned scaffolds, ones coated with 
LP+CS showing up to 82 % cell retention. 
 
 
 
Figure 6.6 HUVEC retention after laminar shear stress (15 dynes.cm -2,1h), evaluated by 
AlamarBlue assay (n=4).  
*, # p < 0.05 with reference to bare and LP-coated surfaces under shear, respectively. 
 
Some cell alignment was observed on the AL mats, as shown on Figure 6.5c by parallel-oriented 
F-actin microfilaments, in contrast with the irregular cell shape observed in Figure 6.5b for the 
random (RL) mats. This was confirmed by quantitative analysis of the nuclear alignment: 80% of 
the cells aligned with the AL fiber direction (angles ˂ 30°, see supplemental data, Figure E2 and 
Table E1), contrary to random cell orientation for the RL scaffolds. Furthermore, there were 
significant differences in cell elongation between the RL and AL mats (circularity 67±12% 
versus 33±20%, respectively, p < 0.05).  
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6.3.6 VSMCs: Bioactivity of Coatings on Scaffolds for the Media Layer  
6.3.6.1 Kcoil Grafting and EGF Capture - Quantification by ELISA 
For the media layer, EGF was additionally immobilized on a LP-CS coating. ELISA confirmed 
successful tethering of the EGF using the Kcoil-Ecoil system, the optical density on 
CS+Kcoil+EEGF being much greater than on other surfaces (9, 12 and 18-fold higher compared 
with simple CS, simple Kcoil and CS incubated with Ecoil EGF in absence of Kcoil, 
respectively, p < 0.05) (Figure E3, Supplemental data). This confirmed the specificity of the E/K 
coiled-coil interaction, as well as its suitability to capture EGF on CS.  
 
6.3.6.2 VSMC Adhesion and Growth 
Metabolic activity of VSMCs after 1 and 7 days on bare and coated mats is illustrated in Figure 
6.7. At day 7, the number of cells was quite small on pristine ePET (see “AM”), but significantly 
greater on the bioactive coatings, increasing in the order: LP, LP+CS and LP+CS+EEGF 
(p<0.05).  
 
Figure 6.7 Adhesion after 24 h (D1) and growth after 7 days (D7) of VSMCs on bare and coated 
substrates [AM: bare aligned mats; (n=8 for each)]. 
*, #, & p < 0.05 with reference to bare, LP, and LP+CS-coated surfaces, respectively. 
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Histological examination (Figure 6.8) confirmed cell infiltration into the bulk of aligned ePET 
(AM) mats, presumably thanks to their larger pore size, albeit to a limited extent since most cells 
were encountered on top. Greater penetration might occur by increasing pore size even more or 
by using dynamic cell seeding.  
 
 
Figure 6.8 Histological section of an LP-coated AM mat, demonstrating cell infiltration (day 21; 
H&E staining, scale bar: 100 µm). 
 
6.3.6.3 VSMC Survival in Serum-Free Medium 
Figure 6.9 presents VSMC survival after 1, 3 and 5 days in serum-free medium on bare and 
coated mats, assessed by the AlamarBlue assay.  A very strong decrease in cell number is 
observed after 5 days on bare and LP surfaces (only ~ 5% survival), indicating that LP did not 
improve cell survival, even though it increased their initial adhesion. VSMC survival increased 
on LP+CS (39% of initial cell count after 5 days; p<0.05 compared to bare and LP), and was still 
further improved by EGF, 49% and 55% of the cells remaining with soluble and immobilized 
EGF, respectively (p<0.05 compared to LP+CS; without significant difference between 
immobilized and EGF in solution). This indicated that EGF triggered cell survival mechanisms 
and that oriented immobilization is at least as efficient as EGF in solution, even though the latter 
was renewed every 2 days. 
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Figure 6.9 VSMC survival on bare and coated aligned (AM) substrates (LP+CS+EEGF: EGF 
immobilized on LP+CS-coated mats; AM+LP+CS+EGF(sol); LP+CS-coated mats with soluble 
EGF added in medium) (mean + SD; n=6). Except LP at D3 and D5, all coatings were 
significantly better than bare mats at each time point (p<0.05, not indicated on the graph) 
* p<0.05 compared to LP; # p<0.05 compared to LP+CS 
 
6.3.7 Combining Bioactive Coatings and Electrospun Mats: A Promising 
Approach for VG 
In this research, we fabricated random and aligned bioactive electrospun PET mats as scaffolds 
for the luminal and media layers of small-diameter synthetic vascular grafts. Electrospinning 
enabled us to mimic the ECM morphology, and to control porosity, favouring either monolayer 
formation (HUVEC) or cell penetration into the bulk (VSMC). We have in addition investigated 
the effect of fiber alignment, since there is still controversy in the literature regarding the effect of 
nano-fiber alignment on cell spreading and –proliferation, some studies reporting increased 
HUVEC growth on aligned mats [14, 99] while others show better results with random scaffolds 
[100]. In the present work, nanofiber alignment was found to have slightly influenced HUVEC 
alignment and elongation, with minor impact (not significant) on cell retention under flow. The 
effect of the bioactive coating clearly dominated over the mat topography: Indeed, LP and 
LP+CS coatings greatly affected cell adhesion, growth and retention on both RL and AL 
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scaffolds. We showed that HUVEC adhesion, growth, and retention under flow-induced shear 
stress were increased by LP coating on ePET mats and smooth PET films [10, 246], but that cell 
retention was not complete. The present results demonstrated that grafting CS further enhanced 
HUVEC adhesion, growth and, most important, their resistance to detachment. The fact that CS 
promotes low platelet adhesion, despite its high propensity for HUVEC adhesion [13] is a clear 
advantage. Such a non-thrombogenic under-layer could help prevent thrombotic events, should 
the endothelium lining be incomplete or partially detach under shear-flow. In contrast, other 
coatings such as simple LP, fibronectin or collagen proposed in the literature are thrombogenic 
[41]. Thanks to its low thrombogenicity, the potential of our coating to capture in situ endothelial 
progenitor cells (EPC) to form a complete monolayer on the lumen could also be studied, because 
it offers a promising alternative to in vitro pre-seeding of cells [41]. 
The LP+CS coating was also found to be an excellent coating for the medial layer of vascular 
grafts of tissue constructs. In addition, the oriented immobilization of EGF enabled strong 
increase in VSMC survival in serum-free media, mimicking the lack of nutrients on the 
abluminal side of the graft. Immobilization of biomolecules has demonstrated great promise by 
their resulting durability and stability, which in turn leads to enhanced and continuous cell 
response [175, 187]. 
An additional advantage of these coatings is their versatility, since they can be created on any 
electrospun material thanks to the plasma polymerization process, in contrast to chemical 
modifications that require optimization as a function of substrate chemistry. In this project, 
electrospun PET was used for practical and regulatory reasons. However their mechanical 
properties may not be ideal in regard to compliance. Our previous studies [10, 11] have shown 
that the Young's moduli of ePET mats, random and aligned, were respectively about 20 MPa and 
100 MPa, well above those of natural arteries. Compliance being indirectly related to Young’s 
modulus, we would expect that of the present electrospun mats to be low. We already proposed to 
resolve this particular issue by chemical means [133] (hydrolysis with concentrated NaOH), or by 
plasma etching [11], if required. But other electrospun materials such as PU or PU/PCL mixture 
may be used instead [337].  
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6.4 Conclusions  
In this project, the combination of electrospinning, plasma polymerization and CS grafting was 
found to promote the formation of a stable endothelial layer. CS is particularly interesting 
because it is stable, biocompatible and it prevents platelet adhesion, a key issue to avoid blood 
clot formation in case of an incomplete EC monolayer or partial cell detachment. Moreover, the 
versatility of these technologies enables one to adapt them to other polymeric biomaterials, in 
order to optimize compliance and biodegradation rate, depending on the application. While 
further work is needed to combine the luminal and medial layers, and to optimize the material for 
compliance, the present results suggest that the combination of electrospinning and bioactive 
coatings can provide adequate scaffolds for small-diameter vascular prostheses. 
 
6.5 Supporting Information 
Cumultive data for endothelial cell orientation on aligned (AL) mats (Table E1), Typical 2D FFT 
alignment plot of aligned mats (Figure E1), Histogram of endothelial cell orientation on aligned 
(AL) mats (Figure E2), Apparent surface densities (absorbance) of oriented tethered EGF, 
measured by direct ELISA; p < 0.05 compared to all other surfaces (n=3) (Figure E3). 
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Supporting Information 
I. Supplementary Table 
 
Table E1: Cumultive data for endothelial cell orientation on aligned (AL) mats 
Fiber angle Frequency Cumulative % 
0 0 0.00% 
10 38 37% 
20 32 67% 
30 15 82% 
40 11 92% 
50 4 96% 
60 1 97% 
70 1 98% 
80 2 100% 
90 0 100% 
More 0 100% 
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II. Supplementary Figures 
 
 
Figure E1: Typical 2D FFT alignment plot of aligned mats. 
 
 
 
 
Figure E2: Histogram of endothelial cell orientation on aligned (AL) mats. 
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Figure E3: Apparent surface densities (absorbance) of oriented tethered EGF,  
measured by direct ELISA; p < 0.05 compared to all other surfaces (n=3). 
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CHAPTER 7 GENERAL DISCUSSION AND 
RECOMMENDATIONS FOR FUTURE RESEARCH 
In this Ph.D. thesis, we proposed to develop vascular prostheses combining 3D electrospun 
nanofiber matrices and bioactive coatings prepared by plasma-polymerization in order to tackle 
the limitations of present day SDVGs, namely graft occlusion due to the lack of compliance and 
thrombogenicity. We have chosen to use PET since it possesses stability, biocompatibility, and 
low cost, but foremost due to the fact that PET VGs have already been FDA-approved and 
clinically used for a few decades. Moreover, literature data suggest that the best anti-
thrombogenic surface is a complete and stable endothelium which inhibits coagulation, 
suppresses platelet aggregation, and stimulates fibrinolysis [338]. Therefore, our approach was to 
create a lumen surface which promotes such endothelium lining by using in vitro pre-seeding 
techniques, or eventually in situ endothelialization.  
This research has been divided into four different steps: (1) combine (i) electrospun nano-fiber 
mats (random and aligned) with (ii) bioactive coatings to generate novel types of scaffolds for 
VG applications; (2) optimize them so as to match mechanical and bio-performances of natural 
blood vessels; (3) evaluate them in terms of EC adhesion, growth, and resistance to flow-induced 
shear for the luminal layer; (4) evaluate them in regard to VSMC adhesion, growth, survival, and 
infiltration of the media layer.  
 
7.1 Electrospun Nanofiber Scaffolds and Plasma Polymerization for 
VG applications 
For the luminal layer of SDVGs, as explained in detail in Chapter 4, we have first combined two 
techniques, namely electrospinning and low-pressure plasma polymerization (L-PPE:N / LP 
coating), to come up with a solution to promote the in vitro endothelialization and to improve 
mechanical properties for SDVGs. Therefore, our first hypothesis was that electrospinning of 
PET can create nanofibrous structures that are more compliant and favor the formation of a 
EC monolayer compared to conventional woven PET or ePTFE structures. 
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Random ePET mats with small pore size were shown indeed to present a nanostructure that 
prevents EC infiltration and promotes the formation of an EC monolayer. This is a more effective 
structure compared with currently used ePTFE and woven Dacron (PET) grafts, where cells 
infiltrate and do not readily form a complete EC monolayer [10]. Our observation by the z-stack 
confocal images confirms a monolayer of ECs on our scaffolds. Neighboring cells interacted with 
each other as well as with the underlying scaffold in a coherent manner, confirmed by the 
expression of specific proteins including VE-cadherin and vinculin.  
In terms of mechanical properties, the Young's moduli of ePET mats, bare or plasma-coated, 
were about 20 ± 6 MPa and 34 ± 7 MPa [10], respectively, therefore above those of natural 
arteries (human coronary artery: 1.5 MPa [339], human femoral artery: 9-12 MPa [255]) 
(Chapter 4). The tensile strength is similar to published values for various arteries and veins. 
Elongation at break was found to be greater than that of arteries in all cases, but not believed to 
be problematic. [10].  
In paper 2 (Chapter 5), Young’s modulus was found to be even higher when fabricating ePET 
with aligned fibers for the media layer of VG, namely more than 100 MPa. As compliance is 
inversely proportional to Young’s modulus, we can expect that the compliance of those 
electrospun mats will be too low. 
In a very recent study by our team [340], a linear analytical model was used to calculate the ratios 
between the elastic modulus and the ultimate strength of an isotropic electrospun mat required to 
achieve both the compliance of the native vessel and the burst pressure of a monolayer VG. The 
results suggest that ePET structures do not meet the mechanical requirements (target ratio: 1.4 
compared with 10 and 40 for random and aligned mats) to be used in the fabrication of a VG.  
These characteristics can be adjusted by chemical means, or by plasma etching, if required. For 
example, wet-chemical treatment (e.g., hydrolysis with concentrated NaOH, among others) has 
so far been the only method proposed in the literature for tuning the mechanical properties of 
electrospun structures [133], but it generally entrains problems of toxicity, environmental impact 
and associated costs, among others [341]. Furthermore, macroscopic damage can result to fibers 
in contact with NaOH [342]. In paper 2 (Chapter 5), we showed that, on the contrary, rapid, 
clean, highly reproducible and environmentally benign plasma etching would offer an attractive 
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alternative to fine-tune the mechanical and surface-chemical properties of ePET fibers [11]. This 
will be discussed further below. 
Other electrospun materials could also be used, instead of ePET. One of the promising materials 
is electrospun polyurethane, which is already commercialized by Nicast Ltd. Electrospun 
nanofabric AVflo™ is a CE certified polyurethane vascular access graft, which is made 
of medical grade biocompatible polycarbonate urethane for hemodialysis patients, improving 
patient care and reducing hospitalization time. It possesses strength, flexibility, durability and 
excellent patency. It is hydrolytically and oxidatively stable and resistant to biodegradation [113, 
343, 344].  
The second hypothesis was that plasma coating can improve the biological properties (EC 
attachment and growth) of electrospun mats.  
Therefore, ePET mats alone or combined with LP coating were tested for EC adhesion, growth 
and retention under flow (Chapter 4). EC adhesion and growth were shown to be increased by 
LP coating. This coating proved to be highly bioactive, reproducible, and sufficiently stable over 
time for different cell types including VSMCs, fibroblasts, and mesenchymal stem cells [163, 
165, 189, 345]. This can be explained by positively-charged chemical functionalities, primary 
amine (-NH2) groups, which quickly attract and bind negatively-charged proteins in culture 
media, leading to formation of integrin complexes. Our observation is in agreement with other 
similar studies which have investigated various plasma-polymerized thin film coatings (e.g. 
cyclopropylamine, 2-methyl-2-oxazoline, allylamine, ethylenediamine, acetylene-ammonia, etc) 
for biomedical applications [346-350]. For example, in a recent study [351], plasma deposited 2-
methyl-2-oxazoline based coatings were shown to reduce biofilm formation and inflammatory 
response, but at the same time promote the cellular growth.  
The HUVEC resistance to flow-induced shear on LP coating was found to be superior to that of 
the bare mats (70 ± 4% and 30 ± 10% of the cells remaining on coated and bare mats, respectively 
(p < 0.05)) (Chapter 4). Substantial cellular detachment still occurs under flow conditions that 
resemble the physiological ones. Our observation is in agreement with other studies addressing 
EC adhesion and retention on various bioactive coated surfaces under physiological shear stress. 
For example, pre-coated vascular prostheses with cell-adhesive substrates (e.g. gelatin, 
fibronectin, collagen, laminin, fibrin, fibronectin/fibrin, etc.) showed increased cell attachment 
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under shear stress [253, 352-355]. Among others, despite different cell seeding densities, our 
flow-dependent retention results were comparable to those of EC on commercial PET/collagen 
(78 % after 40 min and 61 % after 120 min) [356]. Feugier et al. [354] also reported cell retention 
of 66 % and 49 % on type I/III collagen-coated and pristine surfaces, respectively. Moreover, in 
another study, cell retention on laminin coated surfaces dropped significantly to 55 % after 40 
min of flow, and to 50 % after 120 min of flow, compared to static conditions [355]. 
Although LP coating is a promising functional bioactive coating for VG application, the 
feasibility of depositing this coating on the lumen of tubular grafts needs to be investigated. 
Utilizing a plasma jet inside the graft seems to be a plausible solution [357-359], whereby tubular 
VGs are internally LP-coated using a gas mixture passing through the tube. The deposition is 
activated by a plasma created within the tube by high-frequency electric energy applied to the 
precursor gas by means of the plasma jet that could have different configurations (e.g. pen- or 
needle-like, perforated coil-like, or other).  
The originality of this part of the current Ph.D. research is to highlight the feasibility of 
employing LP coating on electrospun nanofiber mats and to demonstrate its ability to enhance 
EC adhesion, growth, and resistance to shear. The LP coating is applicable to a wide variety of 
tissue engineered biomaterials used for vascular applications. This study is the first of its kind to 
investigate the combination of plasma polymerization and electrospinning process for vascular 
graft applications. The results of this part of the work were published in Macromolecular 
Bioscience 2014, 14, 1084–1095 [10]. This was featured by the Editor-in-Chief of the 
Macromolecular Journals on MaterialsViews on August 13, 2014 under the following title 
“Overcoming Clinical Complications of Vascular Prostheses”. It was also honored with several 
prestigious awards including the “Étudiants-Chercheurs Étoiles” Award of the “Fonds de 
Recherche du Québec-Nature et Technologies”, in March 2015, as a promising contribution to 
scientific literature in this field. 
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7.2 CS Grafting on Plasma-Polymerized Electrospun Mats for 
Stable Endothelialization 
Although LP coating was shown to be a promising one to promote HUVEC adhesion, growth and 
resistance to shear stress, cell retention is still limited. Moreover, this underlying LP chemistry is 
thrombogenic and increases the risk of terminal IH through the recruitment of platelets [13].  
Bioactive coatings have been developed to inhibit the coagulation cascade, to prevent platelet 
adhesion and activation, and to promote desirable cell interactions for VG applications[360].  
The development of biomaterials with anticoagulant properties has been actively studied in the 
past. The ECM polysaccharides called glycosaminoglycans (GAGs) have been investigated as 
potential solutions for VG applications. GAG-based bioactive coatings hold promise for this 
application due to their growth-inhibitory effects on VSMCs and their anticoagulant activity 
[361-364]. Among other GAGs, heparin, the most common anticoagulant used clinically, has 
been used in the fabrication of medical devices. Incorporated heparin, on the surface of grafts 
through different approaches, is still known as a gold-standard for the bio-functionalization of 
VGs [365]. Heparin-modified surfaces have shown promising anti-thrombogenic properties 
including reduced activation of coagulation, and inhibited adhesion of plasma platelets and 
proteins in the coagulation cascades [55, 365-368]. 
Immobilization of heparin has been performed through ionic bonding, physical adsorption, bulk 
material incorporation, and covalent linkage. For example, heparin derivative was used to treat 
acellular collagen VGs derived from decellularized subintestinal mucosa. Thrombus formation on 
the heparin-treated grafts after three months was significantly diminished when implanted as 
rabbit carotid artery interposition grafts [369]. ePTFE VGs with heparin coating improved one-
month patency in a rat bypass model [370], while heparin coating on PU grafts also improved the 
patency of VGs [371]. 
Despite many attempts to utilize heparin, its decreased bioactivity after the immobilization 
process is a key issue. This may be due to chemical modification of the heparin, or to physical 
inaccessibility of its binding site [365, 372]. The use of a hydrophilic spacer such as 
poly(ethylene glycol) (PEG) has been shown to improve maintaining the biological activity of 
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heparin by reducing steric hindrance [373, 374]. PEG, itself, can also prevent protein adsorption 
and platelet adhesion to material surfaces [216].  
Additionally, heparin has the ability to bind different biomolecules such as growth factors and 
ECM proteins [375]. However, heparinized devices can trigger neointima formation due to 
inflammatory responses. 
Now, chondroitin sulfate (CS)-containing coatings were already shown to possess anti-apoptotic 
properties for vascular cells, to prevent nonspecific EGF adsorption, promote hemocompatibility 
and prevents platelet adhesion (low-fouling and low-thrombogenic), while promoting HUVEC 
and VSMC adhesion and growth [13, 184, 185]. Therefore, our third hypothesis was that CS 
can further improve the endothelialization and EC resistance to shear stress.  
Therefore, we grafted CS on LP coating deposited on the random and aligned nanofiber 
substrates so as to tackle the thrombogenic properties of LP in case of partial EC detachment 
(Chapter 6). We observed that grafting CS on LP-coated electrospun mats can enhance HUVEC 
adhesion, growth and their resistance to detachment, compared to LP-coated and bare mats 
(82 ± 2% and 76 ± 1% of the cells remaining on CS-coated and LP mats, respectively (p < 0.05)). 
This is a promising finding since the in vitro pre-endothelialization of VGs by ECs prior to 
implantation has been an alternative to increase the patency rate of the VGs [27, 320], but is 
known to be limited by poor cell adhesion and retention under shear flow [354]. Our observation 
is in agreement with other studies using ECM proteins and peptides to reduce the detachment of 
ECs. For example, RGD peptidomimetics (ligands of the αvβ3 integrin) grafted PET showed 
significant increase in cell retention under shear stress [376].  
Several other studies have also explored the use of GAGs such as CS as low platelet adhesion 
layers to prevent platelet adhesion. For example, CS and hyaluronic acid (HA) were used for the 
lumen of VGs [176]. HA grafted to PU was shown to diminish protein adsorption and platelet 
adhesion compared to PEG- or heparin-grafted surfaces. Interestingly, a confluent monolayer of 
ECs was also formed on HA-grafted surfaces [179]. Further in vivo studies are needed to verify 
their bioactivity and performance in more realistic conditions. 
Moreover, EC alignment in the direction of blood flow in the natural arteries is known to increase 
the cells’ capability to resist detachment under shear stress [102, 377]. This is typically achieved 
by a long and resource-consuming method involving in vitro fluid flow preconditioning in a 
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bioreactor prior to implantation [377]. But recent studies have shown an improvement in EC 
attachment by tuning the topography (e.g. orientation) of electrospun fibers [14, 333]. We also 
investigated the effect of fiber alignment on EC adhesion and growth in static culture, and 
resistance under dynamic shear conditions (Chapter 6). To stimulate EC alignment and its 
resistance to flow-induced shear by topographical cues, aligned scaffolds with small pore-size 
were compared with their random counterparts in regard to formation of an EC monolayer. We 
demonstrated that EC resistance to shear stress can be slightly improved if the cells can be 
oriented by tuning electrospun fiber alignment, but this improvement was not very significant.  
From previous studies conducted by our team, it became clear that CS grafting effectively 
inhibited platelet attachment and -activation on flat surfaces. However, thrombosis is a more 
complex process: it is the accumulation of circulating platelets at an injury site, as well as the 
coagulation system that produces thrombin, and ultimately fibrin, to stabilize the clot. It would be 
necessary to confirm anti-thrombogenic properties of CS on 3D ePET mats by in vitro and in vivo 
tests such as specific coagulation cascade measurements, platelet and leukocyte concentration 
measurements, and thromboelastography, to investigate its blood compatibility [378].  
To further extend the investigation, the next logical step could be to examine the potential of CS 
coating combined with other selective biomolecules to capture endothelial progenitor cells 
(EPC), to form a complete monolayer on the lumen as a route to achieve anti-thrombogenicity. 
Generally, in vitro endothelialization is very time-consuming and costly. Therefore, in situ 
endothelialization has recently been extensively explored in attempts to find desirable, fast 
methods [40, 171]. In vivo circulating EPCs could potentially be captured onto a functionalized 
graft for in situ endothelialisation [379]. Unlike in vitro endothelialization, in situ 
endothelialization provides some advantages such as availably upon demand, simpler surgical 
procedures and healthy, functional endothelium formation in vivo [54, 171, 380]. However, 
beside its advantages, it necessitates a complex coating technology to capture and home EPCs. 
The main challenge of in situ endothelialisation is to find a more specific and selective EPC 
capture biomolecule. Once it is selected, the bioactive molecule can be immobilized on the 
biomaterial’s surface via physical adsorption or chemical conjugation [54, 171]. Similar to in 
vitro endothelialization, non-selective cell-adhesive proteins or peptide motifs (collagen [381], 
fibronectin [192], gelatin [194], RGD peptides [193]) have been used to recruit EPCs from blood 
circulation. However, these bioactive coatings are not selective for ECs, so that other circulating 
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cells including platelets, leukocytes and SMCs can also be captured and homed on the lumen, 
leading to IH [194]. Therefore, those bioactive coatings are not desirable choices for enhancing in 
situ endothelialization. Several growth factors and biomolecules have been studied as promising 
candidates for promoting ECP cellular activities [195, 196]. To further accelerate the in vitro and 
in situ endothelialization process, growth factors (GFs) such as vascular endothelial growth factor 
(VEGF) and basic fibroblast growth factor (bFGF) can be immobilized as mitogenic factors [189, 
197-199]. Other GFs such as stromal cell-derived factor-1α (SDF-1α) [192], brain-derived 
neurotrophic factors (BDNF) and nerve growth factor (NGF) [382] can also enhance EPC capture 
and differentiation, and promote endothelialization via paracrine effects. Selective cell-capturing 
biomolecules primarily include antibodies (e.g. Anti-CD34 antibodies (Ab) [210], Anti-VEGFR2 
Ab [383], Anti-VE-cad Ab [384], Anti-CD133 Ab [367]) peptides (e.g. REDV [385], YIGSR 
[386], TPS [365], CRRETAWAC [387], etc.) and aptamers (i.e. short single-stranded 
oligonucleotides [388]). Despite a growing number of research efforts on in situ 
endothelialization and its importance in VG engineering, its clinical application is still limited 
due to the gap between research progress and clinical products. In situ endothelialization is 
therefore still relatively new and complex. The challenge is not only to capture and differentiate 
EPCs, but also to maintain the proper and durable function of an EC monolayer. An optimal 
strategy for future success of in situ endothelialization would be the combination of capturing 
biomolecules, growth factors and careful materials selection.  
The originality of this part of the current Ph.D. research was to investigate the effects of 
topography and bioactive coatings on EC adhesion, growth and resistance to shear stress. The 
results of this part of the research were published in Biomacromolecules, 2017, 18 (1), pp 303–
310 [12]. 
 
7.3 Combination of Electrospinning and Plasma-Etching for VG 
Applications 
The media layer of native blood vessels contains VSMCs and circumferentially-aligned elastin 
and collagen fibers, which are essential for maintaining their mechanical strength and vasoactive 
responsiveness [389]. In addition to the VSMCs’ circumferential alignment, their infiltration into 
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the bulk of the vascular scaffolds is another important factor for the regeneration of SDVGs. For 
this purpose, suitable pore size and highly interconnected porous structure of the scaffolds are 
vital [390]. The main obstacle has been excessively high mechanical properties in the 
circumferential direction of aligned mats (most particularly, their high Young’s modulus). For 
this layer, we thus fine-tuned the processing parameters for electrospinning and plasma etching to 
improve the morphological, mechanical and biocompatibility properties of the final mats 
(Chapter 5).  
Our fourth hypothesis was that combining electrospinning and plasma-etching can create 
aligned structures that are morphologically and biologically suitable for VSMC infiltration 
and better compliance.  
To this aim, the effects of low- and high (atmospheric-) pressure plasma-etching on mechanical, 
morphological, chemical, and biocompatibility properties of aligned ePET mat scaffolds was 
thoroughly studied, specifically for VG applications. We found that our aligned ePET mats with 
large pore size enable VSMCs to induce partial cellular influx and adhesion to the mats. The final 
mats enabled the VSMCs to localize to the graft surface and partially migrate within the mats’ 
thickness (as confirmed by histology in Chapter 6). While final aligned ePET mats designed for 
the media layer have demonstrated the ability to facilitate VSMC infiltration within the scaffold 
bulk, further improvements are still necessary to increase pore size. The latter is necessary to 
facilitate the infiltration of VSMCs, while also exchanging oxygen and nutrients. Currently, cell 
infiltration is localized in some sections of the scaffold, while other deeper areas have yet to be 
infiltrated. This was in agreement with other developments in TEVG of VGs, where robust 
cellular influx, proliferation, and remodeling ultimately form the medial SMC layer [108]. 
Therefore, to resolve these issues, we propose to directly combine living cells into fibers, and to 
generate “living scaffolds”; this will be a versatile new method of bio-fabrication: A 
revolutionary new technique, electrospinning of cells, could provide ‘living fibers’ composed of 
live cells and a biopolymer, mixed with a variety of other biomolecules (including proteins, 
growth factors, among others). Many materials can be used to create such electrospun “living 
fibers”, including collagen, alginates, chitosan, gelatins, and newly-synthesized materials that 
mimic certain features of natural ones, with the ability to signal to cells and allow them to 
infiltrate the finished fibers/scaffolds. This technique will also enable direct handling of a wide 
range of cells (including primary- and stem cells). The resulting living fibre can either be 
128 
randomly arranged, or directed to take specific orientations, e.g. for the media layer of a VG. It 
also has the capacity to handle a wide range of cells without causing genetic, genomic or 
physiological damage in vitro [391, 392].  
Our results showed significant decreases in Young’s modulus following LP-, HP-, and asher-
induced plasma etching (Chapter 5). Among the three etch techniques, the plasma asher (with 
pure oxygen for 5 min) seems to be most advantageous in terms of rapidity, minimal apparent 
damage to fiber surfaces, along with efficacy in changing mechanical properties (reduction in 
Young’s modulus from 100 MPa to less than 20 MPa). These changes could be related to the 
reduction in fiber diameters and to nano/ micro-pit surface defects observed after extended LP 
and HP plasma treatments. Chain scissions, accompanied by molecular weight reduction, were 
observed with all three etching techniques, according to intrinsic viscosity measurements. On the 
other hand, elongation at break was found to be less than that of native arteries in all cases. 
However, even though uni-axial tensile testing allows one to assess elastic properties of the 
fabricated scaffolds, it does not provide a direct measure of compliance (a multi-axial property). 
Therefore, further tests are desirable, particularly ones designed to evaluate compliance and 
fatigue resistance of tubular multilayered graft prototypes. A significant increase in concentration 
of O-bearing functional groups was also observed. Therefore, plasma etching can offer good 
control for tuning mechanical, morphological and surface-chemical properties of electrospun 
fibrous mats. Although this technique is promising, the major limitation of the approach is the 
multi-steps required for fabrication of a VG prior to implantation.   
The originality of this part of this Ph.D. thesis was, for the first time, to investigate the 
combination of electrospinning and an appropriate plasma-etching technique on (3D) scaffold 
for the media layer of SDVGs. This enables one to achieve finely-controlled structural, 
mechanical and surface properties that are required for VG applications. The results of this part 
were published in Plasma Processes and Polymers 2015, 12, 314–327 [11]. This research was 
featured on MaterialsViews on December 1, 2014 under the following title “Plasma etching for 
better vascular grafts”. 
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7.4 CS and Oriented Tethered EGF for Medial Layer of VGs 
Oriented immobilization of EGF on CS had been previously developed by our team [185]. We 
found that: i) this combination was anti-apoptotic for VSMCs, ii) these biomolecules could be 
immobilized on amine-rich plasma coated PET films; and iii) the coatings improved the survival 
of rat and human VSMCs in serum-free medium.  
Our fifth hypothesis was that oriented immobilization of EGF on CS on 3D aligned 
electrospun mats can improve VSMC infiltration inside the structures and increase their 
survival in serum-free medium. 
In line with previous research in our team, for the first time, we transferred these novel bioactive 
coatings (LP + CS + oriented tethered EEGF) on 3D aligned ePET mats with large pore size, so 
as to increase adhesion, growth, survival and infiltration of VSMCs (Chapter 6). Our findings 
showed that CS+EEGF coatings led to dramatically increased VSMC-growth and -survival in 
serum-free medium.  
This step enabled us to demonstrate that this bioactive coating was transferable to any type of 
substrate, including 3D ePET which is extremely porous and chemically inert, without having to 
modify the previously-developed protocol. This work also highlights the versatility of this 
approach to generate bioactive surfaces through the appropriate selection of bioactive moieties 
for VG applications. 
The originality of this part of this Ph.D. thesis was to transfer innovative bioactive coatings 
(LP+CS+ oriented tethered EEGF) on 3D aligned ePET mats for media layer of VGs. The results 
of this part of the work were published in Biomacromolecules, 2017, 18 (1), pp 303–310 [12].  
 
While the results of this part of the project are promising, they also demonstrate important areas 
where further research is required. To further mimic the dynamic physiological conditions, it is 
essential to fabricate composite electrospun tubular grafts and evaluate them in a bioreactor, 
instead of static cell culture conditions. Furthermore, to appropriately challenge these bioactive 
coated grafts and to assess their efficacy (e.g. endothelialization, anti-clotting, compliance and 
thrombin generation properties under flow condition), our optimised candidate tubular design 
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should be directly compared in a large animal model, to both an unmodified tube control and the 
current bioactive-coated structure. 
Although determining the ideal cell culture medium, cell density, and cell lines proved to be 
challenging tasks, further studies would be necessary to investigate the co-culture of ECs and 
SMCs. 
It would also be necessary to use our bioactive coated scaffolds as cell-free VGs to evaluate in 
situ endothelialisation, by taking advantage of host self-remodeling ability: it possesses more 
remarkable advantages including avoidance of donor site morbidity, absence of extensive in vitro 
cell culture, easy storage and transport, ready availability, and potentially closer clinical adoption. 
Therefore, further long-term in vivo investigations need to be done to study the efficacy of the 
electrospun materials and their porosities, the use of bioactive coatings to inhibit thrombosis and 
to promote endothelialization. Such studies will help elucidate the true potential of electrospun 
VGs and enable this proposed VG engineering technology to reach clinical investigation. 
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CONCLUSION 
In conclusion, this study has demonstrated the possible combination of electrospinning, plasma 
polymerization, plasma etching, and grafting of biomolecules (CS, and EEGF) for engineering 
VGs that can provide an adequate scaffold for the luminal and media layers of SDVGs. It enables 
one to achieve the finely-controlled structural, mechanical, and surface properties that are 
required for VG applications. The improvements proposed in this thesis will create great 
innovative advances to help overcome the gaps in current VG technologies, inadequate 
substitutes for the most common occlusion-prone blood vessels (i.e. small-diameter vessels) in 
the human body. The proposed research not only addresses urgent health problems in the world’s 
aging population, but also helps develop technology for one of the most highly demanding 
medical device markets. The efficacy of cell attachment to VGs is currently limited by poor 
resistance to high shear-stress under blood flow, and by compliance mismatch of SDVGs. So far, 
only the patients’ own veins or arteries have been suitable choices for graft material, but these are 
only effective for 5-10 years and typically have limited success rates. Therefore, synthetic 
SDVGs remain the best alternative for vascular surgery. Optimization and testing in animal 
models will benefit transfer to industry and clinics, hence also the economy.   
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